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 Résumé  
RESUME  
 
1 - INTRODUCTION  
 
La complexation d’arènes par le fragment « Cr(CO)3 », bien que ne diminuant pas 
l’aromaticité, modifie de manière spectaculaire les propriétés du noyau aromatique.[1] En 
particulier, les propriétés électroattractrices du chrome rendent possible l’attaque des 
nucléophiles sur l’arène (Schéma 1).[2] Cette attaque s’effectue exclusivement sur la face 
de l’arène opposée au fragment Cr(CO)3 conduisant à un complexe cyclohexadiényle 
anionique. Ainsi l’addition d’un électrophile donne comme résultat l’alkylation, allylation, 
ou propargylation de la unité du Chrome. Selon la nature de l’électrophile et de l’arène 
utilisée, l’élimination réductrice peut être précédée ou non de l’insertion de CO.[3]   
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Schéma 1 
 
L’addition des nucléophiles sur des complexes présentant un groupe oxazoline se fait sur la 
position ortho (Schéma 2). Pour ce type de complexe, les groupes alkyles permettent 
l’insertion de CO, mais c’est une voie très minoritaire pour l’allyl (< 15 %) et inexistante 
pour le propargyl. Quand il y a insertion de CO, est possible l’addition d’un troisième 
électrophile par formation d’un énolate. 
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Schéma 2 
 
La déaromatisation des complexes [Cr(arène)(CO)3] peut se faire de manière asymétrique, 
les méthodes existantes sont : 
a) Utilisation d’un auxiliaire chiral ligand du chrome, en remplacement d’un groupe 
CO.[4]  
b) Utilisation d’un complexe à chiralité planaire.[5]  
c) Utilisation d’un nucléophile chiral formé par la coordination du nucléophile avec 
un ligand chiral.[6]  
d) Utilisation d’un auxiliaire chiral sur l’arène. En particulier l’utilisation des 
oxazolines et hydrazones chiraux a donné les produits avec très bonnes 
diastéréosélectivites.[7]  
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2 - COMPOSES CYCLIQUES [6,n] DE JONCTION CIS  
2.1 – SYNTHESE RACEMIQUE DES SYSTEMES BICYCLIQUES 
 
La formation des cycles est une des étapes les plus importantes dans la synthèse des 
produits polycycliques. Nous pensions que l’utilisation de la réaction de déaromatisation 
des complexes arène chrome, en combinaison avec la réaction de métathèse pouvait être 
une route très efficace pour la synthèse des systèmes cycliques (Schéma 4).   
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Schéma 4 
 
La réaction de déaromatisation a été effectuée sur le complexe 12 utilisant du vinyllithium 
et de l’iodure de méthyle, suivie de la formation de l’énolate pour introduire le méthyle en 
position quaternaire (Schéma 5). Ensuite, l’allylation a conduit au diene 35 qui par réaction 
de métathèse donne le système bicyclique 43. 
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 Résumé  
La synthèse du système [6,8] a été effectuée d’une façon similaire mais avec addition 
d’allylithium comme nucléophile à la place de vinyllithium (Schéma 6). 
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Pour synthétiser le système cyclique [6, 5], le diene 38 a été obtenu a partir de la méthyl 
cétone 34 pour une réaction de type Mannich (Schéma 7). Malheureusement, la métathèse 
de l’énone n’a pas marché même en utilisant le 2éme génération de catalyseur de ruthénium. 
Cependant, nous avons été capables d’obtenir le cycle à 5, par réduction de l’énone suivi 
de la métathèse de l’alcool correspondant.    
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D’autre part, la réaction du type Mannich sur la méthyl cetone 32, a donné l’énone 41 qui a 
pu ensuite être cyclisée pour obtenir le système cyclique [6,6] 44 avec un rendement 
modéré (Schéma 8). Un meilleur rendement a été obtenu par réduction de l’énone 41 suivi 
de la réaction de métathèse pour obtenir l’alcool 49. 
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2. 2 - SYNTHESE DE SYSTEMES BICYCLIQUES ENANTIOENRICHIS 
 
Dans le but d’obtenir des systèmes bicycliques énantiomériquement enrichis, nous avons 
décidé de préparer le complexe 60 (Schéma 9). L’attaque nucléophile avec vinyllithium 
suivi du piégeage de l’anion avec l’iodure de méthyle et l’introduction du méthyle 
quaternaire a donné le cyclohexadiéne 61 avec bon excès diastéréomérique.  
Puis, la méthode mise au point pour les systèmes racémiques a été utilisée dans la synthèse 
du système bicyclique 63, ce qu’a donné l’aldéhyde énantioenrichie 55 par deprotection de 
l’oxazoline.    
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La même séquence des réactions utilisant le complexe RAMP-hydrazone 67 a donné 
comme résultat le nitrile énantiopure 71 (Schéma 10). Pour mesurer l’excès 
énantiomèrique il a été converti en l’aldéhyde 55 par réduction avec DIBAL. 
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3 – SYNTHESE DE LA STRUCTURE CENTRALE DES OTTELIONES 
Les Otteliones A et B sont deux diastereoisomères isolés de la plante marine Ottelia 
Alismoides en 1998 (Schéma 11).[8] L’intérêt des ces composés réside en son activité 
biologique et sa structure 4-mèthylencyclohexe-2-one très particulière.[9] 
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3. 1 – SYNTHESE MOYENANT PROTONATION DIASTEREOSELECTIVE 
 
L’idée était d’utiliser la méthode développée pour la synthèse de systèmes bicycliques dans 
la synthèse de la structure centrale de l’Ottelione. Cependant pour la cyclisation nous 
avons besoin d’un diene avec configuration cis. L’isomérisation de l’enone trans à l’enone 
cis a pu être faite par protonation distéréosélective suivi de réduction du groupe carbonyle. 
Finalement, le cycle à 5 a été obtenu par réaction de métathèse (Schéma 12).     
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Schéma 12 
 
Le problème de cette voie de synthèse c’est l’obtention des faibles rendements qui rend 
difficile l’obtention de suffisamment de produit pour continuer la synthèse de l’Ottelione. 
   
3. 2 – SYNTHESE MOYENANT REDUCTION SELECTIVE DU CYCLOHEXADIENE 
 
Une autre alternative pour arriver à la structure centrale des otteliones a été la réduction du 
degré d’oxydation du cycle à 6 suivi de la cyclisation du diene trans.  
Ainsi nous avons pu obtenir l’enone 121 par réduction sélective du cyclohexadiene avec 
DIBAL suivi d’une réaction de type Mannich (Schéma 13). La réduction du groupe 
carbonyle a ensuite conduit à l’alcool allylique 124 qui par hydrolyse et métathèse a donné 
le système bicyclique 132. Finalement la protection du groupe carbonyle suivi de 
l’oxydation de l’alcool a conduit à l’énone 136. 
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4 – SYNTHESE DE LA STRUCTURE CENTRALE DU TAXOL 
 
Le Taxol est un diterpene isolé en 1973 de la plante Taxus brevifolia. Sa structure et ses 
importantes propriétés biologiques font de cette molécule un objectif synthétique très 
intéressant.[10] 
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 Résumé  
4.1 - INTRODUCTION DU CYCLE A COMME ELECTROPHILE DANS LA 
REACTION DE DEAROMATISATION 
 
Le but était d’accéder au seco-taxane 141 par un couplage des cycles A et C par la réaction 
initiale de déaromatisation (Schéma 15). Finalement, la fermeture du cycle aurait été 
réalisé par une réaction de Nozaki-Hiyama-Kishi.[11] Ainsi, cette élégante approche 
permettrait d’obtenir stéréosélectivement le squelette carboné du Taxol. 
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Schéma 15 
 
Cependant, après l’addition de vinyllithium et réaction avec l’electrophile 140, seul des 
traces de produit sans insertion de CO ont été obtenues (Schéma 16). 
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Schéma 16 
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4. 2 – INTRODUCTION DU CYCLE A APRES LA REACTION DE 
DEAROMATISATION 
 
Une autre stratégie a été envisagée. Le cycle A a été introduit une fois la réaction de 
déaromatisation effectuée. La déaromatisation du complexe [Cr(CO)3(p-methoxy 
oxazoline benzène)] (12) a été realisée avec le dithianyllithium comme nucléophile. Puis le 
cycle A pourrait être introduit, soit par déprotonation du noyau dithiane et addition 1,4, soit 
par la formation de l’aldehyde 158 suivi d’une attaque nucléophile du dérive du lithium 
159.  Finalement, la fermeture de cycle pourrait être réalisée par une réaction aldol.  
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Schéma 17 
 
La séquence d’addition du 2-lithio-1,3-dithiane/iodure de méthyle suivi de l’introduction 
du centre quaternaire a donné le cyclohexadiene 154 (Schéma 18).  
 
 Résumé  
(CO)3Cr
OMe
ON
S S
S
S
O
H
OMe
ON
1. , nBuLi, THF / toluène, 
- 78 °C
2. MeI, DMPU, CO
3. NaOEt, MeI, THF
58 %
12 154  
Schéma 18 
 
La réaction de dearomatisation  sur le complexe RAMP-hydrazone 67 a permis obtenir le 
produit avec un excellent excès diastéréoisomérique. 
L’utilisation de cette réaction dans la synthèse du squelette du Taxol est en cours 
d’investigation.  
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 Chapter I  
 1
I – INTRODUCTION 
 
The development of new synthetic transformations, which proceed with high atom 
economy, a minimal protection strategy and which enable multiple transformations in the 
same reaction vessel, is an exciting challenge of modern day synthetic organic chemistry. 
The new methods have to provide the products with total chemo- and regioselectivity, and 
offer a high degree of stereocontrol. A remarkable way to achieve this goal is the 
transformation of aromatic systems to more functionalised organic compounds.  
Arenes and aromatic heterocycles are widely available, often at low cost, and highly stable. 
They can be easily derivatised by electrophilic subtitution or via ortho-lithiation and 
quenching with suitable electrophiles. Dearomatisation of the arenes can provide in a one-
pot reaction an alicyclic system which contains unmasked functionality, new carbon-
carbon bonds and new stereogenic centres. The difficulty in these kinds of reactions is the 
disruption of the aromatic p system. Indeed, addition of one substituent to a non-activated 
arene is always accompanied by elimination and rearomatisation of the arene.  
In order to address these goals a number of elegant procedures which enable the 
dearomatisation of arenes have been developed and adopted. 
 
I. 1 – DEAROMATISATION OF NON COMPLEXED ARENES 
 
There are a number of efficient synthetic methods available that enables arenes to be 
transformed into alicyclic molecules, the most established is the Birch reduction.[1] It is 
carried out with an alkali metal in liquid NH3 solution usually with a co-solvent such as 
THF and always with an alcohol or related acid to protonate intermediate radical anions or 
related species. The regiochemistry of the reduction depends on the electronic nature of the 
arene substituents. Electron-withdrawing groups give 2,5-cyclohexadienes whereas 
electron-donating substituents give 1,4-cyclohexadienes.  
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Figure 1 
 
The group of Schultz have used chiral amides to provide high diastereoselectivities in this 
reaction (Scheme 1).[2] The method consists of generating the amide enolate by Birch 
reduction and then a diastereoselective alkylation to give the product.  
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CH2CH2CH=CH2
              
d. e. > 98 %
M = Li, K
 
Scheme 1   
 
In a conceptually different approach, Hudlicky and Ley have developed access to 
synthetically important cis-cyclohexadienediols by microbial oxidation of benzene 
derivatives with Pseudomonas putida (Scheme 2).[3] This method is compatible with a 
broad range of different functional groups, and the dihydroxy 1,3-cyclohexadiene is 
obtained as enantiomerically pure compound. The inconvenience of this method is that 
only one of the enantiomers is accessible. 
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R R
OH
OH
P. Putida
O2, H+
R = halogen, alkyl, ether, tioether, vinyl 
Scheme 2 
 
Another classical method is the dearomatisation of naphthalene derivatives (Scheme 3). 
Less energy is needed to break the aromaticity of one of the two aromatic cycles and the 
use of an electron-withdrawing substituent, as an oxazoline, is enough to activate the ring 
towards nucleophilic addition. Using this strategy, Meyers and co-workers have used chiral 
imines and oxazoline naphtyl derivatives to obtain, after nucleophilic/electrophilic 
addition, trisubstituted dihydronapthalenes with excellent diastereoselectivities.[4]  
 
NO
Ph OMe
NO
Ph OMe
E
R1. RLi
2. EX
R = Me, Et, nBu, tBu, Ph, 4-chlorobutyl
EX = iPrOH, TFA, MeI  
Scheme 3 
 
Following the same concept, over the last ten years new methods of dearomatisation 
reactions have been developed. They are based on the use of electron-withdrawing 
substituents on the arene that make possible the nucleophilic addition. 
Yamamoto and co-workers used the coordination of aluminium tris(2,6-
diphenylphenoxide) to the carbonyl group of simple aromatic aldehydes and ketones to 
activate the ring towards nucleophilic alkylation (Scheme 4).[5] By this method they were 
able to dearomatise benzaldehyde, acetophenone and napthylketones. 
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R'
O
R''
OAl
Ph
Ph
Al
R'
O
R''
 R'''
R''
O
R'( )3
Toluene / THF
R'''Li
R''' = nBu, sBu, tBu R' / R'' = H, Me  
Scheme 4 
 
The group of Barluenga has used the electron-withdrawing ability of the pentacarbonyl 
metal fragment of Fischer carbene complexes, to activate the ring of 
menthyloxy(aryl)carbene complexes toward nucleophilic attack (Scheme 5).[6] By this way 
they obtained the diastereoisomerically enriched cyclohexadiene derivatives. 
 
(CO)5Cr
O
(CO)5Cr
O
R
O
O
R
(CO)5Cr
O
OMe
Me
1. RLi, THF
   - 78 °C
2. MeOTf, Et2O
0 °C
C5H5N+O-
Et2O
R = sBu 45 %, d.r.= 1.9 : 1 
1. tBuLi, THF
   - 78 °C
2. MeOTf, Et2O
0 °C
d.r. > 99 : 1
31 %
R = tBu 41 %, d.r.= 1.4 : 1 
 
Scheme 5 
    
Finally, Clayden and co-workers showed that the use of bulky N-benzoyl amides makes 
possible the nucleophilic ortho addition of organolithium reagents, forming an extended 
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enolate which was later alkylated at its terminus to afford the dearomatisated product 
(Scheme 6).[7]  
 
OMe
NO
OMe
NLiO
R
OMe
NLiO
R
E
H
H
RLi, THF
0 °C
E+
R = Me, nBu, sBu E+ = MeI, BnBr, EtI, cyclobutanone 
Scheme 6 
 
I. 2 – DEAROMATISATION OF ARENE-METAL COMPLEXES 
 
Another different approach is the dearomatisation of transition-metal arene complexes. The 
complexation can be done in order to increase the electron density, and render the aromatic 
system active towards electrophiles, or in order to decrease the electron density and make 
possible the attack by nucleophiles.  
 
I. 2. 1 – DEAROMATISATION BY DIHAPTO-COORDINATION 
 
In the h2-coordination, the metal-arene bond is stabilised primarily by the interaction of 
filled metal d p orbitals with the p* system of the arene. This interaction makes the p 
aromatic system more electron-rich, similar to what it is observed for organic arenes 
bearing electron-donating groups.  
A large number of transition metal systems are known to form stable h2 complexes with 
aromatic molecules,[8] however, only d6 octahedral metal complexes have been shown to 
increase the reactivity of the arene towards electrophilic attack.[9] First, this mode of 
activation was only known for pentaamineosmium (II) systems, however, in the past few 
years it has been extended to rhenium (I)[10] and molybdenum (0) complexes.[11]  
Osmium complexes of phenols,[12] anilines,[13] and anisoles[14] undergo electrophilic 
addition exo to the metal moiety with a high regiochemical preference for para addition 
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(Figure 2). Then treatment with base followed by heat affords the aromatic product 1. 
However, what is more interesting is that the stable 4H-arenium species which result after 
electrophilic addition can be treated with a nucleophile to provide, after decomplexation 
(CAN or AgOTf), a cis-1,2-disubstituted cyclohexadiene.[13,15] If naphthalene or benzene 
complexes are used, what it is obtained is the 1,4-addition product.[16]  
 
X X
E
X
E
Nu
X
E
[Os]2+ [Os]2+
[Os]2+
E+
Nu-
+ Base
Heat
Decomplexation
Further osmium 
directed reactions
X = OR, OH, NR2
1
 
Figure 2 
 
I. 2. 2 – MANGANESE MEDIATED DEAROMATISATION 
 
Complexation of arenes with tricarbonyl manganese decreases the electron-density of the 
arene system and allows the attack by a broad range of nucleophiles (Figure 3).[17] 
However, the simple addition of a nucleophile followed by cleavage under acidic or 
oxidative conditions generally leads to either the rearomatised product or, where the 
dearomatised product is isolated, a number of diene isomers. 
(CO)3Mn
Nu
(CO)3Mn
Nu
Nu
Nu
Oxidation
Isomeric mixtures
H+
Nu = PhLi, MeLi, RMgBr, LiAlH4,
ketone enolates, malonates
2
 
Figure 3 
 
 Chapter I  
 7
Therefore, routes to dearomatised products require treatment with two nucleophiles. 
Through this chemistry, a number of dearomatised products have been synthesised with 
interesting selectivities. The nature of the product, either a cis or trans disubstituted 
cyclohexadiene, depends very much on the nature of the nucleophiles involved.[18] The 
nucleophiles that can be used are Grignard reagents, ketone enolates, malonates, and 
hydride (LiAlH4). Also it is possible to use hydroxyl, cyano, and azido anions, but these 
have not been studied extensively.[17] Nucleophilic addition occurs exo to the Mn(CO)3+ 
unit and the reaction results in the neutral stable cyclohexadienyl complex 2. Then, there 
are two general strategies available to obtain the dearomatised product. The first and more 
direct method requires treatment of 2 with a second nucleophile (Figure 4). Addition again 
occurs exo to the manganese unit at a cyclohexadienyl terminus, and this affords a cis-
substituted cyclohexadiene.[18] However this reaction is limited to very reactive 
nucleophiles.  
 
R
(CO)3Mn
R
R'
Ph Ph S S
CN
CO2Et PhPh
Ph
reactive 
nucleophiles/O2
R = MeLi, LiAlH4
R' = -
-
-
--
2
 
Figure 4 
 
The more general method available for double nucleophilic addition to an arene manganese 
tricarbonyl complex requires ‘reactivation’ of the cyclohexadienyl species. Treatment of 2 
with NOPF6 in dichloromethane results in substitution of a CO ligand by NO+ to give 
complex 3 (Figure 5). This complex is more electrophilic than the parent complex, and can 
react with less reactive nucleophiles.[19] For example, they can be reacted with useful 
carbon donors, such as Grignard reagents, although a replacement of a CO ligand by PMe3 
is needed to obtain the dearomatisated diene. [20] Phosphorus and nitrogen nucleophiles 
have been shown to add, but perhaps the most useful conversions are those resulting from 
either hydride or carbon nucleophile addition.[19-21] Hydride and stabilised enolates add 
 Introduction  
 8 
directly to the unsaturated ligand. The addition of hydride has been shown to be endo, 
while stabilised carbon nucleophiles adds exo to the manganese unit.[22] The methods 
described above yield, after oxidative decomplexation of the manganese unit, mono- and 
cis-disubstituted cyclohexadienes respectively.  
When phenyl- and methyllithium reagents are added to the 
[Mn(CO)2(cyclohexadienyl)NO] the mechanism is different. The nucleophilic attack 
occurs now at one of the CO ligands, and is followed by rapid reductive elimination of the 
resulting cyclohexadienyl/acyl moieties and decomplexation to yield a trans-disubstituted 
1,3-cyclohexadiene.[20] 
 
R
(CO)3Mn
R
R'
R
O
R'
R
(CO)2NOMn
1. R'M
2. Me3NO
NOPF6
+
R'Li
R' = Me, Ph
2 3
 
Figure 5 
 
I. 2. 3 – [Cr(h6-ARENE)(CO)3] COMPLEXES  
 
The arene tricarbonyl complexes of chromium are often crystalline compounds that are 
stable to air in the solid state and can be stored for long periods provided they are kept 
away from light. In solution they are moderately air sensitive. The preferred method for the 
synthesis of [Cr(arene)(CO)3] complexes is thermolysis of Cr(CO)6 under an inert 
atmosphere (N2 or Ar) in the presence of an excess of the arene in a high-boiling solvent. 
This can be the arene itself or a variety of solvent mixtures,[23] the most frequently adopted 
procedure is a mixture of the arene, dibutyl ether, and THF.[24] Milder complexation 
conditions are possible with suitable [Cr(CO)3L3] (L = CH3CN, Py, NH3) precursors, 
which allow higher compatibility with arenes bearing functional groups and higher chemo- 
and diastereoselectivity.[25] Complexation of arenes can be carried out at room temperature  
by reaction of the arene with [Cr(CO)3(NH3)3] in the presence of BF3.Et2O. This method is 
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particularly suitable for condensed aromatics.[26] Finally, complexation can also be carried 
out by arene exchange in [Cr(CO)3(naphthalene)].[27] This method has been widely used 
due to highly facile arene exchange and the ease with which this complex can be 
handled.[27, 28]  
The chemistry of the [Cr(arene)(CO)3] complexes is extensive (Figure 6). The h6-
coordinated arene ring is susceptible to a number of synthetic manipulations due to the 
electron withdrawing properties of the Cr(CO)3 unit. The ring hydrogens have increased 
acidity and the [Cr(arene)(CO)3] complexes can be easily metalated with lithium amides or 
organolithium reagents.[29] Benzylic anions are readily formed by deprotonation, but 
despite the predominantly electrophilic character of the Cr(CO)3 unit, benzylic 
carbocations are also readily stabilised.[30] In addition to this, the Cr(CO)3 moiety has 
found widespread use as a ‘stereodirecting’ group in reactions of side chains attached to 
the arene ring.[28a] 
 
R
Y
H
X
H
Cr
OC
CO
CO
Selective side 
chain reactions
    Stabilisation of benzylic 
carbanions and carbocations
Increased acidity of 
ring hydrogens
Steric directing groups
Nucleophilic addition
    to ring carbons
 
Figure 6 
 
Most interesting for us is the nucleophilic addition. The electron-withdrawing properties of 
the Cr(CO)3 group enable direct attack by nucleophiles on the arene ring exo to the 
Cr(CO)3 moiety. The range of nucleophiles that can be used is limited by the moderate 
electrophilicity imparted by the Cr(CO)3 group (comparable to an arene nitro substituent), 
the activation of the arene hydrogens toward deprotonation, and the potential attack by the 
nucleophile at CO. 
It has been shown that the reagents that can be added are: alkyllithium, alkenyllithium, 
lithium enolates of esters and nitriles, lithium dithianes, potassium enolates of ketones and 
LiBHEt3. However, malonates, Grignard reagents and lithium enolates are not reactive 
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towards arene chromium complexes.[31] Nevertheless, the reactivity of the 
[Cr(arene)(CO)3] complexes towards nucleophiles relies also on the substituents of the 
arene. When electron-withdrawings substituents, such as an imine, oxazoline, or 
hydrazone, are attached to the aromatic ring, hard organolithium reagents (e.g. nBuLi, 
MeLi) will act as nucleophiles rather than as bases as is the case in reactions with 
[Cr(benzene)(CO)3].[32]  
Nucleophilic additions to substituted arene complexes are often highly regioselective 
(Figure 7). This and the mild reaction conditions are major advantages of this 
methodology. Resonance donor substituents on the ring direct attack to the meta 
position,[31c,33] while bulky substituents and acceptor substituents direct preferentially to 
the para position (Figure 7).[34] Functional groups that can efficiently coordinate the 
incoming organolithium reagent are orthodirecting.[32]  
R
(CO)3Cr
R'
HR
Cr(CO)3
 
R
R'
R
R'
R
R'
R'Li
-
 
R Product R Product 
MeO meta Imine Ortho 
NMe2 meta Oxazoline Ortho 
Me, Et meta / ortho SiMe3 Para 
Cl ortho / meta CMe3 Para 
Hydrazone ortho / meta CF3 Para 
 
Figure 7 
 
Once the nucleophile has been added, there are different possibilities. Oxidation (I2, 
Ce(IV), Fe(III), O2) results in a overall reaction where one new substituent has been 
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introduced on the arene (Figure 8a). This kind of reaction has been thoroughly investigated 
and applied in the synthesis of natural products by the group of Semmelhack.[35] 
Alternatively, the intermediate anionic cyclohexadienyl complex can be reacted with other 
electrophiles and, depending on their nature and the starting complex, results in different 
reaction pathways and products. It has been shown that in some cases trityl cation can be 
used to abstract the syn-hydride at the cyclohexadienyl sp3 carbon center to yield the 
substituted product with an intact arene-metal bond (b).[28g,36] This method has been used to 
provide a new asymmetric route to planar chiral complexes.[37] Another sequence that 
allows the conservation of the metal-arene bond are ipso-, cine-, and tele-substitution 
reactions (c). The prerequisite for rearomatisation via this method is the presence of a 
leaving group.[38] Finally, trapping with a strong acid or an electrophile, give the 
dearomatised product (d,e). 
 
(CO)3Cr
R
R'
R
(CO)3Cr
R'
Cr(CO)3
R'
R
Cr(CO)3
R'
R
R'
R''
R' O
R''R R
R'
R
R'Li
-
c) H+ 
b) Ph3C+
d) H+
or
e) R''X
(+ isomers)
R = leaving 
    group
a) oxidation
 
Figure 8 
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I. 2. 3. 2 – Chromium Mediated Dearomatisation 
 
The first successful reaction of dearomatisation was accomplished by protonation with a 
strong acid.[31a,39] Unfortunately the reaction yields mixtures of isomeric cyclohexadienes, 
whose distribution depends on reaction conditions. In general the major product is the most 
stable diene.[35] 
 
(CO)3Cr
CN
(CO)3Cr
 
CN CN CN
Me2(CN)CLi
-
1. TFA, THF, 
- 78 °C to rt
2. I2
90 %
+ +
90 : 7 : 3
 
Scheme 7 
More interesting is the trapping of the cyclohexadienyl chromium unit with an electrophile 
to afford a disubstituted cyclohexadiene. Given the modest nucleophilicity of anionic 
[Cr(CO)3(cyclohexadienyl)] complexes, reactions with carbon electrophiles are subject to 
more limitations than simple protonations but have the advantage of being highly 
regioselective. Specifically, these reactions are successful when carbanion dissociation 
from intermediate 4 is slow compared to the reaction with the carbon electrophile. The 
sequential addition is usually carried out as a one-pot reaction, and the proposed reaction 
sequence is that shown in Figure 9. Thus, treatment of 4 with an electrophile results in 
alkylation, allylation, or propargylation at the chromium center. This is followed by CO 
insertion or by endo migration to the h5-cyclohexadienyl ring system to give 5. The diene-
Cr(0) bond in 5 is labile, and decomplexation gives a product of formal trans addition of a 
nucleophile and an electrophile across an arene double bond, which in contrast to the 
nucleophile addition/protonation sequence, has an excellent 1,2-regioselectivity. This is 
due to an irreversible transfer of the acyl, allyl, or propargyl group to one of the two 
termini of the cyclohexadienyl ligand. 
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1 1 1
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2 2
3
-
1
-
2
1
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L
+
2
4 5
 
Figure 9 
 
Carbonylation follows the expected order based on migratory aptitude of R2 to an adjacent 
CO group: ethyl > methyl > benzyl, allyl, propargyl, but the presence of substituents on the 
arene ring also determines whether migratory CO insertion precedes the reductive 
elimination. In the case of benzene, all R2 groups, with the exception of propargyl, undergo 
carbonylation prior to reductive elimination and reactions are cleaner and yields higher 
when they are carried out under CO atmosphere (up to 4 bar) or in the presence of an 
added ligand (PR3, P(OPh)3, NEt3).[40] On the other hand, when either oxazoline or imine 
groups are present, carbonylation takes place with alkyl groups but is a very minor 
pathway with allyl (< 15 %) and does not occur at all with propargyl. This result is 
attributed to the electron-withdrawing properties of the ring substituents and also the use of 
electrophiles which show low migratory aptitude toward CO.  
When CO insertion occurs, there is also potential for the addition of a third carbon unit via 
enolate formation. This is particularly facile if an oxazoline or imine substituent is present 
(Scheme 8). Thus, treatment of compounds 6 and 8 with a base followed by an electrophile 
results in products 7 and 9 in which the diastereoselectivity is governed by the adjacent 
stereogenic center.[41] Remarkably, protonation of the imine intermediate takes place at the 
(harder) nitrogen center whereas alkylation is at the (softer) carbon adjacent to the 
carbonyl function.[41b] 
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H
H
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R'
R''
O
R''
H
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(CO)3Cr
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R''
O
R'
R''
O
O
H
R'Li
R''X, CO,
HMPA
NaH, R'''X R' = Me, Ph, vinyl
R''X = MeI, EtI
8 9  
Scheme 8 
Asymmetric versions of the dearomatisation reactions of [Cr(arene)(CO)3] complexes 
include both enantioselective and diastereoselective approaches (Figure 10).  
 
R*
Cr(CO)3
R'
R''
R
(CO)2L*Cr
R
(CO)3Cr (CO)3Cr
R
R'
(or R*)
R'Li/R"X R'Li/R"X
R'Li/R"XR'Li/L*/R"X
D: Arene bound chiral
       auxiliary
B: Planar chiral
arene complexes
A: Chromium co-ordinated
     chiral ligand
C: Chiral nucleophile
 
Figure 10 
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Approach A implies the use of a chiral ligand at chromium. Here the asymmetric induction 
occurs not in the nucleophilic addition step but during the electrophilic addition.[42] The 
second approach (B) implies the use of planar chiral complexes bearing a para directing 
group (SnMe3 or SiMe3) that can be introduced by diastereoselective or enantioselective o-
lithiation.[43] The third approach (C) is based in the use of chiral amines and ether ligands 
that coordinate the incoming nucleophile and direct it to one of the enantiotopic ortho 
positions.[44] These reactions are done in toluene as a solvent in order to strengthen 
ligand/organolithium interaction.  
The last approach is the use of a chiral auxiliary (D), that would direct the nucleophilic 
addition to one of the two diastereotopic ortho positions.[45]  
 
I. 2. 3. 3 – Application of Sequential Nucleophilic/Electrophilic Addition in Synthesis 
 
Despite the synthetic potential of the nucleophilic/electrophilic addition to 
[Cr(arene)(CO)3] complexes there are to this date few examples of its use in the synthesis 
of interesting molecules. 
[Cr(CO)3(1-Methoxynaphthalene)], has been used as the starting complex in the synthesis 
of the AB ring system of Aklavinone (Scheme 9).[46] Nucleophilic attack to the 
[Cr(CO)3(1-Methoxynaphthalene)] complex under thermodynamic conditions favoured the 
nucleophilic addition to C(5) over addition to C(8) for steric reasons. Then treatment with 
methyl iodide underwent CO insertion to afford a mixture of two isomers from which the 
key intermediate 10 could be isolated by a single crystallization. 
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OMe Cr(CO)3
(MeS)3C
COMe
OMe C(SMe)3
COMe
OMe
OMe
CO2Me
OH
1. (MeS)3CLi,
 -78 °C to - 10 °C
2. HMPA, MeI, CO
+
6 : 1 (73 %)10
 
Scheme 9 
 
A recent example of the use of the dearomatisation of [Cr(arene)(CO)3] complexes is the 
total synthesis of (+)-acetoxytubipofuran,[47] a compound isolated from the Japanese 
stolonifer Tubipora musica Linnaeus in 1986, that shows cytotoxicity against B-16 
melanoma cells in vitro (IC50 = 33 mg/mL) (Scheme 10). Diastereoselective 
nucleophilic/electrophilic addition to the complex incorporating the chiral D-valinol 
derived imine followed by methylation yielded (-)-(4aS,8aR)-11, that was converted in 11 
steps to the natural product. 
 
N
OMe
(CO)3Cr
Li OEt CHO
O
OEt
H
O
AcO
H1. 
THF, -78 °C
2. MeI, CO, 
    THF / HMPA
3. NaOEt, MeI (+)-acetoxytubipofuran
53 %, > 95 % ee
11
 
Scheme 10 
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I. 2. 4 – MOLYBDENUM MEDIATED DEAROMATISATION 
 
The [Mo(arene)(CO)3] is readily accessible from Mo(CO)6. In these complexes the arene-
M bond is stronger than in the analogous chromium complex but it is far more labile. This 
results in a more difficult handling and has retarded their use in synthesis. However,  
recently, the first examples of nucleophile/electrophile addition reactions with 
[Mo(benzene)(CO)3] have appeared in the literature (Scheme 11).[48] This reaction 
sequence show the viability of using h6-arene molybdenum complexes in the 
dearomatisation, and more interestingly has allowed the characterization of intermediates 
that could not be isolated in the Cr-mediated dearomatisation sequence.  
(CO)3Mo
SS
R
SS
R
(CO)3Mo
(CO)3Mo
R'
SS
R Li
SS
R
(CO)2Mo
R'
SS
R O
THF, - 78 °C
CO, 4 atm
R, R' = H
59 %
R = H, R' = Me
- CO
(X-ray)
 
Scheme 11 
 
I. 3 – OBJECTIVES 
 
The idea of this work is to use the nucleophilic/electrophilic addition to [Cr(arene)CO3] 
complexes to provide an efficient access to the skeleton of natural products with interesting 
biological properties. In particular we want to show the enormous potential of the 
dearomatisation of the [Cr(CO)3(p-methoxy oxazoline benzene)] complex[32b] in synthesis. 
This compound has the advantage of having 2 directing groups that can be transformed 
after dearomatisation into useful functional groups. The methoxygroup can be easily 
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converted to a ketone by hydrolysis, and the oxazoline functionality can be used as a chiral 
auxiliary and give after cleavage an aldehyde or a carboxylic acid.  
In total synthesis each and every step is essential. However, the ring formation manoeuvres 
involved in the construction of cyclic molecules are key steps in the formation of cyclic 
compounds. In the last decade, ring closing metathesis (RCM) using the air-stable 
ruthenium alkylidene catalysts, have achieved widespread use to promote a range of 
cyclisations. We thought, which would be very interesting, to combine 
nucleophilic/electrophilic addition to arene chromium complexes and RCM, to provide an 
efficient access to useful cis-fused bicyclic ring systems of different size. 
Finally, it would be very interesting to show the application of this method in the synthesis 
of the core of natural products with interesting biological and structural properties, as is the 
case with Ottelione[49]and Taxol.[50]  
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II – SYNTHESIS OF CIS-FUSED [6,n] RING COMPOUNDS 
 
II. 1 - INTRODUCTION 
 
cis-Fused ring systems containing a quaternary center with a Me group at one ring junction 
are ubiquitious in natural products. We thought that it would be very interesting to 
combine the dearomatisation of  [Cr(arene)(CO)3] complexes with ring closing metathesis 
(RCM) to provide an efficient access to cis-fused bicyclic [6,5], [6,6], [6,7], and [6,8] ring 
compounds.1  
Following this idea, dearomatisation with allyl- or vinyl-lithium would provide the 
methylketone 13. Chain extension would lead to diene 14. Finally, olefin metathesis would 
close the second ring affording the cis fused bicyclic systems.  
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Figure 1 
 
There are several interesting natural products having these skeletons. To mention a few 
(see Figure 2), the bicyclic [6,8] system is the BC ring of taxanes (A),[2] the fused [6,7] 
ring is the core unit of dolestane-derivative compounds (B)[3] and mulinane type 
diterpenoids (C),[4] which exhibit antimalaria activity. The [6,6] skeleton is found in 
clerodane diterpenes (D),[5] which have interest as insect anti-feedants. Finally the [6,5] 
system is part of the structure of gibberelin plant hormones (E)[6] and the aplykurinds 
family (F).[7]  
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II. 2 - RING CLOSING METATHESIS 
 
II. 2. 1 - GENERAL FEATURES 
 
Carbon-carbon bond forming reactions are among the most important family of reactions 
in organic synthesis. One particularly interesting reaction of this type is olefin metathesis, 
which is a metal-catalysed alkylidene exchange between alkenes. 
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R1 R2
R1 R2
+ +
 
Figure 3 
 
The first generation of metathesis catalysts that were used exhibited high activity but poor 
compatibility with polar functional groups due to a strongly Lewis-acidic and alkylating 
character.[8] These properties limited their application to the production of unfunctionalised 
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polymers. However, basic research in organometallic chemistry triggered the development 
of new generations of well-defined, reasonably stable and tolerant catalysts or catalyst 
precursors. The first most popular catalyst of this type (or precatalysts that convert into 
metal alkylidenes in situ) [9] were the molybdenum alkylidene complex 16[10] developed by 
the group of Schrock and the ruthenium carbene complex 17[11] introduced by the group of 
Grubbs (Figure 4). The molybdenum catalyst exhibits higher reactivity of the two toward a 
broad range of substrates with many steric or electronic variations.[12] Nonetheless it is also 
extremely sensible to air and moisture, and decomposes upon storage. On the other hand, 
the ruthenium complex 17 is more stable than the molybdenum complex 16, but 
unfortunately its activity toward tri- and tetrasubstituted olefins is lower. Replacement of 
one of the tricyclohexylphosphine units by the more basic and sterically demanding N,N’-
bis(mesityl)imidazol-2-ylidene or its fully saturated analogue leads to increased thermal 
stability of the resulting the ruthenium complex 18. Due to this fact, this complex exhibits 
increased ring closing activity.[13, 14]  
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II. 2. 2 – CATALYST PREPARATION 
 
For our project we synthesised complex 20 following the procedure optimised by Fürstner 
and co-workers (Scheme 1).[15] This precatalyst is different than the commercial ruthenium 
precatalyst 17 but both complexes supply in the first catalytic turn over (“initiation phase”) 
the real catalyst, a methylidene complex. Thus, the influence of the original carbene unit is 
only in the initiation rate.[9] However, complex 20 can be prepared using commercially 
available compounds and avoiding the use of the hazardous reagents that are needed for the 
preparation of complex 17. Thus, [RuCl2(PPh3)3] prepared from RuCl3 was reacted with 
diphenylpropargyl alcohol to deliver phenylindenyl complex 19. Exchange of the 
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triphenylphosphines ligands for the more electron-donating tricyclohexylphosphines gave 
the desired first generation ruthenium precatalyst 20. 
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Scheme 1 
 
We also prepared the second generation ruthenium precatalyst 29 and 30 by exchanging 
one of the posphines by the saturated and the unsaturated N-heterocycle carbenes. 
The synthesis of the carbene 26 was carried out by the method developed by the group of 
Arduengo (Scheme 2).[16]  Following establish procedure,[17] compound 23 was obtained as 
a yellow solid by condensation of glyoxal with two equivalents of 2,6,6-
trimethylphenylamine. Reduction of 23 with sodium borohydride in the presence of 
hydrochloric acid led to the precipitation of the diamine dihydrochloride 24. When this 
diamine was reacted at elevated temperature with triethyl orthoformiate, cyclisation 
occurred with formation of the imidazolinium chlorine salt 25. Deprotonation with 
potassium hydride in THF led to the imidazolin-2-ylidene 26.  
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Scheme 2 
 
The imidazolium chloride 27 was attained in a multi-component one-pot reaction from 
2,6,6-trimethylphenyl amine, formaldehyde and glyoxal. Deprotonation of the salt with 
potassium tert-butoxide supplied, after recrystallization, the carbene 28 (Scheme 3). Under 
inert atmosphere this carbene can be stored for several days in the refrigerator. 
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Scheme 3 
 
Finally, the ruthenium phsophine complex 20 was reacted with N-heterocycle carbenes 26 
and 28 at moderate temperatures to afford respectively the second generation ruthenium’s 
precatalyst 29 and 30 (Scheme 4). 
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II. 2 - SYNTHESIS OF RACEMIC CIS-FUSED RINGS 
 
II. 2. 1 - DIENE SYNTHESIS 
 
They chose the readily available complex [Cr(CO)3(p-methoxyphenyl oxazoline)] 12[18] as 
substrate for our initial studies (Scheme 5). The use of allyllithium as nucleophile was 
considered first. Coordination of the reagent with the lone-pair of the nitrogen made the 
attack take place exclusively ortho to the oxazoline group. Then, methylation at chromium 
followed by migratory CO insertion and acetyl migration to the less substituted terminus of 
the cyclohexadienyl ligand (reductive elimination), gave the corresponding cyclohexadiene 
(see Chapter I). Next, enolate formation followed by the stereoselective introduction of the 
methyl group from the less hindered face afforded the methyl ketone 32. The overall yield 
of 88 % in this sequence of steps involving a dearomatisation with the chemo-, regio- and 
stereoselective formation of three C-C bonds and two stereogenic centres attests to the high 
efficiency of this procedure. The nucleophilicity of the anionic chromium complex 
intermediate is increased using DMPU, to trap the lithium, or by exchange of lithium by 
tetrabutyl ammonium. The yields reached in both cases are similar, even so, the use of 
nBu4NBr is more convenient for the purification. 
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It was possible directly to synthesise diene 33 in a one-pot procedure by using NaHMDS 
followed by trapping of the enolate with allyl bromide. However mono-allylation proved 
somewhat tricky and was found to depend on the batch and age of the bottle of NaHMDS 
used. A more reproducible procedure consisted of the isolation of 32, subsequent treatment 
with LDA and reaction of the enolate with allyl bromide. 
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Scheme 5 
 
To synthesise precursors for cis-fused bicyclic [6,7] ring compound, dearomatisation of 
complex 12 with vinyllithium and methyliodide followed by the introduction of the angular 
methyl group, afforded the methyl ketone 34 in 88 % yield (Scheme 6). Diene 35 was 
synthesised via enolisation and quenching with allylbromide. As in the previous case, it 
was possible to arrive at the desired diene in a one-pot procedure, but the same problem of 
reproducibility was found. 
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Scheme 6 
 
Access to precursors of cis-fused [6,6] and [6,5] ring compounds was investigated next 
(Scheme 7). The most straightforward strategy would involve the use of vinyl halides in 
the dearomatisation sequence. Nonetheless, alkylation/carbonylation of the anionic 
[Cr(CO)3(cyclohexadienyl)] intermediate involves an SN2 process and it is therefore not 
suitable for this type of electrophiles. Moreover, attempts to use acyl electrophiles (acid 
halides, anhydrides), which could also give suitable precursors for RCM, have failed.[19] 
Thus, the stepwise formation of the required intermediates was envisaged.  
The first approach involved alkylation of complex 12 with vinyl or allyllithium followed 
by ethylation, enolate formation and quenching with methyliodide to achieve 
cyclohexadienes 37 and 40 (Scheme 7). Selenation and elimination yielded the desired 
enones 38 and 41. This route is interesting because it shows that two different electrophiles 
can be used in steps 2 and 3 of the dearomatisation sequence. Though, in this case, one 
purification step was needed before the introduction of the quaternary centre, since residual 
LiOH in the organolithium reagent was sufficient to introduce the angular ethyl group, 
affording a product which cannot be separated from 37 (or 40) by column chromatography.   
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Scheme 7 
 
A second and more efficient approach was to synthesise the enones via the Mannich base 
(Scheme 8). Formation of the silyl enol ether, followed by alkylation with Eschenmoser’s 
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salt, methylation and elimination of the quaternary amine gave enones 38 and 41 in good 
yield and without any intermediate purification step.  
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Scheme 8 
 
II. 2. 2 – RING CLOSURE BY RCM – SYNTHESIS OF THE [6,n] BICYCLES 
 
With our precatalysts in hand, access to cis-fused [6,8] derivative 42 from 33 was 
investigated (Scheme 9). Metathesis reaction with 10 mol % of the first generation 
ruthenium precatalyst 20 in refluxing dichloromethane proceeded smoothly giving the 
product 42 quantitatively. 
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Scheme 9 
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However, when the same conditions were applied for the seven-membered ring formation, 
the reaction was dull and the bicyclic system 43 was obtained in low yield (Scheme 10). 
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Scheme 10 
 
This result is interpreted by the formation of a stable six-membered chelate structure (A) 
(Figure 5). In this chelate the carbonyl group acts as a ligand for the evolving carbene 
specie and sequesters the catalyst in the form of unproductive complex. The same 
behaviour is not observed with the diene 33, since the seven-membered chelate (B) which 
is formed is not stable and allows cyclisation to take place.[20] 
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Fortunately, when the olefin metathesis of 35 was carried out utilising the more efficient 
precatalyst 30 in toluene at 80 °C, the bicyclic [6,7] system 43 was achieved in an 
excellent 88 % yield (Scheme 11).  
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Scheme 11 
 
Cyclisation to access the cis-fused [6,6] and [6,5] ring systems was more problematic 
(Scheme 12). RCM of diene 41 was sluggish and only a 48 % yield of 44 was obtained 
employing 5 mol % of the catalyst 30 after 24 hours in toluene at 80 °C. When the same 
conditions were applied on the diene 38, the starting material was recovered untouched. 
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This behaviour was not totally unexpected since electron-poor dienes are known to be less 
reactive in the metathesis.[21] To circumvent this problem we decided to reduce the enones 
to the corresponding alcohols (Scheme 11). Reduction under Luche conditions proceeded 
with relatively good diastereoselectivity. The stereoselectivity during the protonation is 
interpreted by a Felkin-Anh model (Figure 6).  
R
O
MeO
Ox
Me OMe
NO
OH
H
H-
48  
 
Figure 6 
 
Purification by column chromatography afforded the diasteroisomerically pure allylic 
alcohols 46 and 48. Subsequent reaction with 10 mol % of the ruthenium complex 20 or 17 
furnished the bicyclic systems 47 and 49 in good yields.  
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The relative configuration of the hydroxyl group in 49 was assigned by comparison of its 
NMR spectra with that of its diastereoisomer 50 obtained by reduction of ketone 44 
(Scheme 14).  
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O OMe
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NaBH4
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MeOH, 0 °C
84 %
44 50  
 
Scheme 14 
 
Previous work has shown that reduction of 44 to 50 occurs from the less hindered, convex 
face of the molecule (Figure 7).[22] 
 
Figure 7: Molecular model of compound 44 optimised by PM3 theory. 
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II. 3 - SYNTHESIS OF THE ENANTIOMERICALLY ENRICHED CIS-FUSED 
BICYCLIC [6,7]  RING COMPOUND 
 
Having gained efficient access to cis-fused [6,8], [6,7], [6,6] and [6,5] rings, the 
preparation of these compounds in enantiomerically pure form was considered.  
 
II. 3. 1 - PRECEDENTS FOR ASYMMETRIC DEAROMATISATION OF ARENE 
CHROMIUM COMPLEXES BEARING ARYL OXAZOLINE GROUPS 
 
II. 3. 1. 1 - Enantioselective Dearomatisation with Chiral Ethers 
 
Four chiral ligands have been investigated for the sequential addition of phenyl-, vinyl-, 
and alkyllithium reagents and propargyl bromide to the phenyloxazoline complex 51 
(Scheme 15).[23] In general, the reactions in which phenyllithium was the nucleophile 
resulted in the highest enantioselectivities, whereas n-butyllithium consistently gave more 
modest results. Of the four ligands, the best enantiomeric excesses were reached with the 
readily available dimethoxy diphenyl ethane (52) (Scheme 15).   
NO
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1. RLi, L*, toluene
2. Propargyl bromide
51  
Ligand* RLi Yield,  % ee, % Ligand* RLi Yield, % ee, % 
PhLi 66 93 PhLi 72 81 
vinylLi 53 87 vinylLi 85 50 
MeLi 51 87 MeLi 60 47 
Ph Ph
MeO OMe
52  nBuLi 67 65 
Me Me
MeO OMe  
nBuLi 68 45 
PhLi 66 81 PhLi 72 54 
vinylLi 60 61 vinylLi 87 34 
MeLi 50 84 MeLi 70 47 MeO OMe  nBuLi 75 61 
N
N
H
HH
H  nBuLi 65 36 
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The enantioselectivity is explained by the formation of a chelate between the 
organolithium reagent, the chiral ligand and the nitrogen lone-pair (Figure 8). The chelate 
A would be preferred because of the steric hindrance between the phenyl group of the 
ligand and the Cr(CO)3 fragment. 
 
NLi
R
O
O
Ph
Ph
O
Cr
CO
OC CO
N
O
Li
R
O
O
Ph
Ph
Cr
CO
OC CO
>
A B  
Figure 8 
 
II. 3. 1. 2 –Diastereoselective Dearomatisation with Chiral Auxiliaries 
 
The chiral auxiliaries that have afforded good diastereoselectivies in the dearomatisation of 
[Cr(arene)(CO)3] complexes are the oxazoline derived from L-valinol and L-tert-leucinol, 
and the SAMP hydrazone.[24] 
Reaction of oxazoline complex 53 with alkyl-, vinyl-, and phenyllithium reagents followed 
by alkylation or allylation afforded the highly diasteroisomerically enriched 
cyclohexadienes (Scheme 16). 
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Scheme 16 
 
Product stereochemistry reflects a transition state in which the isopropyl substituent is syn 
to the metal fragment (Figure 9). The transition state arising from the anti rotamer is 
disfavoured because of steric interactions between the bulky oxazoline R group and the 
organolithium reagent. Whilst there is no hard mechanistic evidence for this proposal, an 
X-ray structure of the starting complex shows that the R group in the oxazoline is pseudo-
equatorial and hence does not interact with the Cr(CO)3 group in the endo-
conformation.[24] The model shown is in accord with the observed diastereoselectivity, and 
with the subsequent reports of the same mode of induction in chiral oxazoline mediated 
diastereoselective ortho deprotonations of ferrocenes.[25] 
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Reaction of the SAMP-hydrazone complex 54 with alkyl-, vinyl-, and phenyllithium 
reagents followed by alkylation or propargylation furnished the dearomatisated products 
with excellent diastereoselectivities (Scheme 17). The asymmetric induction during the 
nucleophilic addition is interpreted in terms of the formation of a six-membered chelate 
between the organolithium and the hydrazone, and the preference of a chair-like transition 
state over the boat-like transition state.[24b]  
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II. 3. 2 – PERSONAL RESULTS 
 
The precedents for enantioselective dearomatisation of complex 51 using the (S,S)-1,2- 
dimethoxy-1,2-diphenyl ethane were very promising since vinyllithium gave 87 % e.e. in 
the addition to the phenyloxazoline complex, so we decided to use the same conditions for 
our substrate (Scheme 18). A combination of vinyllithium and the chiral ligand 52 was 
used for the nucleophilic addition to the [Cr(CO)3 (p-methoxy oxazoline benzene)] 
complex (12). Afterwards, dearomatisation was continued as usual to attain the 
enantiomerically enriched cyclohexadiene 34. We tried different HPLC conditions to 
measure the enantiomeric excess, unfortunately none of them gave a good separation of 
both enantiomers. We continued the synthesis of the cis-fused bicyclic [6,7] ring 
compound and reduced the oxazoline to the corresponding aldehyde 55. The enantiomeric 
excess was measured by 1H NMR, using tris[3-(trifluoromethylhydroxymethylene)-d-
camphorato]europium(III) as chiral shift reagent, obtaining an unsatisfactory 40 % e.e.  
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Disappointed by this result we turned our attention to the utilisation of chiral auxiliaries 
that would direct the nucleophilic addition to one of the two diastereotopic ortho positions.  
To synthesise the chiral p-methoxy oxazoline benzene 59, D-valine was reduced with 
sodiumborohydride-iodine in THF at reflux, according to a literature procedure.[26] 
Afterwards, the amino alcohol 57 was reacted with p-anisoylchloride in the presence of 
triethylamine to access to the amide 58. This was treated in situ with p-tosylchloride and a 
catalytic amount of DMAP to deliver the product 59 (Scheme 19).[27]  
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82 %
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67 %
p-anisoylCl
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Scheme 19 
 
Next, complexation of arene 59 under thermolysis conditions was sluggish (Scheme 21). It 
has been reported that addition of a substoichiometric quantity of naphthalene to the 
reaction mixture, can improve the complexation by in situ formation of the labile 
[Cr(CO)3(naphthalene)].[28] In spite of that, when compound 59 was treated with Cr(CO)6 
in the presence of 0.5 equivalents of naphthalene, the yield of the reaction was lower. The 
use of milder conditions did not improve significantly the result.[29] 
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Conditions Yield (%) 
Cr(CO)6 (1 eq.), Bu2O, THF, 150 °C 33  
Cr(CO)6 (1 eq.), Bu2O, THF, 150 °C, naphthalene (0.5 eq.) 18 
[Cr(CO)3(naphthalene)] (0.8 eq.), THF, 60 °C 34 
 
Scheme 20 
 
The sequential nucleophile/electrophile addition to the chiral oxazoline complex 60 
afforded the methyl ketone 61 with a diasteroisomeric excess of 88 % measured by 1H 
NMR (Scheme 21). The stereochemistry of compound 61 was established by analogy to 
the previous results.[24] Formation of the enolate with LDA followed by allylation yielded 
the diene 62. This compound was cyclised in quantitative yield using the ruthenium 
complex 30. Finally, cleavage of the oxazoline gave the enantiomerically enriched 
aldehyde 55. 
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Scheme 21 
 
Aldehyde complex 66 was synthesised by thermal complexation of anisaldehyde dimethyl 
acetal (64), followed by hydrolysis of the acetal moiety (Scheme 22). Subsequent treatment 
with the RAMP-hydrazone in the presence of molecular sieves led access to complex 67.  
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Scheme 22 
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Compound 70 was obtained by the same reaction sequence as was used to synthesise 63 
(Scheme 23). In this case, a higher diastereoisomeric excess (> 95 %) [30] was observed. 
Next, the enantiomerically enriched system was reached by cleavage of the hydrazone 
using magnesium monoperoxyphtalate hexahydrate in methanol:phosphate buffer (1:1).[31] 
In order to measure the enantiomeric excess by 1H NMR, using tris[3-
(trifluoromethylhydroxymethylene)-d-camphorato]europium(III) as chiral shift reagent, the 
nitrile 71 was reduced and hydrolysed to aldehyde 55. 
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Scheme 23 
It is worth noting that intermediates 61 and 68 should give access to enantiomerically 
enriched cis-fused [6,5] systems by a similar sequence to the one described above. 
On the other hand, cis-fused [6,8] and [6,6] rings, require the dearomatisation with 
allyllithium as nucleophile. Unfortunately, addition of this reagent to the chiral complexes 
60 and 67, proceeded with poor diastereoselectivities (Scheme 24). 
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Scheme 24 
 
Another possible access to the [6,8] bicyclic system would be to cyclise diene 74. 
Nonetheless this approach did not afford satisfactory result. Quenching of the lithium, 
sodium or potassium enolates with 1-bromo-4-butene proceeded with low conversions 
(Scheme 25).  
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Scheme 25 
 
In order to improve the yields we synthesised the silyl enol ether 75 via enolisation and 
quench with trimethylsilyl chloride (Scheme 26). Nevertheless, reaction with 
tetrabutylammonium difluorotriphenylstannate and 1-bromo-4-butene afforded again the 
diene 74 in low yield.[32]  
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Scheme 26 
 
The low conversions are attributed to the fact that the enolate acts like a base, inducing the 
elimination in the electrophile. 
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II. 4 – CONCLUSIONS 
 
We have developed an efficient and straightforward synthesis of functionalised bicyclic 
cis-fused [6,8], [6,7], [6,6], and [6,5] ring compounds. Key steps are the dearomatisation of 
arene chromium complexes and ring closing metathesis. 
The dearomatisation reaction with vinyl or allyllithium as nucleophile and methyliodide as 
electrophile affords regio- and stereoselectively the corresponding methyl ketone in a one 
pot reaction.  
Next, the cis-fused [6,8] and [6,7] rings were synthesised by enol formation, quenching 
with allylbromide and metathesis. Cyclisation of the eight-membered ring utilising catalyst 
20, afforded the product in quantitative yield, whereas, the metathesis of the seven-
membered ring required the use of the more active catalyst 30. 
The dienes for the cis-fused [6,6] and [6,5] systems were efficiently synthesised via a 
Mannich type reaction. However the RCM was sluggish affording the cis-fused [6,6] ring 
compound in low yield and leaving the diene for the five-membered ring intact. Reduction 
of the enones to the corresponding allylic alcohols allowed the metathesis to take place. 
Finally, the synthesis of the enantiomerically enriched [6,7] bicyclic system was possible 
using the isopropyloxazoline and the RAMP-hydrazone as chiral auxiliaries.  
Part of the experiment of this chapter has been done by Prof. K. Kaliappan, Dr. A. Pape 
and Dr. S. Radix. 
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III – SYNTHESIS OF THE CORE OF THE OTTELIONES  
 
III. 1 – INTRODUCTION  
 
The isolation of the two diastereomeric Otteliones A and B from the fresh water plant Ottelia 
alismoides was reported in 1998 (Figure 1).[1] Otteliones have attracted much attention for the 
presence of a unique 4-methylenecyclohex-2-enone substructure and their remarkable 
biological activity. Extracts of Ottelia alismoides, which are rich in Otteliones, have been 
reported to have antitubercular effect, and in clinical trials two cases of bilateral tuberculosis 
of the cervical lymph gland were cured in three months.[2] At the National Cancer Institute, in 
vitro screening against a panel of 60 human cancer cell lines showed that Otteliones exhibited 
cytotoxicity at nM-pM levels.[1] More recent results have shown that Ottelione A is an 
efficient inhibitor of tubulin polymerization (IC50 = 1.2 µM) and is able to disassemble 
preformed microtubules in a manner reminiscent of the colchicines, vinblastine, and 
vincristine.[3] The exceptional therapeutic potential, the desirability of access to analogues, the 
presence of four contiguous stereogenic centers and the rare and sensitive 4-
methylenecyclohex-2-enone functionality make Otteliones challenging synthetic targets.[4] 
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Figure 1 
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III. 1. 1 – REPORTED TOTAL SYNTHESIS OF OTTELIONES 
 
Several synthetic studies directed towards Otteliones have appeared in the literature,[4a,b] but it 
was not until 2003 when two groups provided a total synthesis of both compounds.[4c-e] 
Metha and co-workers were the first to synthesise and settle the absolute configuration of 
Otteliones A and B by comparing the specific rotation of the naturally occurring Otteliones 
with the synthetic enantiomers.[4e] The key features of their synthesis are the use of the readily 
available Diels-Alder adduct 76 of cyclopentadiene and benzoquinone as starting material, and 
the lipase catalyzed transesterification to furnish the enantiopure monoacetate 78. From this 
compound, protection, deprotection manipulation followed by oxidation and Lombardo 
methylenation gave 79, which was subjected to controlled ozonolysis to deliver 80. Wittig 
reaction and oxidation afforded the lactone 81, that was reacted with the corresponding 
organolithium reagent to introduce the aryl group. Finally reduction of the benzylic alcohol, 
followed by generation of the 4-methylenecyclohex-2-enone moiety and deprotection gave 
Ottelione A, which underwent epimerization at C9 on exposure to base to yield Ottelione B. 
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Reagents and conditions: a) LiAlH4, ether, 0 °C, 78 %; b) PCC, DCM, 0 °C, 82 %; c) DIBAL-H, DCM, - 78 °C, 
83 %; d) Lipase PS (amano), vinyl acetate, THF, rt, 85 %; e) TBDMSCl, imidazole, DMAP, DCM, 90 %; f) 
K2CO3, MeOH, 0 °C, 80 %; g) PDC, DCM, rt, 86 %; h) Zn-TiCl4-CH2Br2, DCM, 0 °C, 79 %; i) TBAF, THF, rt, 
88 %; j) i. O3, MeOH, - 78 °C, ii. Me2S, rt, 72 %; k) Ph3PCH3+I−, nBuLi, THF, 0 °C, 86 %; l) PCC, DCM, 0 °C, 
90 %; m) 4-bromo-1-methoxy-2-(tertbutyldimethylsiloxy)benzene, nBuLi, THF, − 78 °C  to rt, 88 %; n) Li, liq. 
NH3, THF, − 33 °C, 65 %; o) PCC, DCM, 0 °C, 87 %; p) i. LiHMDS, PhSeCl, THF, − 78 °C; ii. 30 % H2O2, 
DCM, 0 °C, 70 % (two steps); q) TBAF, THF, 0 °C, 72 %; r) DBU, benzene, 65 °C, 83 %. 
Scheme 1 
  
The second total synthesis reported to date was achieved by the group of Katoh (Scheme 2).[4d] 
They use as starting material the tricyclic compound 82, that was synthesised from (-)-quinic 
acid by a procedure developed in their group.[5] Reduction of the ketone and oxidative 
cleavage employing Lemieux-Johnson procedure delivered lactol 83. Next, nucleophilic attack 
of the aryllithium reagent followed by base-induced cyclic hemiacetal opening/epimerization 
led to the formation of aldehyde 84. Different reduction/oxidation manipulations followed by 
a two fold Wittig methylenation gave the diene 85. The final steps were the deprotection of the 
diol, Corey-Winter olefination and changing of the protective group of the phenol to yield 
compound 86. The alcohol was then oxidised to form the 4-methylene-2-cyclohexenone 
system and the deprotection of the phenol gave Ottelione A, that was converted to Ottelione B 
by epimerization of C9 with tBuOK (use of DBU only afforded a 1:1 diasteroisomeric 
mixture). 
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Reagents and conditions: a) NaBH4, THF-H2O, 0 °C, 87 %; b) OsO4, NaIO4, t-BuOH-THF-H2O, 0 °C to rt, 62 %; 
c) 4-bromo-1-methoxy-2-(methoxymethoxy)benzene, n-BuLi, THF, - 78 °C, 80 %; d) DBU, toluene, reflux, 30 
% (60 % recovery of  SM); e) LiAlH4, THF, 0 °C, 96 %; f) Ac2O, DMAP, pyridine, rt, 95 %; g) Li, liquid NH3, 
THF, - 78 °C, 98 %; h) Dess-Martin periodinane, CH2Cl2, rt, 90 %; i) Ph3P+CH3Br-, t-BuOK, benzene, rt to 
reflux, 95 %; j) TFA, THF-H2O, 0 °C, 86 %; k) Ac2O, 2 M NaOH, i-PrOH, rt, 91 %; k) CSCl2, DMAP, CH2Cl2, 
rt, 93 %; l) (EtO)3P, reflux, 78 %; m) TBAF, THF, rt, 83 %; n) (CHCl2CO)2O, pyridine, CH2Cl2, rt, 52 %; o) 
Dess-Martin periodinane, CH2Cl2, rt, 95 %; p) 50 % aq NaHCO3-MeCN (1:1), rt, 90 %; q) t-BuOK, t-BuOH, rt, 
79 % (A : B = 23:77 by 1H NMR); isolation of A by HPLC, 23 %. 
 
Scheme 2 
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III. 2 – SYNTHESIS OF THE CORE OF THE OTTELIONE VIA DEAROMATISATION 
OF [Cr(ARENE)(CO)3] COMPLEXES 
 
The key feature in the synthesis of the otteliones is the construction of the bicyclic [6,5] ring 
system (Scheme 3). Building on the synthetic method developed in chapter II, we argued that 
dearomatisation of the [Cr(CO)3(p-methoxyoxazoline benzene)] complex (12) could afford 
rapid access to such a core bearing the required functionalities to introduce subsequently all 
the substituents that would complete the Ottelione A. Indeed, the 1,4-disubstituted 
cyclohexadiene fragment resulting from nucleophilic/electrophilic addition on 12 should lead 
rapidly to the methylene cyclohexenone unit by cleavage of the oxazoline to the aldehyde, 
reduction to the alcohol and hydrolysis of the methoxy enol ether. Thus, Ottelione A should be 
obtained from 88, that could be synthesised from 89 by reduction of the benzylic olefin.  
Compound 89 would be synthesised by Wittig reaction and 1,4-addition to the cis-fused [6,5] 
bicyclic compound 90. 
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Scheme 3 
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Thus, our first target was to apply the combination of dearomatisation of arene chromium 
tricarbonyl complexes with the RCM (ring closing metathesis) to synthesise 90, a bicyclic 
system that has the required functionalities to access Ottelione A. 
   
III. 2. 1 – ATTEMPTS TO CYCLISE THE TRANS ISOMER 
 
The difference between 90 (the core of Ottelione A) and the cis-fused [6,5] bicycle previously 
synthesised is the absence of the angular Me group at the ring junction. Taking into account 
that the product obtained after the nucleophilic/electrophilic addition to the chromium 
complex is trans and not cis, every strategy towards 90 requires the introduction of an 
epimerisation step. 
The first retrosynthetic analysis that we investigated, involved isomerisation of the trans 
bicyclic system 91 to the more stable cis-fused system as final step of the synthesis. Then, 
compound 91 would be obtained by RCM of the enone 92 (Scheme 4), and this enone would 
be synthesised by nucleophilic/electrophilic addition to the chromium complex 12 followed by 
a Mannich type reaction. 
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Scheme 4 
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Following this plan, nucleophilic/electrophilic addition of vinyllithium and methyliodide to 
[Cr(CO)3(p-methoxyoxazoline benzene)] complex (12) delivered the methyl ketone 93 
(Scheme 5). In this addition it is important to use nBuLi that does not contain residual LiOH 
since this leads to the formation of the enolate which reacts with the excess of methyliodide 
and results in lower yields. 
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H
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N O
(OC)3Cr
Sn 
2. nBu4NBr, CO,  
    MeI, - 78 oC to rt
78 %
1. 
4
, nBuLi, THF,
 - 78 °C 
12 93  
Scheme 5 
 
Then, the next challenge of this route was the synthesis of the enone 92. When the angular 
methyl group is present, only one silyl enol ether can be formed (see Chapter II). However, 
with substrate 93 there are two possible enolates, the thermodynamic one at the tertiary center 
and the kinetic one at the primary center. In addition, in our substrate we would have to deal 
with the fact that theoretically the enolisation at the tertiary position is highly favoured 
because of conjugation with the double bonds of the cyclohexadiene moiety. Despite these 
potential problems, the silyl enol ether 94 was exclusively formed after reaction with NEt3 and 
TMSOTf (conditions that normally are used to form the thermodynamic enolate). Subsequent, 
treatment with the Eschenmoser’s salt, methylation and elimination delivered enone 92. The 
moderate yield that is achieved is due to the formation of aromatised products (Scheme 6). 
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Scheme 6 
 
Next, we treated enone 92 with 10 mol % of the catalyst 29 for two days in toluene at 80 °C, 
but the only product obtained was the arene 95, formed by a dehydrogenation/hydrogenation 
mechanism where the ruthenium acts as catalyst [6] (Scheme 7). This result was not surprising 
since enones have revealed as poor subtrates for the metathesis in the previous synthesis of the 
bicyclic ring compounds (Chapter II). So, we reduced the enone 92 to the allylic alcohol 96. 
Even so, this compound was recovered intact after treatment with 10 mol % of the catalyst 29 
in toluene at 80 °C. 
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Scheme 7 
 
Similar problems in the cyclisation of trans cyclohexadienes have already been reported in our 
group, and have been attributed to the rigid diaxial disposition of the two side chains (Figure 
2).[7]  
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Figure 2: Molecular model of diene 96 optimised by the PM3 method. 
 
III. 2. 2 – DIASTEREOSELECTIVE PROTONATION APPROACH 
 
To overcome the problems related to the cyclisation of the trans diene, we envisioned its 
isomerisation to the cis diene prior to the RCM.  
Diastereoselective protonations of chiral enolates are carried out frequently in the synthesis of 
natural products.[8] This is easiest under thermodynamic substrate control. An example is the 
conversion of Ottelione A to Ottelione B.[4] Unfortunately, in substrate 92 the trans isomer  is 
more stable and under equilibrating conditions it is the only product that is reached. However, 
we thought that kinetic protonation on the less hindered face, anti to the vinyl group, would 
afford the desired cis isomer (Figure 3).  
NO
H
H
MeO OH
96
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Figure 3: Molecular model of the enol form of ketone 92 optimised by the PM3 method. 
 
III. 2. 2. 1 – Precedents in Kinetic Diastereoselective Protonation 
 
The most notable examples of kinetic diastereoselective protonation in the literature are the 
use of chelating proton donors.[9] The group of Krause has studied the use of different salicilyc 
acid derivatives in the protonation of the enolates of 2,3-dimethylcyclohexenone (Scheme 8). 
They found that ethyl salicylate provides good diasteroisomeric excess of the kinetic 
product.[9a] 
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Scheme 8 
 
They argued that the particularly high cis selectivities were due to a proton transfer via 
formation of a chelate between the enolate metal ion and the carbonyl and hydroxyl oxygen 
atom of the salicylate (Figure 4). The loss of regioselectivity seen upon the introduction of the 
methyl group at C-3 would be due to severe repulsive interactions between the proton donor 
and the equatorial hydrogen of the cyclohexenone that prevents the formation of the chelate. 
Thus, the proton transfer probably would occur via another, less rigid, complex of reactants.  
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Figure 4 
 
Another example of kinetic diastereoselective protonation has been provided by Eames and 
co-workers (Scheme 9). They studied the protonation of 2,4-dimethyl-1-tetralone using 
carbonyl based chelating proton donors.[9b] On this substrate, nitrogen based amides gave poor 
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diastereoisomeric control, whereas the use of acetic acid and dicarbonyl compounds, such as 
pentane-2,4-dione and ethyl acetoacetate gave satisfactory results. The use of cyclic diones 
decreased the selectivity probably because they have a more rigid structure that makes 
coordination with the metal ion harder.  
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III. 2. 2. 2 – Personal Results 
 
Diastereoselective protonation was first studied on the methyl ketone 93 and the results are 
summarised in Table 1. The compounds attained after diastereoselective protonation could not 
be isolated, since the angular proton is too acidic and only the more stable trans isomer was 
obtained after the column chromatography with silica gel. Thus, to study the reaction, we 
identified the ratio of the products by 1H NMR of the crude product mixture (Figure 5). There, 
we could identify three different species. Two of them are the trans (A) and the cis isomer (B), 
but the third one, compound C, comes from the 1,4-protonation of the enolate.  
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Figure 5 
 
Different chelating proton donors were used and acetic acid was the one which gave better 
diastereoselectivities (Table 1). Of all the bases tested, tBuONa gave the best and most 
reproducible results. Next, we observed that the proportion of compound C was considerably 
decreased when toluene was used as solvent. Changing of the nature of the chelating metal did 
not afford satisfactory results. Finally, the use of the optimised conditions at - 93 °C (bath of 
toluene-dry ice) gave the cis isomer in a 69 % 1H NMR yield. 
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Base Aditive Solvent Proton source Temperature Ratio A:B:C1 
NaOEt No THF CH3COOH - 78 °C 35 : 30 : 32 
NaOEt No THF 
O O
 
- 78 °C 70 : 14 : 14 
NaOEt No THF 
OH
OEt
O
 
- 78 °C 100 : 0 : 0 
NaOEt No THF p-nitrophenol - 78 °C 100 : 0 : 0 
NaH No THF CH3COOH - 78 °C 48 : 28 : 23 
NaOEt BEt3 THF CH3COOH - 78 °C 44 : 28 : 27 
tBuONa No THF CH3COOH - 78 °C 20 : 47 : 33 
tBuOK No THF CH3COOH - 78 °C 32 : 36 : 32 
tBuOLi No THF CH3COOH - 78 °C 100 : 0 : 0 
tBuONa BEt3 THF CH3COOH - 78 °C 33 : 30 : 37 
tBuONa MnCl2 THF CH3COOH - 78 °C 100 : 0 : 0 
tBuONa No THF 
Ph
COOH
Ph
Ph  
- 78 °C 100 : 0 : 0 
tBuONa No THF CF3COOH - 78 °C 31 : 35 : 34 
tBuONa No Toluene CH3COOH - 78 °C 28 : 57 : 14 
tBuONa No Toluene CH3COOH - 93 °C 15 : 69 : 16 
1 Ratios are calculated from the 1H NMR of the crude. 
Table 1 
 
The best conditions were applied to the enone 92 and after work-up the product was directly 
subjected to reduction of the carbonyl group using Luche conditions (Scheme 10). 
Unfortunately, the reduction was not chemoselective and 6 different products were formed (3 
different diastereoisomers of the saturated and unsaturated alcohol), and after purification, 
alcohol 98 was acquired in low yield as a 53:47 diasteroisomeric mixture. The synthesis was 
pursued and after RCM and purification by column chromatography, the two diasteroisomers 
99 and 100 were obtained separately. This synthetic sequence was repeated twice with similar 
results.  
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Scheme 10 
 
This synthetic route provides a rapid access to the core of the Ottelione with only 4 
purification steps from the [Cr(CO)3(p-methoxyoxazoline benzene)] complex (12). The key 
features are the use of kinetic diastereoselective protonation and metathesis of the cis diene. 
Nevertheless, the overall yield was not satisfactory and we decided to explore other synthetic 
pathways. 
 
III. 2. 3 – ATTEMPTS TO INTRODUCE A REMOVABLE GROUP 
 
We argued that introduction of an auxiliary group (ester or thioether) would mimic the methyl 
group of the previously synthesised cis-fused [6,n] ring compounds (Chapter II), and at the 
end could be removed to access the desired core of the Ottelione. 
Following this idea, the bicyclic system 90 could be obtained by removal of the auxiliary 
group from 101 (Scheme 11). This compound would be attained C-C disconnection from the 
enone 102. This enone would be synthesised via Mannich type reaction from the methyl 
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ketone 103. The key step would be the introduction of the auxiliary group by quenching the 
enolate of 93 with a suitable electrophile. 
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Scheme 11 
 
III. 2. 3. 1 – Attempts of C-Acylation 
 
The first idea was to introduce an ester by C-acylation of the enolate. At the end, this 
functionality would be removable by simple dealkoxycarbonylation.[10] The challenge in this 
approach is to carry out a regioselective acylation of the enolate anion. W e can find a large 
amount of work in the literature that has been devoted to the exploration of conditions 
designed to effect preferential carbon or oxygen acylation.[11] In general C-acylation is 
favoured by acid chlorides (vs. anhydrides),[12] divalent countercations (vs. alkali metals),[13] 
diethyl ether as solvent (vs dimethoxyethane),[14] low temperature,[14] and inverse addition of 
enolate to acid chloride.[15] However, enolate acylation is extremely substrate–dependent, and 
it is known that with certain substrates O-acylation competes or even predominates despite the 
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use of conditions that should lead to reaction at the carbon center.[16] In particular, delocalised 
enolates, as it is our case, tend toward oxygen acylation as a consequence of the greater 
electron density on the oxygen atom.[17]  
With these precedents on hand we decided to study the reactivity of 93 towards C-acylation. 
Initially, the sodium enolate of ketone 93 was quenched with methyl chloroformate, but only 
the O-acylated product 104 was formed (Scheme 12).  
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Scheme 12 
 
As mentioned before, one method to favour the C-acylation is the use of divalent cations. 
They bind strongly to oxygen and diminish their effective negative charge. [13] In spite of that, 
reaction of the magnesium enolate of 93 (generated by treatment of ketone 93 with 
diisopropylmagnesium bromide in ether) with methyl chloroformate afforded the Z-carbonate 
105 (Scheme 13). The configuration of this compound was unambiguously assigned by 1H 
NOESY spectroscopy.  
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Scheme 13 
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The different results in the diastereoselectivity of the O-acylation can be explained by the 
influence of the metal center in the enolate configuration (Figure 6). When a divalent cation is 
used, there is a coordination of the metal with the two oxygen atoms giving the Z-
configuration, otherwise the E-configuration is obtained due to the repulsion of the negative 
charge and the lone-pair of the oxygen in the methoxy group.  
 
N O
OMeO
Mg
N O
OMe
NaO
E-enolateZ-enolate  
Figure 6 
 
Another possibility to favour C-acylation, is to change the acylating reagent. In particular, acyl 
cyanides have proved to be effective where others reagents failed.[18] However, treatment of 
the sodium enolate of 93 with methyl cyanoformate resulted in recovery of the starting 
material. 
The tendency of the enolate of 93 towards O-acylation can be explained by two factors, the 
higher accessibility of the oxygen center, and the stability of the conjugated enolate that it is 
formed. 
Nevertheless, this preference towards O-acylation could be exploited if we could cyclise the 
enol carbonate 107. With this idea on mind, we reacted enone 106 with sodium methoxide and 
methyl chloroformate to obtain product 107 (Scheme 14). Then, treatment with the ruthenium 
catalyst 29 afforded the compound 108 that readily isomerises to the more stable aromatised 
carbonate 109. 
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Scheme 14 
 
 
III. 2. 3. 3 – Attempts to Introduce a Thioether 
 
Another functional group that could be introduced is a thioether. This functionality can be 
introduced by quenching of the enolate with the corresponding disulphide. Upon oxidation 
thioethers readily eliminate by a radical reaction.  
However treatment of the sodium enolate of compound 93 with diphenyl disulphide in THF or 
toluene only delivered the product of g-thioetherification (Scheme 15). When the same 
reaction was carried out in a polar solvent (DMF), the thioetherification in the g-position was 
accompanied by aromatisation.  
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On the other hand, quenching of the sodium enolate of ketone 93 with the less hindered 
dimethyl disulphide in DMF only produced aromatisation (Scheme 16).  
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III. 2. 4 – SYNTHESIS BY SELECTIVE REDUCTION OF THE CYCLOHEXADIENE 
 
Attempts to introduce a removable group in the angular position were unsuccessful and the 
isomerisation of the enone prior to the RCM afforded modest results. Thus, the alternative was 
the reduction of the cyclohexadiene moiety to give more flexibility to the six-membered ring, 
and to allow the cyclisation of the trans isomer. The retrosynthetic analysis that was proposed, 
involved isomerisation of the trans bicyclic system 114 to the more stable cis fused system 
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113 as the final step of the synthesis (Scheme 17). Compound 114 would be reached by olefin 
metathesis of the enone 115, and this enone would be synthesised by nucleophilic/electrophilic 
addition to the chromium complex 12 followed by a Mannich type reaction and selective 
hydrogenation of the C(1)=C(2) bond.  
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Scheme 17 
 
There are precedents for the selective reduction of the double bond a to the oxazoline moiety 
in a similar substrate (Scheme 18).[19] Treatment of cyclohexadiene 116 with DIBAL in ether 
afforded regioselectively the cyclohexene 118. The reaction presumably occurs via initial 
coordination of the Lewis acidic aluminium center with the nitrogen lone-pair. 
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Scheme 18 
 
 Following the same approach, reaction of compound 93 with t-butyldimethyl silyl triflate 
(TBDMSOTf) and triethylamine gave the silyl enol ether 119 (Scheme 19). Then selective 
DIBAL hydrogenation delivered the cyclohexene 120. Next, treatment with the 
Eschenmoser’s salt, methylation and elimination of the quaternary amine afforded the enone 
121. The same synthetic sequence utilising trimethyl silyl triflate (TMSOTf) instead of 
TBDMSOTf, and using in each step the crude of the reaction, led to the enone 121 in 62 % 
overall yield and 64 % d.e. 
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Scheme 19 
 
121 and 122 were separated by chromatography and the synthesis was continued with 121.[20] 
The diastereoselectivity in the reaction is attributed to a protonation of intermediate 123 from 
the less hindered face, syn to the vinyl group (Figure 7).  
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Figure 7. Molecular model of intermediate 123 optimised by the PM3 method. 
 
Next, treatment of the electron poor diene 121 with 10 mol % of the catalyst 29 in toluene at 
80 °C resulted in recovery of the starting material. Enone 121 was therefore reduced to the 
corresponding allylic alcohol using the method developed in the synthesis of the cis-fused 
[6,n] bicyclic systems (Chapter II). Despite these precedents, reduction under Luche 
conditions gave an inseparable mixture of the saturated and unsaturated alcohol in a 1:1 ratio 
(Scheme 20). Variation of the solvent, the number of equivalents or the use of anhydrous 
cerium trichloride did not change the situation. The use of other reducing agents that have 
been reported in the literature for selective 1,2- vs. 1,4-reduction (DIBAL,[21] DIBAL-NEt2[22]) 
only afforded the saturated alcohol 125. Treatment with catalyst RuCl2(PPh3)3 in the presence 
of ethylene diamine and potassium hydroxide under H2 atmosphere,[23] resulted in recovery of 
the starting material. Only the Meerwein-Ponndorf-Verley[24] reduction led exclusively to the 
allylic alcohol 124. This reaction can be carried out with a catalytic amount of aluminium 
ONAl
TMSO
H
H
OMe
123
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alkoxide, though the great affinity of the metal for the ketone and the produced alcohol results 
in a slow ligand exchange that inactivates the catalyst. More convenient is the use of 
lanthanide alkoxides which have high rates of ligand exchange. [25] Nevertheless, the use of a 
catalytic amount of samarium isopropoxide in isopropanol in this case resulted in the 
activation towards Michael addition of the alcohol affording the compound 127.[26] 
 
N O
H
H
OMeO
N O
H
H
OMeHO
N O
H
H
OMeHO
N O
H
H
OMeO
N O
H
H
OMeO
O
 
+ + +
121 124 125 126 127  
 
Entry Reagents Solvent T Product (Yield) 
1 CeCl3. 7 H2O (1 eq.), NaBH4 (4 eq.) MeOH 0 °C 
124 + 125  
(ratio: ~1:1) 
2 CeCl3 (1 eq.), NaBH4 (4 eq.) MeOH 0 °C 
124 + 125  
(ratio: ~1:1) 
3 CeCl3. 7 H2O (4 eq.), NaBH4 (4 eq.) MeOH 0 °C 
124 + 125  
(ratio: ~1:1) 
4 CeCl3. 7 H2O (1 eq.), NaBH4 (4 eq.) EtOH 0 °C 
124 + 125  
(ratio: ~1:1) 
5 DIBAL (1 eq.) Toluene - 78 °C 125 
6 DIBAL (1 eq.), HNEt2 (1 eq.) Ether 0 °C 125 
7 RuCl2(PPh3)3 (0.2 %), ethylene diamine (0.2 %), KOH (0.4 %), H2 (4 atm) 
iPrOH 25 °C SM 
8 Al(OiPr)3 (6 eq.) Toluene 80 °C 124 (57 %) 
9 Sm(OiPr)3 (0.2 eq.), iPrOH (10 eq.) Toluene 80 °C 127 (88 %) 
 
All the experiments were done in a 0.2 mmol scale. 
Scheme 20 
 
As shown in entry 1 reduction with Al(OiPr)3 gave alcohol 124 with complete 
diastereoselectivity (Scheme 21)[27] but moderate yield. The relative stereochemistry of the 
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hydroxyl group in 124 can be explained by the same mechanism proposed for the reduction of 
enone 41 (Chapter II). Subsequent reaction of the alcohol 121 with 10 mol % of the catalyst 29 
in toluene at 80 °C delivered the cis-fused [6,5] ring compound 128 (Scheme 21). 
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N N MesMes
Ph
Toluene, 80 °C
(10 mol %)
61 %
Al(OiPr)3
Toluene, 80 °C
57 %
121 124 128
29
 
 
Scheme 21 
Manganese oxide has been frequently used as a selective and mild oxidizing agent for allylic 
alcohols,[28] in spite of that, treatment of compound 127 with this reagent only resulted in 
partial degradation of the starting material. On the other hand, Dess Martin periodinane and 
tetrapropylammonium perruthenate (TPAP) led to product decomposition (Scheme 22).  
 
N O
OMeOH H
H
N O
OMeO H
H
128 129  
Reactant Solvent Temperature Time Result 
MnO2 (20 eq.) Ether 20 °C 18 h SM + decomposition 
Dess Martin (1.5 eq.) CH2Cl2 20 °C 1 h decomposition 
TPAP (1 eq.), 4Ǻ CH2Cl2 0 °C 30 min Only base line product 
TPAP (10 %), 
NMO (1.5 eq.), 4Ǻ CH2Cl2 20 °C 16 h SM 
Scheme 22 
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The difficulties encountered in this oxidation can be attributed to the strain introduced in the 
trans-fused cyclopentenone product 129. Indeed, the oxidation of the cis-fused [6,5] ring 47 
synthesised previously occurs readily as shown in Scheme 23.  
 
N O
H
OMe
OH
N O
H
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O
MnO2 (20 eq.)
Et2O, 2 h
100 %
47 130  
Scheme 23 
 
To continue the synthesis of the core of the Ottelione, the solution would be to synthesise the 
cis-fused [6,5] ring compound, and then oxidise the allylic alcohol to the desired 
cyclopentenone.  
With this idea on mind, hydrolysis of the methyl enol ether 124 was carried out with p-toluene 
sulfonic acid (PTSA) in acetone. Olefin metathesis of 131 afforded the trans-fused isomer 
that, after stirring for 15 hours with silica gel in ether, gave the cis-fused isomer 132 
exclusively. The relative configuration of the four stereogenic centers was determined 
unambiguously by 1H NOESY spectroscopy (Scheme 24).  
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Scheme 24 
 Chapter III  
 79 
Once we had the desired bicyclic [6,5] compound 132 we envisioned the protection of the 
cyclohexanone as a cyclic acetal. The choice of this protecting group relies in its robustness  
towards the conditions needed for the synthesis of the Ottelione (reductive agents and 
nucleophiles). At the end, it can be easily cleaved by acid-catalysed hydrolysis, or 
oxidation.[29]  
Treatment of the ketone 132 in toluene with ethylene glycol, and a catalytic amount of PTSA 
in the presence of molecular sieves resulted in low conversion after 24 hours of reflux 
(Scheme 25). The addition of more equivalents of PTSA only caused polymerisation of the 
product.  
The use of non-acidic conditions (bistrimethylsilyl derivative of ethylene glycol and 
Me3SiOTf),[30] resulted in recovery of the starting material. Better results were achieved when 
the ketone 132 was stirred at 80 °C in neat ethylene glycol in the presence of copper (II) 
bromide. Unfortunately, the work-up and purification were difficult and only 30 % yield of the 
product 133 was obtained. 
To simplify the purification we decided to protect the carbonyl group as an acyclic acetal 
using methanol and 20 mol % of CuBr2. However, after 24 hours of stirring at reflux the 
conversion was only 57 %. The rate of the reaction was increased by addition of 5 equivalents 
of trimethylorthoformate and the product 134 was attained in 40 % yield. 
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OH H
H
RO OR
N O
H
H
MeO MeO OMe
 133 R = -CH2-CH2-  
134 R= -CH3         
+
132 135
 
Reagents Solvent Temperature Time (h) Conversion % Yield % 
PTSA (10 %), ethylene 
glycol (2 eq.), 4 Å Toluene 80 °C 24 10 - 
PTSA (1 eq.), ethylene 
glycol (2 eq.), 4 Å Toluene 80 °C 24 Polymerisation - 
TMSOTf (10 %), 
TMSO OTMS
(2 eq.)
 
CH2Cl2 - 78 °C to rt 16 0 - 
CuBr2 (20 %) 
Ethylene 
glycol 80 °C 4 100 30 (133) 
CuBr2 (20 %), 4 Å MeOH 70 °C 16 57 - 
CuBr2 (20 %), 
CH(OMe)3 (5 eq.) 
MeOH 70 °C 16 100  
40 (134) + 
19 (135) 
Scheme 25 
 
Subsequent oxidation of the allylic alcohol 134 with manganese dioxide worked sluggishly 
and the conversion after 18 hours was only 10 % (Scheme 26). Addition of more equivalents 
improved the conversion but the formation of the product 136 was accompanied by 
degradation. Use of TPAP only produced degradation of the starting material, and finally, 
Dess Martin periodinane delivered the enone 136 as the only product. 
 
 Chapter III  
 81 
N O
OH H
H
MeO
OMe
N O
O H
H
MeO
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134 136  
 
Reagents Solvent Temperature Yield 
MnO2 (20 eq.) Ether 25 °C 10 % conversion 
TPAP (1 eq.) CH2Cl2 0 °C Decomposition 
Dess-Martin periodinane (1.5 eq.) CH2Cl2 25 °C 56 % 
Scheme 26 
 
With this result we have provided a synthetic route to the core of the Ottelione, that it is 
summarised in Scheme 27. 
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Scheme 27 
 
 To continue the synthesis of the Ottelione next step would be 1,4-addition of vinyl Grignard 
to enone 136. This reaction has been tested using cyclopentenone 130 as a model, and on this 
substrate, the best temperature for the addition was - 40 °C. At lower temperature some 
unreacted starting material was recovered. Also, addition of DMPU was crucial to improve the 
diastereoselectivity of the reaction. In its absence a mixture of two diastereoisomers, in a ratio 
7:3, was obtained. This is presumably due to a coordination of the incoming nucleophile with 
the nitrogen lone pair which allows the attack to the more hindered endo face. The relative 
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stereochemistry of compound 137 could not be established unambiguously, even so, the attack 
is supposed to occur from the less hindered exo face (Scheme 28). 
 
N O
H
OMeO
N O
H
OMeO
MgBr , CuI
Additive, THF, T
130 137  
Additive Temperature Conversion (%) Yield (%) d.e. (%)[31] 
- - 78 °C 64 n.d. n.d. 
- - 40 °C 100 100 40 
DMPU  (10 eq.) - 40 °C 100 84 > 95 
Scheme 28 
 
III. 3 – CONCLUSION 
 
We have achieved the synthesis of the core of the Otteliones from the [Cr(CO)3(p-
methoxyphenyl oxazoline)] complex (12). The more straightforward route, led access to the 
desired cis-fused [6,5] skeleton with only 4 purification steps: dearomatisation of the 
chromium complex, enone formation via Mannich type reaction, isomerisation/reduction of 
the enone, and metathesis. However, the low yield obtained in the isomerisation/reduction step 
was not satisfactory to provide an efficient route towards the synthesis of Ottelione A. To 
circumvent this problem, we proposed a new synthetic route, where the key step is a selective 
reduction of cyclohexadiene 93. Subsequent, enone formation, reduction of the allylic alcohol, 
metathesis and isomerisation afforded the desired cis-fused [6,5] skeleton. 
The use of a chiral auxiliary would provide the diastereosiomerically enriched compound.[32]  
The synthesis of the Ottelione A from this central core is quite straightforward. 1,4- addition 
with vinyl Grignard followed by Wittig reaction and benzylic reduction would lead 
foreseeable to compound 138 with the right stereochemistry (Scheme 29). Next, cleavage of 
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the oxazoline, reduction, elimination and hydrolysis would afford the ketone 139 that can be 
converted in the Ottelione A.[4] 
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Scheme 29 
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IV – PRELIMINARY APPROACHES TOWARDS THE CORE OF TAXOL 
 
IV.1 - INTRODUCTION 
 
The taxane diterpenes[1] (Figure 1) isolated from several types of yew tree have a common 
tricarbocyclic structure containing an sp2 carbon on their bridgehead C11-sites. Such a 
unique structural feature as well as many oxygenated asymmetric centers has made them 
extremely challenging synthetic targets. Among them Taxol, a diterpene produced by 
several plants of genus Taxus,[2] and isolated in 1971 from the cytotoxic methanolic 
extracts of the bark of T. brevifolia[3] has interesting biological properties. It interacts with 
microtubules in a manner that catalyses their formation from tubulin and stabilises the 
resulting structures.[4] In cells this phenomenon leads to an altered morphology with the 
microtubules forming stable bundles and the cell being unable to assemble a normal 
mitotic spindle.[5] Cells treated with Taxol normally arrest at the transition between 
interphase and mitosis and die. These properties have made this compound an efficient 
clinical agent,[6] experiencing rapid development for the treatment of breast,[7] ovarian,[8] 
skin,[9] lung,[10] and head and neck[11] cancers. In 1993, Taxol was approved by the FDA 
for use in the treatment of breast and ovarian cancers.  
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Whilst there are six total syntheses to date,[12] none provide a rapid route which enables 
plentiful supplies of Taxol. Thus, the natural source of Baccatin III (Figure 1) and 10-
deacetylbaccatin III, which are isolable in quantity from leaves of T. Baccata, provide the 
renewable source from which commercial products are made.  
A brief survey of the Taxol structure highlights a forward synthesis which would benefit 
significantly from the inclusion of the dearomatisation methodology developed in our 
laboratory.[13] 
Dearomatisation of an arene complexed to the Cr(CO)3 fragment leads in a single step to 
highly functionalized 1,2-cyclohexadienes that can be considered as precursors for the C-
ring of the taxanes’ skeleton. A suitable choice of the nucleophile and electrophile might 
enable one to bring together fragments leading to ring A. Then, the tricyclic structure 
would be completed by ring closure of the B ring.  
In this chapter we briefly present the preliminary studies that have been carried out in our 
laboratory in order to use the [Cr(CO)3(p-methoxy oxazoline benzene)] complex (12) in 
the synthesis of the central structure of Taxol. 
 
IV. 2 – ATTEMPTS TO USE THE A RING AS ELECTROPHILE IN THE 
DEAROMATISATION 
 
An elegant approach carried out by Dr. A. Pape (post-doctoral associate in this group), 
foresaw in the coupling of the A and C rings in the initial dearomatisation of complex 12.  
Indeed, nucleophilic addition with vinyllithium and quenching with an appropriate A 
fragment would provide access to the advanced intermediate 141 (Scheme 1).  
In the dearomatisation of [Cr(arene)(CO)3] complexes bearing an oxazoline moiety, 
carbonylation is a minor pathway with allyl halides.[14] However, it was hoped that 
migratory CO insertion of the less reactive, bulky allylic bromide 140 would precede the 
reductive elimination. Next, the angular methyl group would be introduced via enolate 
formation. This process would deliver in a single step a unit containing all of the necessary 
carbons for the synthesis of the tricarbocyclic structure in a highly selective fashion, from 
readily available starting materials. 
Once the A and C ring are coupled, the next steps would involve functional group 
transformations and ring closure by Nozaki-Hiyama-Kishi coupling.[15] This strategy 
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should also provide the opportunity to introduce the correct stereochemistry for the ring 
junction by epimerisation of the intermediate aldehyde.  
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Scheme 1 
 
To synthesise allylic bromide 140, diketone 144 was obtained on a 50 gram scale using 
known procedures (Scheme 2).[16] Then, the less hindered ketone was selectively 
protected[17] and converted to vinyl iodide 146.[12d] This compound was readily 
homologated to the alcohol 147 after halo-lithiation and trapping with paraformaldehyde. 
Finally, conversion to the allylic bromide 148 using standard substitution chemistry 
provided the A-ring electrophile of Taxol.  
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Dearomatisation was attempted by nucleophilic addition of in situ generated vinyllithium 
and electrophilic quenching with the allylic bromide 140 (Scheme 3). Nonetheless, the 
products 149 and 150 coming from the monoaddition of vinyllithium were mainly 
recovered. This result presumably is due to the steric hindrance of the electrophile that 
avoids the reaction at the chromium center. The formation of the products 149 and 150 is 
explained by the quenching of the [Cr(CO)3(h5-cyclohexadienyl)] complex with a proton 
source during work-up or by dehydrobromination of 140. 
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Scheme 3 
 
The use of the less hindered unprotected ketone 151 afforded traces of the coupling 
product 152 which had not undergone CO insertion (Scheme 4). Therefore the prediction 
that a more hindered allylic bromide would undergo CO insertion was not correct. The low 
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yield achieved is due to a competitive b-elimination in the electrophile induced by the 
[Cr(CO)3(h5-cyclohexadienyl)] complex. The result does however show that complex alkyl 
units can be used as electrophiles in the dearomatisation chemistry expanding the scope of 
this reaction.  
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Scheme 4 
 
IV. 3 – SYNTHESIS OF THE C RING BY DEAROMATISATION 
 
Another approach that would benefit from the inclusion of the dearomatisation method 
would be the synthesis of the functionalised C ring 154 (Scheme 5). This would be 
obtained by nucleophilic/electrophilic addition of 2-lithio-1,3-dithiane and methyliodide to 
the [Cr(arene)(CO)3] complex 12, followed by the introduction of the angular methyl 
group.  
The interest in the synthesis of the cyclohexadiene 154 relies in the useful and varied 
functional groups that are included in the molecule. Further transformation would allow 
the introduction of all the functionalities of the C ring of Taxol. In particular, the dithiane 
moeity can be used to couple the A ring via Michael addition to 2,6-dimethyl-2-
cyclohexanone (155) and quenching with methyliodide. Or, another alternative, would be 
cleavage of the thioacetal to the corresponding aldehyde and then nucleophilic attack of the 
A ring 159 would give the seco-taxane 160. Finally, ring closure by aldol condensation 
would supply the tricyclic structure 157 or 161 respectively. 
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Scheme 5 
 
IV. 3. 1 – NUCLEOPHILIC ADDITION OF 2-LITHIO-1,3-DITHIANE 
 
Despite the numerous examples of using a dithiane derivative in the dearomatisation of 
[Cr(arene)(CO)3] complexes,[18] previous attempts in our group to introduce this 
functionality on [Cr(arene)(CO)3] complexes bearing an electron-withdrawing group had 
failed.  
We studied the addition of 2-lithio-1,3-dithiane to the [Cr(CO)3(p-methoxy oxazoline 
benzene)] complex 12 by in situ IR spectroscopic measurements. Complex 12 is 
characterized by its CO stretching bands at 1969 and 1891 cm-1 in the IR spectrum in THF. 
On addition of 2 equivalents of the nucleophile, the nCO bands of the starting complex 
totally disappeared. The spectrum of the clear yellow solution now showed 5 new nCO 
bands corresponding to two different compounds. The resonance bands of lower intensity 
appeared at 1903, 1818 and 1787 cm-1. These bands are similar to those of the anionic 
cyclohexadienyl chromium complex previously reported by Semmelhack and to 
intermediates obtained in our laboratory.[14b,19] However, the nCO bands of higher intensity 
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(1938 and 1849 cm-1) were assigned to the ortho-metallated arene 163 by analogy to the 
nCO bands of the reported metalated [Cr(CO)3(naphthalene)] complexes.[20] This 
supposition was confirmed by the disappearance of these two bands and regeneration of 
the starting complex by addition of methanol. Therefore, ortho-metalation, and not 
nucleophilic addition was the main reaction taking place.  
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Lithium dithianes are known to be good nucleophiles in the nucleophilic addition to 
[Cr(arene)(CO)3].[21] Thus, the behaviour as a base in our substrate was attributed to the 
steric environment of the arene. The use of non-polar media has been reported to favour 
nucleophilic addition versus deprotonation.[22] We decided then to test the nucleophilic 
addition in toluene. The procedure was the following: once the lithium species had been 
prepared in THF the solvent was partially evaporated and toluene was added. Finally, this 
mixture was added via a cannula to a solution of complex 12 in toluene. We followed the 
course of the reaction by in situ IR spectroscopy measurement and we observed after 
addition of the nucleophile the appearance of three nCO bands at 1905, 1830 and 1741, 
corresponding to the [Cr(CO3)(h5-cyclohexadienyl)] complex 162 (Scheme 7). 
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Once we had optimised the conditions for the nucleophilic addition of 2-lithio-1,3-dithiane, 
we pursued the reaction sequence by trapping the [Cr(CO)3 (h5-cyclohexadienyl)] complex 
162 with methyliodide under CO atmosphere and using DMPU as co-solvent.[23] 
Subsequent enolisation and introduction of the angular methyl, delivered the ketone 154 in 
58 % yield (Scheme 8). 
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H
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Scheme 8 
 
In order to see the influence of the electrophile in the dearomatisation, we also trapped the 
[Cr(CO)3(h5-cyclohexadienyl)] complex 162 with allylbromide. However, in this case, the 
yield was only 28 % and we attained the products 165 and 166 coming from the 
addition/protonation sequence (Scheme 9).  
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Scheme 9  
 
We argued that the low reactivity of the Cr(CO)3 unit towards the electrophile was due to 
the low concentration of coordinative ligands. Thus, to enhance the reactivity of the 
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cyclohexadienyl anion, the reaction was then performed using a mixture of toluene/THF 
(1:2) during the electrophilic addition (Scheme 10). While this still needs optimisation, the 
approach proved successful and the dearomatised product 164 was achieved in 40 % yield. 
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Scheme 10 
 
IV. 3. 2 – DIASTEREOSELECTIVE DEAROMATISATION USING 2-LITHIO-1,3-
DITHIANE AS NUCLEOPHILE 
 
Our approach towards the synthesis of the tricarbocyclic structure of Taxol requires the 
initial synthesis of optically pure dearomatised product. In chapter II we discussed the 
existing methods for the asymmetric dearomatisation of [Cr(arene)(CO)3] complexes.[24] 
However, the behaviour of the 2-lithio-1,3-dithiane respecting these methods was an 
incognita.   
Dearomatisation with 2-lithio-1,3-dithiane and methyliodide using (S,S)-1,2-diphenyl-1,2-
dimethoxyethane as a chiral ligand,[24a] followed by the introduction of the angular methyl 
group, afforded the desired cyclohexadiene in 61 % yield. However, analysis by chiral 
HPLC showed a low enantiomeric excess (Scheme 11). 
OMe
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S
Ph Ph
MeO OMe
2. DMPU, MeI, CO
     - 78 °C to rt 
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 nBuLi, Toluene,
   - 78 °C 
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61 %
e.e. = 16 %12 154  
Scheme 11 
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In order to provide a better asymmetric access to the dearomatisated product, we turned 
our attention to the use of chiral auxiliaries on the arene.[24b,c] The sequential 
nucleophile/electrophile addition to the chiral oxazoline complex 60 and the RAMP-
hydrazone complex 67, previously synthesised, yielded the methyl ketone 167 and 168 
with a moderate diasteroisomeric excess in the first case and an excellent in the second. 
The yields of these two reactions have not been optimised yet (Scheme 12).  
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Scheme 12 
 
IV. 3. 3 – PRELIMINARY ATTEMPTS TO COUPLE THE A RING 
 
Having gained access to the diasteroisomerically enriched dearomatised product. The next 
target was the A-C ring coupling either by nucleophilic 1,4-addition of the metalated 
dithiane derivative or by cleavage of the thioacetal moiety.  
 
IV. 3. 3. 1 – Metalation of the Dithiane Derivative 
 
In order to investigate the metalation of the dithiane derivative 154 we protected the 
carbonyl group as a t-butyl dimethyl silyl enol ether using standard conditions. Then, 
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deprotonation a to the thioacetal moiety was attempted using nBuLi followed by 
quenching with methyliodide, however, only starting material was recovered. In the 
literature there are precedents of difficult metalation of dithiane derivatives, and in these 
cases the combination of nBuLi with TMEDA or tBuONa with nBuLi were used to form 
the desired metalated species.[25] We used these reagents and we quenched the reaction 
with methyliodide, unfortunately, again, only starting material was obtained. Use of tBuLi 
did not change this situation (Scheme 13).  
 
S
S
TBDMSO
H
OMe
N O
S
S
O
H
OMe
N O
S
S
TBDMSO
H
OMe
N O
1. Base, THF
2. MeI, T to rt
TBDMSOTf, NEt3
CH2Cl2
64 %
154 169 170  
Base T (°C) 
nBuLi (1.5 eq.) - 20  
tBuONa (1.05 eq.), nBuLi (1.05 eq.) - 78  
TMEDA (1.05 eq.), nBuLi (1.05 eq.) - 40  
tBuLi (1.05 eq.) - 20  
Scheme 13 
 
This unexpected result could be explained because the steric environment prohibits the 
abstraction of hydrogen, or by some kind of stabilising interaction of the hydrogen with the 
oxazoline moiety. If these hypotheses are correct, cleavage of the oxazoline moiety and/or 
change of the carbonyl protecting group, would led to the desired metalated intermediate. 
 
IV. 3. 3. 2 – Cleavage of the Dithiane Moiety 
 
To benefit from the introduction of the dithiane moiety, another alternative is the cleavage 
to the corresponding aldehyde, followed by the nucleophilic attack of a suitable A ring. 
Thus, compound 154 was treated with N-chlorosuccinimide (NCS) and NaHCO3 in 
acetone:H2O (9:1),[26] and after appropriate work-up, we could observe the presence of a 
large aldehyde peak in the 1H NMR of the crude (Scheme 14). Unfortunately the aldehyde 
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was very unstable and could not be isolated by column chromatography. Nevertheless, the 
formation of aldehyde 171 was unequivocally confirmed by treatment of the crude mixture 
with t-butyl dimethyl silyl triflate and NEt3 to lead to compound 172 (Scheme 14). 
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Scheme 14 
 
IV. 4 – CONCLUSIONS 
 
We have presented the preliminary results in the use of the [Cr(CO)3 (p-methoxy oxazoline 
benzene)] complex (12) in the synthesis of the tricarbocyclic structure of Taxol.  
The more ambitious approach, the coupling of the A and C rings in the initial 
dearomatisation of the [Cr(arene)(CO)3] complex 12 did not produce the desired results 
since the dearomatisated product was obtained without insertion of CO. Nevertheless, the 
result shows that complex alkyl units can be used as electrophiles in the dearomatisation 
chemistry expanding the scope of this reaction. 
The second approach relied on the synthesis via dearomatisation of a functionalised C ring, 
which would be posteriorly coupled with the A ring. Thus, we have optimised the 
nucleophilic addition of 2-lithio-1,3-dithiane to the [Cr(CO)3(p-methoxy oxazoline 
benzene)] complex (12). Next, the intermediate [Cr(CO)3(h5-cyclohexadienyl)] complex  
has been trapped with allylbromide and methyliodide to obtain the corresponding 
dearomatised products. An asymmetric access to the diasteroisomerically pure 
cyclohexadiene has been provided using RAMP-hydrazone as a chiral auxiliary.  
The enormous potential use of cyclohexadiene 154 in the synthesis of taxanes’ skeleton is 
still under investigation.   
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V – EXPERIMENTAL PART 
 
V.1 - GENERAL 
 
Reactions and manipulations were generally carried out under an atmosphere of N2 using a 
N2/vacuo double manifold, and standard Schlenk techniques, using oven and heat gun-
dried glassware. Solvents were dried by filtration on alumina drying columns using 
Solvtek system. Commercially available solid chemicals were usually used without 
purification unless indicated; liquids were flash-distilled prior to use. When necessary, they 
were purified or dried following standard procedures.[1] Degassed solutions were obtained 
via three freeze/pump/thaw cycles. Flash chromatography was performed in air under 
pressure (0.2-0.3 bar) using silica gel (32-63, 60 Å, Brunschwing) or Florisil (100-200 
mesh, Fluka). Celite 545 and neutral aluminium oxide (50-200 micron) were used as 
filtering materials. IR spectra were measured on a Perkin-Elmer 1650 and on a Perkin-
Elmer One FT-IR spectrometer with a NaCl cell. Some reactions were followed by using 
React-IR 1000 with Sicomp probe with a spectral window between 4450-650 cm-1. NMR 
spectra were measured on a Varian XL-200 or a Bruker AMX-300, AMX-400 or AMX-
500 MHz spectrometer. Diastereoisomeric excess was measured by 1H NMR integration. 
Analytical data corresponds to the major diasteroisomer unless indicated. Chemical shifts 
were referenced to solvent residual peak and are given in ppm relative to SiMe4 (d = 0 
ppm). Optical rotations were measured were measured at 22 °C on a Perkin-Elmer 241 
polarimeter using a quartz cell (l = 10 cm) with a sodium high-pressure lamp (l = 589 nm). 
High resolution mass spectra (HRMS) were measured on a VG analytical 7070E 
instrument (data system 11250, resoln. 7000). HRMS (ESI) were recorded on a QSTAR 
XL (AB / MDS Sciex). Elemental analyses were performed by H. Eder, Service de 
Microanalyse, Section de Pharmacie, Université de Genève. Melting points were measured 
on a Büchi 510 apparatus. 
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V. 2 - EXPERIMENTAL PART RELATED TO CHAPTER II 
 
Tris(triphenylphosphine)dichlororuthenium(II)[2]  
 
Ruthenium trichloride trihydrate (1.0 g, 3.8 mmol) was dissolved in methanol (250 mL) 
and the solution was stirring at reflux for 5 min. After cooling, triphenylphosphine (6.0 g, 
22.9 mmol) was added and the solution was again stirred at reflux under N2 for 3 h. The 
complex precipitated from the hot solution as shiny black crystals; on cooling, they were 
filtered under N2, washed several times with degassed ether, and dried in vacuo to obtain 
the ruthenium complex (2.70 g, 68 %) as grey precipitate; 31P NMR (162 MHz, CDCl3,): d 
= 30.6 (s). 
 
Triphenylphosphine indenylidene ruthenium complex (19)[3]  
 
A two-necked flask equipped with a reflux condenser, was charged 
with [RuCl2(PPh3)3] (3.17 g, 3.3 mmol). THF (185 mL) and 
diphenylpropargyl alcohol (1.02 g, 4.9 mmol) were introduced and the 
resulting mixture was stirred at reflux for 2.5 h. During this period, the 
mixture turned dark-red. Solvent was evaporated in vacuo, the residue was suspended in 
hexane (125 mL) and the suspension was stirred for 3 h until the solid had a homogeneous 
appearance. The powdered solid was filtered off and dried in vacuo affording complex 19 
in quantitative yield; 1H NMR (400 MHz, CD2Cl2): d = 7.60-7.55 (m, 9H), 7.54 (s, 1H), 
7.50 (s, 2H), 7.48-7.42 (m, 13H), 7.38-7.32 (m, 17H),  7.31 (td, J = 7.5 Hz, 1H), 7.25 (dd, 
J = 7.5 Hz, 1H), 7.08 (dd, J = 7.3 Hz, 1H), 6.67 (td, J = 7.4 Hz, 1H), 6.38 (s, 1H); 31P 
NMR (162 MHz, CDCl3): d = 29.8 (s). 
 
Tricyclohexylphosphine indenyliden ruthenium complex (20)[3]  
 
PCy3 (1.0 g, 3.6 mmol) was added to a solution of complex 19 in 
CH2Cl2 (25 mL) and the resulting mixture was stirred for 2 h at 25 °C. 
The solvent was evaporated and the crude product was suspended in 
hexane (40 mL). The suspension was stirred for 3 h at 25 °C, and the 
finely powdered complex was filtered off. Then it was carefully washed with hexane (30 
Ru
Ph
PPh3
PPh3
Cl
Cl
Ru
Ph
PCy3
PCy3
Cl
Cl
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mL) in several portions. Drying of the product in vacuo afforded complex 20 as an orange 
powder (536 mg, 59 %); 1H NMR (400 MHz, CD2Cl2): d = 8.67 (dd, J = 7.5 Hz, 1H), 
7.80-7.73 (m, 2H), 7.55-7.48 (m, 1H), 7.42-7.38 (m, 2H), 7.39 (s, 1H), 7.38 (td, J = 7.3 
Hz, 1H), 7.29 (td, J = 7.5 Hz, 1H), 7.27 (dd, J = 7.3 Hz, 1H), 2.63-2.54 (m, 6H), 1.82-1.75 
(m, 4H), 1.74-1.70 (m, 4H), 1.69-1.66 (m, 8H), 1.65-1.60 (m, 8H), 1.56-1.51 (m, 6H), 
1.50-1.44 (m, 12H), 1.25-1.15 (m, 18H); 31P NMR (162 MHz, CDCl3): d = 33.6 (s). 
 
N,N’-Bis-(2,4,6-trimethylphenylamino)ethane (23)[4] 
 
To a solution of glyoxal (4.6 mL, 40 mmol, 40 % wt in H2O) in iPrOH (50 mL) 
and H2O (50 mL) was added mesitylamine (12.8 mL, 88 mmol) at 0 °C. The 
reaction mixture was warmed up to rt. Immediately upon addition of the amine, 
yellow precipitates formed. After 24 h of stirring at ambient temperature, the 
precipitates were filtered and washed with H2O and 3 times with hexanes. The yellow solid 
obtained was dried  in vacuo to yield the diimine 23 (9.8 g, 84 %); mp = 157-158 °C; 1H 
NMR (400 MHz; CDCl3): d = 8.13 (s, 2H), 6.93 (s, 4H), 2.32 (s, 6H), 2.19 (s, 12H); 13C 
NMR (100 MHz; CDCl3): d = 163.0, 147.4, 134.1, 128.9, 126.5, 20.7, 18.2. 
 
N,N’-Bis-(2,4,6-trimethylphenylamino)ethane dihydrochloride (24)[4] 
 
To a solution of diimine 23 (5.0 g, 17 mmol) in THF (60 mL) was added 
NaBH4 (2.57 g, 68 mmol) at 0 °C. Concentrated HCl (3.4 mL, 34 mmol) was 
added dropwise. After the HCl addition, the reaction mixture was stirred at 0 
°C for 1 h. Then, 3 M HCl (156 mL) was added carefully to the flask at 0 °C 
and the mixture was stirred for an additional 1 h, allowing the temperature to rise to rt. The 
resulting white precipitates were filtered and washed with water (120 mL) and 5 % 
acetone-ether (100 mL) in vacuo. The product 24 (4.98 g, 80 %) was obtained as a white 
solid and dried; mp > 250 °C; 1H NMR (200 MHz, DMSO-d6): d = 6.96 (s, 4H), 3.67 (s, 
4H), 2.44 (s, 12H), 2.22 (s, 6H); 13C NMR (50 MHz, DMSO-d6): d = 137.6, 132.3, 131.4, 
129.4, 50.7, 20.9, 18.3. 
 
N
N
Mes
Mes
NH
NH
Mes
Mes
 HCl
HCl
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1,3-Bis-(2,4,6-trimethylphenyl)imidazolinium Chloride (25)[4]  
 
A solution of the diimine salt 24 (6.0 g, 16 mmol) in 
triethylorthoformiate (19 mL, 112 mmol) with two drops of formic 
acid was prepared in a two necked flask with distillation apparatus. 
The solution was then heated to 120 °C and was stirred at this temperature for 5 h with 
removal of ethanol by distillation. Then, the solution was cooled to rt and hexane (140 mL) 
was added. After 1 h of stirring, the solution was filtered off, and the precipitate was 
washed 3 times with hexane first, and then 3 times with THF to obtain compound 25 (4.4 
g, 85 %) as a white solid; mp > 250 °C; 1H NMR (200 MHz, DMSO-d6): d = 9.21 (s, 1H), 
7.10 (s, 4H), 4.49 (s, 4H), 2.37 (s, 12H), 2.31 (s, 6H); 13C NMR (200 MHz, DMSO-d6): d 
= 160.2, 139.5, 135.3, 130.8, 129.3, 50.9, 20.5, 17.2. 
 
1,3-Bis-(2,4,6-trimethylphenyl)imidazolin-2-ylidene (26)[4] 
 
Compound 25 (1,3 g, 3.7 mmol) was added to a suspension of KH 
(606 mg, 15.1 mmol) in THF (60 mL). The mixture was stirred for 3 
hours at 25 °C and then the yellow solution was filtered under N2 
through a frit covered with celite. The solvents were evaporated to recover a yellow oil 
(425 mg, 50 %) that was used directly in the next step. 
 
1,3-Bis-(2,4,6-trimethylphenyl)imidazolium chloride (27)[4] 
 
A solution of trimethyl aniline (7 mL, 50 mmol) in toluene (8 mL) was 
prepared and added slowly with a dropping funnel to a solution of 
paraformaldehyde (750 mg, 25 mmol) in toluene (7 mL). The mixture 
was then heated to 100 °C, until it became clear (aprox. 5 min). It was cooled to 40 °C and 
HCl 6M (4.15 mL, 25 mmol) was added slowly. When the addition was completed, the 
mixture was stirred for 5 min before addition of glyoxal (40 % in water, 2.9 mL, 25 mmol). 
Then, the solution was heated at 100 °C with removal of water by distillation for 2 h. The 
mixture was then cooled to rt and the solvents were evaporated to give compound 27 (7.41 
g, 97 %) as a black solid; 1H NMR (DMSO-d6): d = 9.74 (s, 1H), 8.28 (s, 2H), 7.19 (s, 4H), 
2.48 (s, 6H), 2.11 (s, 12H). 
NN MesMes
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1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (28)[4] 
 
A two-necked flask equipped was charged with the imidazolium salt 27 
(1.0 g, 3.3 mmol) and THF (8 mL). The resulting suspension was stirred 
for 15 min, and then potassium tert-butoxide (1M in THF, 3.6 mL, 3.6 
mmol) was added to the solution. The mixture was stirred for 20 min, then, the volatiles 
were removed in vacuo. The residue was extracted with warm toluene and filtered through 
Celite under nitrogen atmosphere. The solvent was then removed in vacuo to provide 
product 28 (690 mg, 77 %) brown solid. Crystallization in hexanes gave the product as 
brown crystals; 1H NMR (200 MHz, THF-d8): d = 7.04 (s, 2H), 6.94 (s, 4H), 2.30 (s, 6H), 
2.02 (s, 12H). 
 
(1,3-Bis-(2,4,6-trimethylphenyl)imidazolin-2-ylidene) (PCy3)Cl2Ru (3-
phenylindenylid-1-ene) (29) 
 
Complex 20 (900 mg, 0.98 mmol) was added in one portion to a 
suspension of compound 26 (425 mg, 1.4 mmol) in benzene (25 mL). 
The mixture was heated for 30 min with stirring at 40 °C. After the 
solvent was filtered off and the precipitate washed 3 times with 
pentane to obtain complex 29 (712 mg, 83 %) as a violet sand powder; 1H NMR (400 
MHz, C2Cl2): d = 8.62-8.55 (m, 1H), 7.85-7.77 (m, 2H), 7.65-7.12 (m, 6H), 7.08-7.02 (m, 
2H), 6.42 (s, 1H), 6.04 (s, 1H), 4.05-3.71 (m, 4H), 2.70 (s, 6H), 2.37 (m, 3H), 2.20 (s, 3H), 
2.08 (s, 3H), 1.95  (s, 3H), 1.89-1.85 (m, 3H), 1.84 (s, 3H), 1.82-1.30 (m, 21H), 1.17-0.93 
(m, 6H); 31P NMR (162 MHz, C6D6): d = 26.5(s). 
 
(1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene) (PCy3)Cl2Ru (3-phenylindenylid-1-
ene) (30)[5] 
 
Carbene 28 (38 mg, 0.125 mmol) was suspended in hexanes (7 mL) 
before complex 30 (116 mg, 0.126 mmol) was added in one portion. 
The mixture was heated for 2.5 h at 60 °C. After the solvent was 
filtered off and the precipitate was washed 3 times with pentane to 
obtain complex 30 (80 mg, 67 %) as a red sand powder; 1H NMR (400 MHz, C6D6): d = 
NNMes Mes
Ru
Ph
PCy3
Cl
Cl
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9.10-9.07 (m, 1H), 7.85 (m, 2H), 7.80 (s, 1H), 7.05-7.30 (m, 6H), 6.91 (s, 2H), 6.42 (s, 
1H), 6.10 (s, 2H), 5.98 (s, 1H), 2.63 (s, 3H), 2.62 (s, 3H), 2.47 (m, 3H), 2.19 (s, 3H), 2.17 
(s, 3H), 2.00 (s, 3H), 1.89-1.85 (m, 3H), 1.76 (s, 3H), 1.74-1.70 (m, 3H), 1.57-1.53 (m, 
3H), 1.51-1.48 (m, 3H), 1.00-1.41 (m, 18H); 31P NMR (162 MHz, C6D6): d = 28.9 (s). 
 
4,4-Dimethyl-2-[4-methoxyphenyl]-4,5-dihydro-oxazole (31)[6] 
 
A three-necked flask equipped with a reflux condenser and a dropping funnel 
was charged with 2-amino-2methylpropan-1-ol (20 mL, 209 mmol) dissolved in 
CH2Cl2 (80 mL). Then p-anisoylchloride (14 mL, 104 mmol) in CH2Cl2 (60 
mL) was slowly added at 0 °C. The resultant white precipitate was allowed to 
warm up to rt for 6 h. The solvent was partially removed in vacuo until 30 mL. 
Then, thionyl chloride (30 mL, 416 mmol) was slowly added at 0 °C, and the 
mixture was allowed to warm up for 16 h. Ether (100 mL) was added and the solution was 
neutralised with NaOH (20 % in water). The organic layer was separated and the water 
phase was washed three times with ether. Combined ether extracts were washed with brine 
and dried with MgSO4. Evaporation of the solvents gave the pure oxazoline 31 (20.5 g, 96 
%) as pale yellow oil; IR (CH2Cl2): n = 2946, 1646, 1610, 1463, 1354, 1308, 1252, 1170, 
1069, 1030, 842 cm-1; 1H NMR (200 MHz, C6D6): d = 7.89 (d, J = 8.9 Hz, 2H), 6.89 (d, J 
= 8.9 Hz, 2H), 4.08 (s, 2H), 3.82 (s, 3H), 1.37 (s, 6H); 13C NMR (50 MHz, C6D6): d = 
162.0, 130.1, 120.2, 113.6, 79.1, 77.7, 77.0, 76.4, 67.2, 55.3, 28.4; MS (m/z): 205 (20), 191 
(12), 190 (100), 162 (19), 134 (34); HRMS (EI) on (M+) for C12H15NO2 requires: 
205.1102, found: 205.1093.  
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-benzene chromium 
tricarbonyl (12)[7] 
 
A solution of the oxazoline 31 (15.0 g, 73 mmol), chromium 
hexacarbonyl (16.0 g, 73 mmol) dibutylether (300 mL) and THF (30 mL) 
was degassed.  The solution was heated at 140 °C in the absence of light 
for 64 h. The mixture was transferred to another flask and concentrated 
under reduced pressure to give a green oil. The residue was dissolved in 
ether and filtered through Celite. Then it was recrystallised in 150 mL of 
OMe
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a mixture (ether:hexane / 1:2) to obtain the complex 12 (15.0 g, 60 %) as a bright yellow 
solid; mp: 104 °C; IR (CH2C12): n = 1972, 1897 cm-1; lH NMR (200 MHz, C6D6): d = 6.02 
(d, J = 7.1 Hz, 2H), 4.28 (d, J = 6.5 Hz, 2H), 3.59 (s, 2H), 2.85 (s, 3H), 1.10 (s, 6H); MS 
(m/z): 341 (2), 285 (6), 257 (28), 185 (41); HRMS (EI) on (M+) for C15H15CrNO5 requires: 
341.0355, found: 341.0348.  
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-allyl-cyclohexa-
2,4-dienyl]-ethanone (32) 
 
nBuLi (1.6 M in hexanes, 2 mL, 3.25 mmol) was rapidly added to 
tetraallyltin (385 mL, 1.6 mmol) at 25 °C. The white suspension was stirred 
for 2 h and then cooled to – 78 °C before addition of THF (20 mL). 
Complex 12 (852 mg, 2.5 mmol) was added as a solid in one portion and 
the resulting orange solution was stirred at – 78 °C for 1 h. nBu4NBr (1.047 
g, 3.25 mmol) and MeI (750 mL, 12.5 mmol) were next added and the 
mixture was placed under an atmosphere of CO (1.5 bar) and warmed to rt for 16 h. Excess 
CO was vented and the volatiles were removed under reduced pressure. The residue was 
dissolved in THF (25 mL), cooled to – 78 oC and sodium ethoxide (2.56 M (freshly 
prepared by slow addition of Na to EtOH), 940 mL, 3.75 mmol) was added. The mixture 
was stirred for 1 h before methyl iodide (470 mL, 7.5 mmol) was added and the mixture 
was allowed to warm to rt for 16 h. The solution was concentrated under reduced pressure 
and purification by FC (cyclohexane:AcOEt / 1:1) afforded 32 (668 mg, 88 %) as a pale 
yellow solid; mp = 56-58 °C; IR (CH2Cl2): n = 2964, 2932, 1703, 1605, 1572, 1458, 1354, 
1245, 1201, 1043, 1000, 913 cm-1; 1H NMR (200 MHz, CDCl3): d = 6.98 (d, J  = 6.7 Hz, 
1H), 6.22-6.02 (m, 1H), 5.09-4.93 (m, 2H), 4.77 (d, J = 6.7 Hz, 1H), 3.71 (d, J = 7.9 Hz, 
2H), 3.44 (t, J = 6.4 Hz, 1H), 3.04 (s, 3H), 2.47 (t, J = 6.4 Hz, 2H), 2.03 (s, 3H), 1.45 (s, 
3H), 1.23 (s, 3H), 1.19 (s, 3H); 13C NMR (50 MHz, CDCl3): d = 207.3, 165.3, 162.1, 
136.7, 119.9, 115.4, 93.3, 78.3, 67.4, 56.6, 54.6, 44.4, 35.7, 30.7, 28.0, 21.6; MS (m/z): 
303 (14), 274 (10), 260 (89), 220 (100), 149 (29), 148 (28); HRMS (EI) on (M+) for 
C18H25NO3 requires: 303.1834, found: 303.1823. 
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1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-allyl-cyclohexa-
2,4-dienyl]-pent-4-en-1-one (33) 
 
Procedure 1: nBuLi (1.6M in hexanes, 1.25 mL, 2.0 mmol) was added 
very slowly to a solution of tetraallylstannane (120 mL, 0.5 mmol) in 
Et2O (2.5 mL) at - 10 oC. The turbid mixture was stirred for 30 min and 
then THF (1 mL) was added to give a clear yellow solution and stirring 
was continued for a further 10 min. The solution was then diluted with 
THF (5 mL) and cooled to - 78 oC, before complex 12 (341 mg, 1 mmol) 
was added as a solid in one portion. The yellow solution was stirred 16 h at – 40 °C in the 
absence of light.  The orange solution was cooled to - 78 oC and DMPU (1.2 mL, 10 
mmol), followed by methyl iodide (330 mL, 5.3 mmol), was added. The mixture was 
placed under an atmosphere of CO (3.0 Bar) and stirred at rt for 7 h. The CO was vented 
and the volatiles were removed under reduced pressure.  The residue was dissolved in THF 
(10 mL), cooled to – 78 oC and sodium ethoxide (2.5 M, 600 mL, 1.5 mmol) was added.  
The mixture was stirred for 1 h before methyl iodide (100 mL, 1.5 mmol) was added and 
the mixture was allowed to warm to rt for 16 h. The volatiles were removed in vacuo. The 
residue was dissolved in THF (10 mL) and NaHMDS (1M in THF, 1.2 mL, 1.2 mmol) was 
added dropwise at - 78 oC.  The mixture was stirred at 0 oC for 1 h and then allyl bromide 
(220 mL, 2.5 mmol) was added at - 78 oC. The solution was warmed to rt 16 h and then 
concentrated under reduced pressure. The residue was purified by FC (cyclohexane:Et2O / 
6:4) to give 33 (251 mg, 73 %) as a pale yellow oil. 
Procedure 2: A solution of the methyl ketone 32 (290 mg, 0.96 mmol) in THF (8 mL) was 
added to freshly prepared LDA (addition of nBuLi (1.6 M, 700 mL, 1.12 mmol) to a 
solution of diisopropylamine (200 mL, 1.43 mmol) in THF (5 mL) at 0 ºC) at – 78 oC.  The 
mixture was stirred for 2 h and then allyl bromide (200 mL, 2.31 mmol) was added.  The 
yellow/brown solution was allowed to warm to rt for 16 h and then a saturated aqueous 
ammonium chloride solution was added.  The aqueous layer was separated and extracted 3 
times with ether. The organic phases were combined, washed with brine, dried over 
MgSO4 and concentrated under reduced pressure. Purification by FC (cyclohexane:AcOEt 
/ 1:1) gave 33 (250 mg, 76 %) as a pale yellow oil; IR (CH2Cl2): n = 2971, 2934, 1703, 
1606, 1572, 1461, 1265, 1247, 1207, 1001, 916 cm-1; 1H NMR (200 MHz, C6D6): d = 6.94 
(d, J = 6.7 Hz, 1H), 6.22-5.98 (m, 1H), 5.87-5.66 (m, 1H), 5.09-4.88 (m, 4H), 4.74 (d, J = 
OMe
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6.7 Hz, 1H), 3.68 (d, J = 7.9 Hz, 2H), 3.43 (t, J = 7.1 Hz, 1H), 3.02 (s, 3H), 2.58-2.29 (m, 
6H), 1.41 (s, 3H), 1.20 (s, 3H), 1.15 (s, 3H); 13C NMR (50 MHz, C6D6): d = 209.0, 166.1, 
162.6, 138.2, 137.0, 119.9, 115.8, 115.2, 93.8, 78.7, 67.7, 56.9, 54.9, 44.9, 42.1, 36.0, 28.7, 
28.4, 21.9; MS (m/z): 343 (4), 261 (12), 260 (58), 220 (73), 204 (10), 149 (13); HRMS 
(EI) on (M+) for C21H29NO3 requires: 343.2147, found: 343.2152. 
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-vinyl-cyclohexa-
2,4-dienyl]-ethanone (34) 
 
Complex 12 (1.364 g, 4 mmol) was treated with vinyllithium (prepared 
from nBuLi and tetravinyltin) and MeI/CO following the procedure 
described for the preparation of 32. Purification by FC (cyclohexane:AcOEt 
/ 6:4) gave the cyclohexadiene 34 (1.021 g, 88 %) as a pale yellow solid; 
mp = 94-97 °C; IR (CH2Cl2): n = 2970, 1706, 1607, 1571, 1461, 1269, 
1203, 1039, 1001 cm-1; 1H NMR (200 MHz, C6D6): d = 6.94 (d, J = 6.7 Hz, 
1H), 5.98-5.78 (m, 1H), 5.34 (dd, J = 1.92, 16.9 Hz, 1H), 4.95 (dd, J  = 1.92, 9.9 Hz, 1H), 
4.72 (d, J = 6.7 Hz, 1H), 3.77 (d, J = 9.5 Hz, 1H), 3.67 (s, 2H), 2.95 (s, 3H), 2.02 (s, 3H), 
1.49 (s, 3H), 1.18 (s, 3H), 1.13 (s, 3H); 13C NMR (50 MHz, C6D6): d = 206.4, 165.0, 161.1, 
136.0, 119.1, 117.2, 93.5, 78.5, 67.6, 57.9, 54.8, 50.7, 31.2, 28.5, 28.3, 22.9, 20.6; MS 
(m/z): 289 (20), 260 (14), 247 (18), 246 (100), 230 (33), 220 (20), 175 (20), 149 (12); 
HRMS (EI) on (M+) for C17H23NO3 requires: 289.1678, found: 289.1670.  
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-vinyl-cyclohexa-
2,4-dienyl]-pent-4-en-1-one (35) 
 
Procedure 1: Complex 12 (341 g, 1 mmol) was treated with vinyllithium 
(prepared from nBuLi and tetravinyltin) and MeI/CO following the 
procedure 1 described for the preparation of 33. Purification by FC 
(cyclohexane:Et2O / 6:4) gave 35 (254 mg, 77 %) as a pale yellow oil. 
Procedure 2: Compound 34 (289 mg, 1 mmol) was treated following the 
procedure 2 described for the preparation of 32. Purification by FC 
(cyclohexane:Et2O / 1:1) gave 35 (263 mg, 80 %) as a pale yellow solid; mp= 87-89 °C; 
IR(CH2Cl2): n = 2972, 2939, 1705, 1607, 1571, 1461, 1378, 1263, 1039, 1002, 919 cm-1; 
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1H NMR (200 MHz, C6D6): d = 6.93 (d, J = 6.7 Hz, 1H), 6.18-5.71 (m, 2H), 5.53 (dd, J = 
2, 17 Hz, 1H), 5.08-4.91 (m, 3H), 4.73 (d, J = 6.7 Hz, 1H), 3.78 (d, J = 9.6 Hz, 1H), 3.66 
(s, 2H), 2.94 (s, 3H), 2.61-2.32 (m, 4H), 1.49 (s, 3H), 1.18 (s, 3H), 1.12 (s, 3H); 13C NMR 
(50 MHz, C6D6): d = 208.1, 164.9, 160.8, 138.2, 135.2, 118.4, 117.1, 114.4, 93.5, 78.2, 
67.4, 57.5, 54.5, 50.6, 42.5, 28.5, 28.3, 28.1, 20.4; MS (m/z): 329 (12), 247 (24), 246 
(100), 230 (27), 220 (71), 175 (21), 149 (25); HRMS (EI) on (M+) for C20H27NO3 requires: 
329.1991, found: 329.1970.  
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-cyclohexa-2,4-dienyl]-
propan-1-one (36) 
 
nBuLi (1.6 M in hexanes, 750 mL, 1.2 mmol) was rapidly added to 
tetravinyltin (110 mL, 0.6 mmol) at 25 °C. The white solution was stirred 2 
h and then cooled to - 78 °C before addition of THF (8 mL). Complex 12 
(341 mg, 1 mmol) was added as a solid in one portion and the resulting 
orange solution was stirred at this temperature for 1 h. After this time, 
DMPU (1.2 mL, 10 mmol) and EtI (800 mL, 10 mmol) were next added. 
The mixture was placed under an atmosphere of CO (1.5 Bar) and warmed up to rt for 16 
h. Then, it was stirred at 50 °C for 1 h. Excess CO was vented and the volatiles were 
removed under reduced pressure. The residue was purified by FC (cyclohexane:Et2O / 6:4) 
to give cyclohexadiene 36 (194 mg, 67 %) as a pale yellow solid; mp = 67-69 °C; 1H NMR 
(500 MHz, CDCl3): d = 6.77 (bs, 1H), 5.86-5.80 (m, 1H), 5.23 (d, J = 5.8 Hz, 1H), 5.05 (d, 
J = 6.4 Hz, 1H), 5.01 (d, J = 10.4 Hz, 1H), 3.97 (d, J = 4.9 Hz, 1H), 3.95 (d, J = 7.9 Hz, 
1H), 3.89 (d, 2J = 7.9 Hz, 1H), 3.70 (s, 3H), 3.06 (s, 1H), 2.60-2.47 (m, 2H), 1.32 (s, 3H), 
1.26 (s, 3H), 1.01 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3): d = 207.1, 161.5, 
158.9, 136.2, 114.2, 94.5, 78.6, 67.1, 55.4, 55.4, 53.2, 39.1, 33.1, 28.3, 28.1, 7.7; MS 
(m/z): 289 (15), 274 (4), 258 (2), 233 (23), 232 (100), 230 (11), 207 (10), 206 (70).   
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1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-vinyl-cyclohexa-
2,4-dienyl]-propan-1-one (37) 
 
Sodium ethoxide (2.46 M (freshly prepared by slow addition of Na to 
EtOH), 820 mL, 2.01 mmol) was added dropwise to a solution of 36 (387 
mg, 1.34 mmol) in THF (10 mL) at – 78 oC.  The mixture was stirred for 1 
h before methyl iodide (125 mL, 2.01 mmol) was added and the mixture was 
allowed to warm to rt for 16 h. The solution was concentrated in vacuo and 
purified by FC (cyclohexane:Et2O / 6:4) to give 37 (384 mg, 95 %) as a 
colourless oil; IR (CH2Cl2): n = 2974, 2934, 1706, 1654, 1607, 1570, 1456, 1378, 1246, 
1039, 1003 cm-1; 1H NMR (400 MHz, C6D6): d = 6.84 (d, J = 6.7 Hz, 1H), 5.78 (dt, J = 
16.9, 9.7 Hz, 1H), 5.21 (dd, J = 16.9, 2.0 Hz, 1H), 4.84, (dd, J = 9.7, 2.0 Hz, 1H), 4.69 (d, 
J = 6.7 Hz, 1H), 3.65 (d, J = 9.7 Hz, 1H), 3.62-3.57 (m, 2H), 2.94 (s, 3H), 2.34-2.16 (m, 
2H), 1.40 (s, 3H), 1.10 (s, 3H), 1.05 (s, 3H), 0.99 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, 
C6D6): d = 209.3, 164.9, 135.2, 127.1, 118.5, 116.7, 93.3, 78.0, 67.2, 57.4, 54.4, 50.5, 35.9, 
28.1, 27.9, 20.2, 7.8; MS (m/z): 303 (9), 302 (2), 246 (100), 220 (37) , 175 (20), 149 (12); 
HRMS (EI) on (M+) for C18H25O3N requires: 302.1756, found 302.1712. 
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-vinyl-cyclohexa-
2,4-dienyl]-propenone (38) 
 
Procedure 1: NaHMDS (1M in THF, 2.3 mL, 2.30 mmol) was added 
dropwise to a solution of 37 (348 mg, 1.15 mmol) in THF (16 mL) at – 78 
oC.  The mixture was stirred for 4 h and then phenylseleniumbromide (408 
mg, 1.73 mmol) was added in one portion. The mixture was warmed to rt 
for 16 h. A saturated aqueous NH4Cl solution was added and the mixture 
was extracted with Et2O. The organics were combined, washed with brine, 
dried over MgSO4 and concentrated in vacuo. The residue was purified by FC 
(cyclohexane:Et2O / 7:3) to give the product of selenation (389 mg) as a mixture of  the 
two diastereoisomers. They were dissolved in CH2Cl2 (5 mL) and cooled to – 78 °C before 
dropwise addition of 30 % aqueous solution of hydrogen peroxide (200 mL, 1.70 mmol). 
The mixture was stirred at 0 oC for 3 h and then concentrated and purified by FC 
(cyclohexane:Et2O / 3:7) to give 38 (160 mg, 46 %) as a white solid. 
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Procedure 2: TMSOTf (270 mL, 1.5 mmol) was slowly added to a solution of 34 (289 mg, 
1 mmol) and NEt3 (210 mL, 1.5 mmol) in CH2Cl2 (14 mL) at 0 °C. The mixture was stirred 
1 h and then filtered with ether over a pad of neutral alumina activated with 10 % water. 
Solvents were evaporated and the oil was dissolved in CH2Cl2 (12.5 mL) and added via 
syringe to a suspension of Eschenmoser’s salt (364 mg, 2 mmol) in CH2Cl2 (25 mL) at 0 
°C. The mixture was stirred for 2 h and then NaOH (1 M in H2O, 1.3 mL, 1.3 mmol) was 
added and the mixture was poured onto H2O and extracted 3 times with CH2Cl2. The 
combined organic layers were washed with brine and dried with Na2SO4. Solvents were 
evaporated to obtain a grey-green oil which was dissolved in CH2Cl2 (25 mL) and MeI (90 
mL, 1.5 mmol) was added. After 15 min a precipitate appeared and the mixture was stirred 
for 1.5 h. Then a saturated NaHCO3 aqueous solution was added and the mixture was 
extracted 3 times with CH2Cl2 and the combined organic layers were washed with brine 
and dried with MgSO4. Solvents were evaporated and the residue was purified by FC 
(cyclohexane:AcOEt  / 3:7) to give 38 (222 mg, 74 %) as a white solid; mp= 87-89 °C; IR 
(CH2Cl2): n = 2970, 2934, 1697, 1609, 1573, 1456, 1398, 1246, 1039, 1003 cm-1;  1H 
NMR (400 MHz, C6D6): d = 6.90 (d, J = 6.7 Hz, 1H), 6.25-6.23 (m, 2H), 5.77 (dt, J = 19.2, 
9.6 Hz, 1H), 5.28 (dd, J =  1.9, 16.9 Hz, 1H), 5.04 (dd, J = 6.7, 5.6 Hz, 1H), 4.92 (dd, J = 
1.9, 9.6 Hz, 1H), 4.69 (d, J = 6.7 Hz, 1H), 3.79 (d, J = 9.6 Hz, 1H), 3.60 (m, 2H), 2.89 (s, 
3H) 1.50 (s, 3H), 1.11 (s, 3H), 1.04 (s, 3H); 13C NMR (125 MHz, C6D6): d = 197.9, 164.8, 
161.1, 136.6, 135.0, 127.5, 123.9, 119.3, 117.9, 93.8, 78.5, 67.7, 55.8, 54.8, 50.9, 28.5, 
28.3, 20.4; MS (m/z): 301 (4), 273 (5), 246 (100), 230 (37), 175 (25), 149 (15); HRMS 
(EI) on (M+) for C18H23O3N requires: 301.1677, found: 301.1646. 
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-allyl-cyclohexa-
2,4-dienyl]-propan-1-one (39). 
 
Complex 12 (682 mg, 2.0 mmol) was treated with allyllithium 
(prepared from nBuLi and tetraallylstannane) and EtI/CO following the 
procedure described for the preparation of 36. Purification by FC 
(cyclohexane:Et2O / 6:4) gave 39 (530 mg, 87 %) as a pale yellow oil; 
IR (CH2Cl2): n = 2972, 2933, 1713, 1608, 1578, 1457, 1379, 1348, 
1298, 1199, 1172, 1031, 996 cm-1; 1H NMR (400 MHz; C6D6): d = 6.90 
(d, J = 6.5 Hz, 1H), 5.83-5.77 (m, 1H), 5.02-4.94 (m, 2H), 4.80 (d, J = 6.5 Hz, 1H), 3.82 
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(dd, J = 10.1, 4.2 Hz, 1H), 3.59 (d, J = 7.8 Hz, 1H), 3.53 (d, J = 7.8 Hz, 1H), 3.10 (s, 1H), 
3.02 (s, 3H), 2.67-2.53 (m, 1H), 2.30-2.12 (m, 3H), 1.06 (s, 6H), 0.83 (t, J = 7.2 Hz, 3H); 
13C (100 MHz, C6D6): d = 206.9, 161.9, 159.7, 136.8, 129.0, 122.3, 117.9, 95.0, 78.8, 67.9, 
54.9, 54.8, 37.3, 36.9, 33.5, 28.6, 28.4, 8.3; MS (m/z): m/z (EI) 303 (7), 246 (25), 206 
(100), 190 (6), 135 (18); HRMS (EI) on (M+) for C18H25O3N requires: 303.1834, found: 
303.1820.  
 
1-[6-Allyl-5-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-cyclohexa-
2,4-dienyl]-propan-1-one (40) 
 
Compound 39 (519 mg, 1.71 mmol) was treated following the procedure 
described for the preparation of 37. Purification by FC 
(cyclohexane:Et2O / 1:1) gave 40 (461 mg, 85 %) as a colourless oil; IR 
(CH2Cl2): n = 2972, 2936, 1706, 1606, 1572, 1460, 1379, 1247, 1044, 
1002, 975 cm-1; 1H NMR (400 MHz; C6D6): d = 6.90 (d, J = 6.7 Hz, 1H), 
6.12-6.01 (m, 1H), 4.97 (dd, J = 14.9, 1.2 Hz, 1H), 4.88 (ddd, J = 10.0, 
2.2, 1.2 Hz, 1H), 4.66 (d, J = 6.7 Hz, 1H), 3.65 (d, J = 7.8 Hz, 1H), 3.58 (d, J = 7.8 Hz, 
1H), 3.38 (t, J = 6.8 Hz, 1H), 2.94 (s, 3H), 2.39-2.36 (m, 2H), 2.29-2.12 (m, 2H), 1.37 (s, 
3H), 1.14 (s, 3H), 1.10 (s, 3H), 0.96 (t, J = 7.1 Hz, 3H); MS (m/z): 317 (11), 274 (8), 260 
(91), 220 (100), 204 (16), 149 (25); HRMS (EI) on (M+) for C19H27O3N requires: 
317.1991, found: 317.1955.  
 
1-[6-Allyl-5-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-cyclohexa-
2,4-dienyl]-propenone (41) 
 
Procedure 1: Compound 40 (422 g, 1.33 mmol) was treated following the 
procedure 1 described for the preparation of 38. Purification by 
chromatography (cyclohexane:Et2O / 1:1) gave 41 (249 mg, 79 %) as a 
pale yellow powder.  
Procedure 2: Compound 32 (303 mg, 1 mmol) was reacted following the 
procedure 2 described for the preparation of 38. Purification by FC 
(cyclohexane:AcOEt / 6:4) gave 41 (185 mg, 59 %) as a pale yellow powder; mp = 125-
126 °C; IR (CH2Cl2): n = 2971, 2934, 1693, 1609, 1573, 1398, 1246, 1048, 1003 cm-1; 1H 
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NMR (500 MHz, C6D6): d = 7.0 (d, J = 6.7 Hz, 1H), 6.48 (dd, J = 16.9, 10.0 Hz, 1H), 6.36 
(dd, J = 16.9, 2.2 Hz, 1H), 6.15-6.06 (m, 1H), 5.13 (dd, J = 10.0, 2.2 Hz, 1H), 5.05 (d, J = 
16.9 Hz, 1H), 4.97 (d, J = 10.0 Hz, 1H), 4.79 (d, J = 6.7 Hz, 1H), 3.74 (d, J = 7.8 Hz, 1H), 
3.67 (d, J = 7.8 Hz, 1H), 3.53 (dd, J = 9.0, 4.9 Hz, 1H), 3.00 (s, 3H), 2.59-2.47 (m, 2H), 
1.58 (s, 3H), 1.22 (s, 3H), 1.18 (s, 3H); 13C NMR (125 MHz, C6D6): d = 198.9, 165.3, 
162.3, 137.1, 136.2, 128.3, 127.6, 124.9, 120.7, 115.6, 93.8, 78.6, 67.7, 55.6, 54.9, 45.2, 
36.1, 28.2, 21.4; MS (m/z): 315 (4), 300 (9), 260 (91), 220 (93), 149 (28); HRMS (EI) on 
(M+) for C19H25O3N requires: 315.1834, found: 315.1877. 
 
1-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-4a-methyl-6,7,10,10a-
tetrahydro-4aH-benzocycloocten-5-one (42) 
 
A solution of 33 (150 mg, 0.44 mmol) and RCM catalyst 20 (40 mg, 10 
mol %) in CH2Cl2 (44 mL) was degassed and then heated at 48 °C, under 
N2 for 16 h. The mixture was then concentrated and the residue was 
purified by FC (cyclohexane:Et2O / 1:1) to give 42 (138 mg, 100 %) as a 
brown solid; mp = 127-129 °C; IR (CH2Cl2): n = 2969, 2934, 1703, 1606, 
1573, 1455, 1378, 1248, 1204, 1045, 1007, 708 cm-1; 1H NMR (200 
MHz, C6D6): d = 6.91 (d, J = 6.7 Hz, 1H), 5.88-5.71 (m, 1H), 5.58-5.45 (m, 1H), 4.75 (d,  J 
= 6.7 Hz, 1H), 3.69 (d, J = 7.9 Hz, 1H), 3.65 (d, J = 7.9 Hz, 1H), 3.15-2.98 (m, 3H), 2.95 
(s, 3H), 2.72-2.50 (m, 1H),  2.38-2.20 (m, 2H), 2.18-1.93 (m, 1H), 1.46 (s, 3H), 1.17 (s, 
3H), 1.14 (s, 3H); 13C NMR (50 MHz, C6D6): d = 210.2, 165.1, 161.6, 130.8, 126.1, 121.9, 
93.1, 78.6, 67.7, 55.6, 54.9, 44.9, 41.2, 29.2, 28.7, 28.5, 26.4, 21.1; MS (m/z): 315 (13), 
220 (100), 204 (44), 149 (19); HRMS (EI) on (M+) for C19H25O3N requires: 315.1834, 
found: 315.1814. 
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1-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-4a-methyl-4a,6,7,9a-tetrahydro-
benzocyclohepten-5-one (43) 
 
A solution of 35 (120 mg, 0.36 mmol) and RCM catalyst 30 (17 mg, 5 mol 
%) in toluene (40 mL) was degassed and then warmed at 80 °C, for 2 h. 
The mixture was then concentrated under reduced pressure and the residue 
was purified by FC (cyclohexane:AcOEt / 7:3) to give 43 (96 mg, 88 %) 
as a brown solid; mp = 58-59 °C; IR (CH2Cl2): n = 2968, 2953, 1712, 
1607, 1577, 1463, 1257, 1204, 1084, 1008 cm-1; 1H NMR (200 MHz, 
C6D6): d = 6.94 (d, J = 6.7 Hz, 1H), 6.18-6.08 (m, 1H), 5.75-5.61 (m, 1H), 4.65 (d, J = 6.7 
Hz, 1H), 3.85 (d, J = 4.7 Hz, 1H), 3.70 (d, J = 7.9 Hz, 1H), 3.68 (d, J = 7.9 Hz, 1H), 2.90 
(s, 3H), 2.53 (s, 3H), 1.67-1.48 (m, 1H), 1.53 (s, 3H), 1.16 (s, 3H), 1.13 (s, 3H); 13C NMR 
(50 MHz, C6D6): d = 207.7, 164.9, 161.7, 132.9, 127.1, 120.6, 92.6, 78.7, 67.7, 55.1, 54.7, 
47.0, 45.4, 28.5, 21.9, 21.7; MS (m/z): 301 (14), 286 (20), 273 (73), 258 (41), 244 (33), 
152 (29), 149 (100); HRMS (EI) on (M+) for C18H23O3N requires: 301.1677, found: 
301.1670. 
 
1-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-4a-methyl-4a,6,7,9a-tetrahydro-
benzocyclohexen-5-one (44) 
 
Compound 41 (129 mg, 0.41 mmol) was treated following the procedure 
described for the preparation of 43. The residue was purified by FC 
(cyclohexane:AcOEt / 6:4) to give 44 (57 mg, 48 %) as a brown solid; mp = 
153-156 °C; IR (CH2Cl2): n = 2971, 2932, 1676, 1602, 1566, 1395, 1344, 
1244, 1179, 1079, 1007, 762, 706 cm-1; 1H NMR (400 MHz, C6D6): d = 
6.90 (d, J = 6.4 Hz, 1H), 6.27-6.25 (m, 1H), 6.07 (dd, J = 2.3, 10.2 Hz, 1H), 
4.73 (d, J = 6.6 Hz, 1H), 3.72 (d, J = 8.1 Hz, 1H), 3.71 (d, J = 8.1 Hz, 1H), 3.52 (dd, J = 
10.5, 5.5 Hz, 1H), 2.94 (s, 3H), 2.49 (ddt, J = 19.4, 5.5, 0.8 Hz, 1H), 2.30 (ddt, J = 19.4, 
10.5, 2.6 Hz, 1H), 1.57 (s, 3H), 1.20 (s, 3H), 1.19 (s, 3H); 13C NMR (400 MHz, C6D6): d = 
195.0, 163.5, 161.4, 147.9, 129.4, 128.0, 120.9, 92.7, 78.4, 67.3, 55.0, 50.6, 42.7, 28.4, 
28.2, 27.9, 18.9; MS (m/z): 287 (100), 219 (15), 204 (100), 176 (12), 148 (16); HRMS (EI) 
on (M+) for C17H21NO3 requires: 287.1521, found: 287.1523. 
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1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-vinyl-cyclohexa-
2,4-dienyl]-prop-2-en-1-ol (46) 
 
Sodium borohydride (12 mg, 0.31 mmol) was added to a solution of 38 
(100 mg, 0.31 mmol) and cerium trichloride heptahydrate (118 mg, 0.31 
mmol) in MeOH (3 mL) at 0 oC. The mixture was stirred for 1 h and then 
concentrated and purified by FC (Et2O:cyclohexane / 1:1) to give 46 (66 
mg, 70 %, d.e. = 76 %) as a colourless oil; IR (Et2O): n = 3586, 2952, 
2825, 1654, 1609, 1574, 1381, 1371, 1130, 1114, 1066 cm-1; 1H NMR 
(400 MHz, C6D6): d = 6.79 (d, J = 6.4 Hz, 1H), 6.20-6.05 (m, 1H), 5.91 (dt, J = 19.4, 9.3 
Hz, 1H), 5.70 (dt, J = 17.0, 0.9 Hz, 1H), 5.46 (dd, J = 17.6, 2.2 Hz, 1H), 5.16 (dt, J  = 17.0, 
0.9 Hz, 1H), 5.01 (dd, J = 9.1, 2.2 Hz, 1H), 4.65-4.63 (m, 1H), 4.55 (d, J = 6.4 Hz, 1H), 
3.65 (d, J = 9.3 Hz, 1H), 3.61 (d, J = 7.8 Hz, 1H), 3.57 (d, J = 7.8 Hz, 1H), 3.36-3.35 (m, 
1H), 2.73 (s, 3H), 1.32 (s, 3H), 1.11 (s, 3H), 1.07 (s, 3H); 13C NMR (100 MHz, C6D6): d = 
168.2, 161.0, 135.4, 133.4, 120.8, 117.0, 116.8, 93.0, 78.0, 72.7, 67.2, 54.5, 48.6, 45.6, 
28.2, 27.9, 26.8, 15.4; MS (m/z): 303 (2), 288 (4), 246 (100), 230 (39), 220 (74), 190 (12), 
175 (29), 149 (21); HRMS (EI) on (M+) for C18H25O3N requires: 303.1834, found: 
303.1859. 
 
4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-7-methoxy-7a-methyl-3a,7a-dihydro-1H-
inden-1-ol (47). 
 
A solution of 46 (445 mg, 1.46 mmol) and RCM catalyst 20 (10 mol %, 134 
mg, 0.15 mmol) in CH2Cl2 (100 mL) was degassed and then heated 16 h at 
reflux. The mixture was then concentrated to give a brown residue which 
was purified by FC (cyclohexane:Et2O / 1:1) to give 47 (338 mg, 84 %) as a 
pale yellow solid; mp = 107-109 °C; IR (CH2Cl2): n = 3586, 2966, 2932, 
2869, 1660, 1606, 1578, 1453, 1235, 1093, 1011, 814, 503 cm-1; 1H NMR  
(500 MHz, C6D6): d = 6.97 (d, J = 6.8 Hz, 1H) 6.11 (dd, J = 5.7, 1.9 Hz, 1H), 6.01-5.99 
(m, 1H), 5.10 (s, 1H), 4.73 (d, J = 6.8 Hz, 1H), 4.19-4.17 (m, 1H), 3.72 (d, J = 7.9 Hz, 1H), 
3.70 (dd, J = 7.9 Hz, 1H), 3.02 (s, 3H), 1.98 (bs, 1H), 1.43 (s, 3H), 1.22 (s, 3H), 1.21 (s, 
3H); 13C NMR  (125 MHz, C6D6): d = 167.8, 162.7, 135.9, 132.5, 128.2, 116.2, 91.6, 81.7, 
78.5, 67.5, 54.8, 51.9, 50.5, 28.5, 28.4, 20.2; MS (m/z): 275 (15), 260 (11), 246 (6), 220 
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(7), 190 (5), 175 (5), 161 (6), 149 (100), 115 (4); HRMS (EI) on (M+) for C16H21NO3 
requires: 275.1521, found: 275.1509. 
 
1-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-4a-methyl-4a,6,7,9a-tetrahydro-
benzocyclohexen-5-one (48) 
 
Compound 41 (129 mg, 0.41 mmol) was treated following the procedure 
described for the preparation of 46. The residue was purified by FC 
(cyclohexane:AcOEt / 6:4) to give 48 (94 mg, 80 %, d.e. = 84 %) as a 
brown solid; mp = 153-156 °C; IR (CH2Cl2): n = 2971, 2932, 1676, 
1602, 1566, 1395, 1344, 1244, 1179, 1079, 1007, 762, 706 cm-1; 1H 
NMR (400 MHz, C6D6): d = 6.90 (d, J = 6.4 Hz, 1H), 6.27-6.25 (m, 1H), 
6.07 (dd, J = 2.3, 10.2 Hz, 1H), 4.73 (d, J = 6.6 Hz, 1H), 3.72 (d, J = 8.1 Hz, 1H), 3.71 (d, 
J = 8.1 Hz, 1H), 3.52 (dd, J = 5.5, 10.5 Hz, 1H), 2.94 (s, 3H), 2.49 (ddt, J = 19.4, 5.5, 0.8 
Hz, 1H), 2.30 (ddt, J = 19.4, 10.5, 2.6 Hz, 1H), 1.57 (s, 3H), 1.20 (s, 3H), 1.19 (s, 3H); 13C 
NMR (400 MHz, C6D6): d = 195.0, 163.5, 161.4, 147.9, 129.4, 128.0, 120.9, 92.7, 78.4, 
67.3, 55.0, 50.6, 42.7, 28.4, 28.2, 27.9, 18.9; MS (m/z): 317 (2), 260 (27), 220 (39), 205 
(26), 190 (28), 149 (14), 134 (12); HRMS (EI) on (M+) for C17H21NO3 requires: 287.1521, 
found: 287.1523. 
 
5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-8-methoxy-8a-methyl-1,4,4a,8a-tetrahydro-
naphthalen-1-ol (49) 
 
Compound 48 (40 mg, 0.14 mmol) was treated following the procedure 
described for the preparation of 47. Purification by FC (Et2O) gave 49 (35 
mg, 87 %) as a pale yellow oil; IR (CH2Cl2): n = 3593, 3030, 2967, 2931, 
1646, 1599, 1560, 1454, 1345, 1223, 1011, 811 cm-1; 1H NMR (500 MHz, 
C6D6): d = 6.95 (d, J = 6.4 Hz, 1H), 6.04-6.01 (m, 1H), 5.81-5.77 (m, 1H), 
4.75 (d, J = 6.4 Hz, 1H), 4.56 (s, 1H), 3.73 (d, J = 7.9 Hz, 1H), 3.721 (d, J = 7.9 Hz, 1H), 
3.45 (dd, J = 10.1, 6.5 Hz, 1H), 3.02 (s, 3H), 2.70-2.62 (m, 1H), 2.17-2.08 (m, 1H), 1.97 (s, 
1H), 1.54 (s, 3H), 1.24 (s, 3H), 1.21 (s, 3H); 13C NMR (125 MHz, C6D6) : d = 168.4, 
162.6, 131.1, 128.9, 128.3, 123.2, 92.8, 78.5, 67.3, 64.2, 54.9, 42.6, 34.8, 30.1, 28.6, 28.5, 
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21.5; MS (m/z): 289 (6), 274 (8), 229 (3), 220 (34), 204 (100), 149 (64), 119 (89); HRMS 
(EI) on (M+) for C17H23O3N requires: 289.1678, found: 289.1693. 
 
5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-8-methoxy-8a-methyl-1,4,4a,8a-tetrahydro-
naphthalen-1-ol (50) 
 
Compound 44 (17 mg, 0.06 mmol) was treated following the procedure 
described for the preparation of 46. Purification by FC (cyclohexane:AcOEt 
/ 1:1) afforded 50 (16 mg, 84 %) as a pale yellow oil; IR (CH2Cl2): n = 
3560, 2927, 2854, 1602, 1566, 1462, 1271, 1259, 1235, 1181, 1080, 969 
cm-1; 1H NMR (400 MHz, C6D6): d = 6.80 (d, J = 6.4 Hz, 1H), 5.98-5.95 
(m, 1H), 5.55-5.51 (m, 1H), 4.64 (d, J = 6.4 Hz, 1H), 4.27 (d, J = 12.1 Hz, 
1H), 3.69 (d, J = 7.9 Hz, 1H), 3.68 (d, J = 7.9 Hz, 1H), 3.40 (d, J = 12.1 Hz, 1H), 3.32-3.26 
(m, 1H), 2.78 (s, 3H), 2.65-2.58 (m, 1H), 2.06-2.00 (m, 1H), 1.52 (s, 3H), 1.19 (s, 3H), 
1.17 (s, 3H); 13C NMR (100 MHz, C6D6): d = 169.4, 161.9, 132.6, 128.9, 126.9, 124.0, 
94.4, 78.6, 74.9, 67.5, 54.8, 42.8, 32.3, 30.1, 28.6, 28.5, 22.0; MS (m/z): 289 (3), 274 (3), 
220 (34), 204 (100), 149 (12), 113 (6); HRMS (EI) on (M+) for C17H23O3N requires: 
289.1678, found: 289.1661. 
 
D-valinol (56)[8] 
 
A three-neck flask equipped with a reflux condenser, and an addition funnel 
was charged with sodium borohydride (2.73 g, 72 mmol) and THF (100 
mL). D-Valine (3.5 g, 30 mmol) was added in one portion, and the mixture 
was cooled to 0 °C. A solution of iodine (7.63 g, 30 mmol) in THF (25 mL) was added 
dropwise over 30 min, resulting in vigorous evolution of hydrogen. After addition of 
iodine was complete and gas evolution had ceased, the flask was heated to reflux for 18 h. 
The solution was cooled to rt and methanol was added cautiously until the mixture became 
clear. After stirring for 30 min, the solvent was removed in vacuo leaving a white paste 
which was dissolved by addition of KOH (20 % in water, 60 mL). The solution was stirred 
for 4 h, extracted 3 times with CH2Cl2, and the combined organics layers were dried over 
MgSO4. Solvents were evaporated affording product 56 (2.57 g, 82 %) as a yellow light oil 
which was used without any further purification; [a] D20  = -14.3 (c = 1.094, EtOH); 
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NMR (200 MHz; CDCl3): d = 3.62 (dd, J = 10.5, 4.0 Hz, 1H), 3.27 (dd, J = 10.5, 8.5 Hz, 
1H), 2.54 (ddd, J = 8.5, 6.5, 4 Hz, 1H), 1.89 (bs, 3H), 1.56 (octuplet, J = 6.5 Hz, 1H), 0.91 
(d, J = 6.5 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz; CDCl3): d = 64.3, 58.3, 
30.9, 19.4, 18.9; MS (m/z): 104 (5), 86 (22), 73 (100), 60 (12), 57 (8); HRMS (EI) on (M+ 
+ 1) for C5H14NO requires: 104.1074, found: 104.1075. 
 
 (R)-4-Isopropyl-2-(4-methoxy-phenyl)-4,5-dihydro-oxazole (59) [9] 
 
 A solution of D-Valinol (1.32 g, 12.8 mmol) and NEt3 (1.8 mL, 12.9 mmol) 
in CH2Cl2 (6 mL) was added dropwise to a solution of p-anisoyl chloride (1.7 
mL, 12.6 mmol) in CH2Cl2 (30 mL) at 0 °C. The mixture was stirred at rt for 
16 h, and then NEt3 (3.6 ml, 25.8 mmol) was added. After 1 h at 25 °C, 
DMAP (40 mg, 0.33 mmol) and p-tosylchloro benzene (freshly recrystallised 
in hexanes) (2.68 g, 14 mmol) were successively added in one portion each 
and the mixture was stirred at rt for 16 h. The residue was dry loaded onto silica and 
purified by FC (cyclohexane:Et2O / 7:3) to give 59 (1.891 g, 67 %) as a pale yellow light 
oil; [a] D20  = + 40.4 (c = 0.986, EtOH); IR(CH2Cl2): n = 3053, 2958, 2929, 1648, 1610, 
1513, 1465, 1356, 1308, 1248, 1170, 1077, 1030, 842 cm-1; 1H NMR (200 MHz; CDCl3): d 
= 8.11 (d, J = 9 Hz, 2H), 6.69 (d, J = 9 Hz, 2H), 4.03-3.75 (m, 3H), 3.17 (s, 3H), 1.66 
(octuplet, J =  6.5 Hz, 1H), 1.03 (d, J = 6.5 Hz, 3H), 0.82 (d, J = 6.5 Hz, 3H); 13C NMR 
(100 MHz; CDCl3): d = 163.2, 162.6, 130.6, 121.5, 114.2, 73.3, 70.5, 55.0, 33.6, 19.2, 
18.9; MS (m/z): 219 (12), 177 (25), 148 (100), 136 (32), 121 (10), 99 (9), 77 (5), 63 (6); 
HRMS (EI) on (M+) for C13H17NO2 requires: 219.1257, found: 219.1259.  
 
(+)-(4R)-Isopropyl-2-(4-methoxy-phenyl)-4,5-dihydro-oxazole chromium tricarbonyl 
complex (60). 
 
A degassed solution of oxazoline 59 (3.0 g, 13.7 mmol), chromium 
hexacarbonyl (3.0 g, 13.7 mmol) diisobutylether (100 mL) and THF was 
heated at reflux in the absence of light for 17 h. The mixture was then 
filtered through Celite and concentrated in vacuo to give a brown oil that 
was purified by FC (cyclohexane:Et2O / 7:3) and then recrystallised 
(hexanes:Et2O / 2:1) to give 60 (1.625 g, 33 %) as a bright yellow solid; 
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[a] D20  = + 89.2 (c = 0.96, CH2Cl2); IR (CH2Cl2): n = 1973, 1897 cm
-1; 1H NMR (500 MHz, 
C6D6): d = 6.15 (d, J = 6.6 Hz, 1H), 6.04 (d, J = 6.6 Hz, 1H), 4.33-4.30 (m, 2H), 3.83-3.68 
(m, 3H), 2.87 (s, 3H), 1.63-1.57 (m, 1H), 0.95 (d, J = 6.6 Hz, 3H), 0.84 (d, J = 6.6 Hz, 3H); 
13C NMR (125 MHz, C6D6): d = 232.2, 160.4, 143.8, 94.6, 94.6, 85.3, 76.6, 76.5, 72.7, 
70.7, 55.1, 32.9, 18.4, 18.3; MS (m/z): 355 (4), 299 (8), 271 (12), 201 (100), 185 (31), 176 
(12), 121 (5), 77 (6); HRMS (EI) on (M+) for C16H17O5NCr requires: 355.0516, found: 
355.0512. 
 
(+)-1-[(1R, 6S)-5-((4R)-4-Isopropyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-1-methyl-6-
vinyl-cyclohexa-2,4-dienyl]-ethanone (61). 
 
Complex 60 (355 mg, 1 mmol)  was treated following the procedure 
described for the preparation of 32. Purification by FC (cyclohexane:AcOEt 
/ 7:3) afforded 61 (254 mg, 84 %, d.e. = 88 %) as a pale yellow oil; [a] D20  = 
+ 159.3 (c = 1.01, CHCl3); IR (CH2Cl2): n = 2963, 2934, 1705, 1610, 1572, 
1385, 1353, 1270, 1265, 1044, 1001 cm-1;  1H NMR (500 MHz, C6D6): d = 
6.95 (d, J = 6.4 Hz, 1H), 5.89 (m, 1H), 5.35 (d, J = 16.7 Hz, 1H), 4.97 (d,  J 
= 9.8 Hz, 1H), 4.78 (d, J = 6.4 Hz, 1H), 3.93-3.70 (m, 4H), 3.0 (s, 3H), 2.0 (s, 3H), 1.68-
1.62 (m, 1H), 1.5 (s, 3H), 0.95 (d, J = 6.6 Hz, 3H), 0.79 (d, J = 6.6 Hz, 3H); 13C NMR (125 
MHz, C6D6): d = 206.7, 165.0, 162.6, 135.8, 127.7, 118.9, 117.5, 93.6, 73.1, 69.7, 58.0, 
54.9, 50.8, 33.2, 30.1, 20.4, 18.9, 18.4; MS (m/z): 303 (26), 260 (100), 244 (28), 234 (18), 
218 (6), 192 (15), 176 (33), 149 (22), 135 (10), 91 (11), 84 (14); HRMS (EI) on (M+) for 
C18H25NO5 requires: 303.1824, found: 303.1834. 
 
(+)-1-[(1R, 6S)-5-((4R)-4-isopropyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-
vinyl-cyclohexa-2,4-dienyl]-pent-4-en-1-one (62). 
 
Compound 61 (161 mg, 0.53 mmol) was treated following the procedure 
2 described for the preparation of 33. Purification by FC 
(cyclohexane:Et2O / 8:2) gave 62 (146 mg, 80 %) as a pale yellow oil; 
[a] D20  = + 81.3 (c = 1.03, CHCl3); IR (CH2Cl2): n = 3048, 2963, 2904, 
1705, 1605, 1571, 1462, 1384, 1274, 1253, 1158, 1082, 1044, 1002, 920 
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cm-1; 1H NMR (200 MHz, C6D6): d = 6.93 (d, J = 6.6 Hz, 1H), 6.0-5.7 (m, 2H), 5.32 (dd, J 
= 17.3, 2.0 Hz, 1H), 5.05-4.89 (m, 3H), 4.74 (d, J = 6.6 Hz, 1H), 3.92-3.56 (m, 4H), 2.96 
(s, 3H), 2.65-2.30 (m, 4H), 1.62 (m, 1H), 1.50 (s, 3H), 0.95 (d, J = 6.6 Hz, 3H), 0.79 (d, J 
= 6.6 Hz, 3H); 13C NMR (400 MHz, C6D6): d = 207.3, 165.6, 163.5, 136.8, 119.7, 115.6, 
113.7, 93.4, 73.0, 69.7, 56.6, 54.6, 44.7, 35.7, 33.3, 30.8, 21.7, 18.7; MS (m/z): 343 (12), 
300 (8), 274 (8), 260 (100), 246 (27), 234 (80), 220 (11), 204 (55), 190 (97), 176 (98), 162 
(27), 149 (46); HRMS (EI) on (M+) for C21H29NO5 requires: 343.2144, found: 343.2147. 
 
(+)-(4aS,9aS)-1-((R)-4-Isopropyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-4a-methyl-
4a,6,7,9a-tetrahydro-benzocyclohepten-5-one (63) 
 
Compound 62 (106 mg, 0.31 mmol) was treated following the procedure 
described for the preparation of 43. The mixture was then concentrated 
under reduced pressure and the residue was purified by FC 
(cyclohexane:AcOEt / 7:3) to give 63 (105 mg, 100 %) as a brown oil; 
[a] D20  = + 115.3 (c = 1.06, CHCl3); IR (CH2Cl2): n = 2963, 1704, 1609, 
1573, 1516, 1381, 1243, 1075, 1006 cm-1; 1H NMR (200 MHz, C6D6): 
d =  6.94 (d, J = 6.8 Hz, 1H), 6.14 (ddd, J = 11.8, 4.7, 2.4 Hz, 1H), 5.73-5.54 (m, 1H), 4.69 
(d, J = 6.8 Hz, 1H), 3.97-3.67 (m, 4H), 2.91 (s, 3H), 2.75-2.68 (m, 2H), 2.62-2.35 (m, 2H), 
1.69-1.56 (m, 1H), 1.55 (s, 3H), 0.95 (d, J = 6.7 Hz, 3H), 0.77 (d, J = 6.7 Hz, 3H); 13C 
NMR (125 MHz, C6D6): d =  207.9, 165.2, 163.3, 133.0, 128.3, 127.2, 120.6, 92.8, 73.5, 
70.3, 55.3, 54.9, 51.3, 45.6, 33.6, 22.1, 21.7, 19.2, 18.9; MS (m/z): 315 (1), 287 (4), 272 
(6), 244 (10), 234 (10), 205 (20), 190 (15), 176 (86), 149 (38), 135 (14), 121 (26); HRMS 
(EI) on (M+) for C19H25O3N requires: 315.1834, found: 315.1842. 
 
(+)-(4aS,9aS)-4-methoxy-4a-methyl-5-oxo-5,6,7,9a-tetrahydro-4aH-
benzocycloheptene-1-carbaldehyde (55). 
 
Procedure 1: A solution of the chiral oxazoline 64 (70 mg, 0.22 mmol) in 
MeI (5 mL) was stirred 3 days at reflux. Excess of MeI was then 
evaporated in vacuo. The residue was dissolved in a mixture of THF (1.5 
mL), MeOH (0.5 mL) and CH2Cl2 (1 mL) and the solution was cooled to 0 
°C. NaBH4 (25 mg, 0.66 mmol) was then added and the mixture was 
stirred for 15 min. H2O was then added and the solution was extracted 3 times with ether. 
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The combined organic layers were washed with brine and dried with MgSO4. The solvent 
was evaporated and the residue was dissolved in a mixture of THF (2 mL) and H2O (1 mL) 
and p-toluene sulphonic acid (84 mg, 044 mmol) was added. The solution was stirred for 
1.5 h and then extracted with Et2O. The organic layers were combined, washed with brine 
and dried with MgSO4. The product was purified by FC (cyclohexane:AcOEt / 7:3) to 
obtain 55 (42 mg, 82 %) as a colourless oil; ee = 88 %, [a] D20  = + 222.5 (c = 1.05, CHCl3) 
Procedure 2: DIBAL (1.5 M in toluene, 77 mL, 0.11 mmol) was slowly added to a solution 
of the nitrile 71 (24 mg, 0.1 mmol) in 5 mL of toluene at – 78 °C. The solution was stirred 
for 4 h and then a saturated aqueous solution of Rochelle’s salt (5 mL) was added. The 
solution was extracted 3 times with ether, and the combined organic phases were dried 
with MgSO4. Solvents were evaporated and the residue was purified by FC 
(cyclohexane:AcOEt / 4:6) to give product 55 (12 mg, 52 %) as a colourless oil; ee > 95 %, 
[a] D20  = + 498 (c = 0.15, CHCl3); mp = 65-68 °C; IR (CH2Cl2): n = 2928, 2854, 1706, 
1664, 1553, 1455, 1377, 1184, 1091, 909 cm-1; 1H NMR (400 MHz, C6D6): d = 9.32 (s, 
1H), 6.10 (d, J = 6.7 Hz, 1H), 5.74-5.70 (ddd, J = 11.6, 4.8, 2.5 Hz, 1H), 5.51-5.45 (m, 
1H), 4.52 (d, J = 6.7 Hz, 1H), 3.59-57 (m, 1H), 2.81 (s, 3H), 2.61 (dd, J = 4.6, 1.8 Hz, 1H), 
2.58 (d, J = 4.6 Hz, 1H), 2.27-2.18 (m, 1H), 1.54-1.46 (m, 1H), 1.27 (s, 3H); 13C NMR 
(125 MHz, C6D6): d = 206.6, 189.7, 169.2, 141.8, 133.6, 131.9, 127.6, 93.1, 55.6, 54.8, 
45.3, 43.8, 22.0, 21.8; MS (m/z): 232 (91), 203 (25), 189 (49), 186 (35), 175 (100), 161 
(98), 149 (76), 128 (32), 115 (42); HRMS (EI) on (M+) for C14H16O3 requires: 232.1104, 
found: 232.1104. 
 
1-Dimethoxymethyl-4-methoxy-benzene chromium tricarbonyl complex (65) 
 
A solution of anisaldehyde dimethyl acetal (5.6 mL, 33 mmol), 
chromium hexacarbonyl (6.6 g, 30 mmol) diisobutylether (100 mL) 
and THF (10 mL) was degassed. The solution was heated at 160 °C in 
the absence of light for 64 h. The mixture was transferred to another 
flask and concentrated in vacuo to give a brown oil. The residue was dissolved in toluene 
(3 x 20 mL), filtered through Celite and concentrated to give 65 (8.86 g, 93 %) as a bright 
yellow solid; IR (Hexane): n = 1977, 1908, 746 cm-1; 1H NMR (400 MHz; C6D6): d =  5.43 
(d, J = 6.9 Hz, 2H), 4.87 (s, 1H), 4.45 (d, J = 6.9 Hz, 2H), 3.15 (s, 6H), 2.98 (s, 3H); 13C 
NMR (100 MHz, C6D6): d = 233.0, 143.0, 101.0, 100.2, 93.4, 76.7, 54.8, 52.8; MS (m/z): 
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318 (13), 287 (8), 262 (9), 234 (37), 187 (15), 174 (33), 151 (100), 135 (8); HRMS (EI) on 
(M+) for C13H14O6Cr requires: 318.0196, found: 318.0215. 
 
4-Methoxy-benzaldehyde chromium tricarbonyl complex (66) 
 
2M HCl (35 mL) was added to a solution of complex 65 (8.65 g, 27 mmol) 
in THF (35 mL) at rt. The mixture immediately became red and was 
stirred for 16 h. The solution was neutralised with an aqueous saturated 
NaHCO3 solution. The aqueous layer was separated and then extracted 3 
times with ether. The organic phases were combined, washed with brine, dried over 
MgSO4 and concentrated in vacuo to give 66 (7.07 g, 96 %) as a red oil; IR (Hexane): n = 
1990, 1932, 1706, 746 cm-1;  1H NMR  (400 MHz;  C6D6): d = 8.89 (s, 1H), 5.36 (d, J = 
6.2 Hz, 2H), 4.25 (d, J = 6.2 Hz, 2H), 2.93 (s, 3H); 13C NMR (100 MHz, C6D6): d = 230.4, 
185.7, 144.2, 94.2, 90.9, 76.4, 54.9; MS (m/z): 272 (11), 188 (42), 135 (10), 77 (4), 52 
(100); HRMS (EI) on (M+) for C11H8O5Cr requires: 271.9777, found: 271.9778. 
 
(+)-(4-Methoxy-benzylidene)-(1R)-(2-methoxymethyl-pyrrolidin-1-yl)-amine 
chromium tricarbonyl complex (67) 
 
R-1-Amino-2-(methoxymethyl)pyrrolidine (340 mL, 2.55 mmol) was 
added to a solution of 66 (660 mg, 2.43 mmol) in Et2O (10 mL) and 
stirred over 4Å molecular sieves (1.8 g) for 18 h at rt. The mixture was 
filtered through Celite and concentrated in vacuo to give a yellow oil. 
The residue was crystallised (Et2O:hexane / 1:2) to give 67 (623 mg, 67 
%) as a very fine yellow powder; [a] D20  = + 7.5 (c = 0.86, CHCl3); IR 
(Hexane): n = 1971, 1903, 746 cm-1; 1H NMR (400 MHz; C6D6): d = 6.36 (s, 1H), 5.66 
(dd, J = 6.8, 1.3 Hz, 1H), 5.59 (dd, J = 6.8, 1.3 Hz, 1H), 4.70 (dd, J = 7.0, 2.2 Hz, 1H), 
4.66 (dd, J = 7.0, 2.2 Hz, 1H), 3.76-3.74 (m, 1H), 3.66 (d, J = 4.6 Hz, 1H), 3.48 (d, J = 4.6 
Hz, 1H), 3.27 (s, 3H), 3.05 (s, 3H), 2.96-2.87 (m, 1H), 2.68-2.60 (m, 1H), 1.84-1.68 (m, 
3H), 1.57-1.44 (m, 1H); 13C NMR (100 MHz, C6D6): d = 233.9, 141.6, 124.1, 90.9, 78.3, 
77.8, 74.4, 62.8, 58.6, 54.8, 47.9, 26.7, 21.9; MS (m/z): 384 (2), 300 (2), 298 (3), 203 (62), 
165 (26), 134 (25), 70 (100), 45 (30); HRMS (EI) on (M+) for C17H20O5N2Cr requires: 
384.0777, found: 384.0780. 
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(+)-1-((1S,6S)-2-Methoxy-5-{[(R)-2-methoxymethyl-pyrrolidin-1-ylimino]-methyl}-1-
methyl-6-vinyl-cyclohexa-2,4-dienyl)-ethanone (68) 
 
Complex 67 (768 mg, 2 mmol) was treated with vinyllithium (prepared 
from nBuLi and tetravinyltin) following the procedure described for the 
preparation of 32. The residue was purified by FC (cyclohexane:AcOEt / 
7:3) to give 68 (483 mg, 73 %) as a pale yellow oil; [a] D20  = + 230.8 (c = 
0.57, CHCl3); IR (CH2Cl2): n = 2976, 2931, 1704, 1667, 1634, 1567, 
1458, 1352, 1240, 1111, 1002 cm-1; 1H NMR (400 MHz, C6D6): d = 6.99 
(s, 1H), 6.08 (dt, J = 18.3, 9.8 Hz, 1H), 5.92 (d, J = 6.6 Hz, 1H), 5.44 (dd, J = 18.3, 2.2 Hz, 
1H), 5.10 (dd, J =  9.8, 2.2 Hz, 1H), 5.03 (dd, J = 6.6 Hz, 1H), 3.95 (d, J = 9.8 Hz, 1H), 
3.78-3.72 (m, 2H), 3.49 (dd, J = 9.1, 6.7 Hz, 1H), 3.24 (s, 3H), 3.19 (s, 3H), 3.12-3.06 (m, 
1H) 2.78-2.74 (m, 1H.), 2.28 (s, 3H), 1.86-1.75 (m, 3H), 1.57-1.49 (m, 1H); 13C NMR (125 
MHz, C6D6): d = 207.8, 161.3, 137.4, 132.7, 130.4, 120.2, 116.5, 94.7, 75.1, 63.1, 58.9, 
58.1, 54.6, 49.2, 47.1, 31.7, 27.1, 22.3, 20.6; MS (m/z): 332 (2), 289 (2), 229 (9), 203 
(100), 129 (2), 70 (57), 45 (8); HRMS (EI) on (M+) for C19H28O3N2 requires: 332.2099, 
found: 332.2074. 
 
(+)-1-((1S,6S)-2-Methoxy-5-{[(R)-2-methoxymethyl-pyrrolidin-1-ylimino]-methyl}-1-
methyl-6-vinyl-cyclohexa-2,4-dienyl)-pent-4-en-1-one (69) 
 
Compound 68 (290 mg, 0.9 mmol) was treated following the procedure 
described for the preparation of 33. The residue was purified by FC 
(cyclohexane:AcOEt / 3:7) to give 69 (247 mg, 76 %) as a pale yellow 
oil; [a] D20  = + 114.4 (c = 0.70, CHCl3); IR (CH2Cl2): n = 2976, 2932, 
1702, 1633, 1565, 1458, 1337, 1240, 1152, 1119, 1005, 918, 812 cm-1; 
1H NMR (400 MHz, C6D6): d = 6.82 (s, 1H), 5.98-5.77 (m, 2H), 5.75 
(d, J = 6.6 Hz, 1H), 5.25 (dd, J = 17.0, 1.8 Hz, 1H), 5.01 (dd, J = 17.0, 2.2 Hz, 1H), 4.92-
4.86 (m, 3H), 3.78 (d, J = 9.8 Hz, 1H), 3.60-3.50 (m, 2H), 3.32 (dd, J = 9.1, 6.8 Hz, 1H), 
3.07 (s, 3H), 3.03 (s, 3H), 2.92 (m, 1H), 2.71-2.40 (m, 5H), 1.74-1.55 (m, 3H), 1.51 (s, 
3H), 1.40 (m, 1H); 13C NMR (125 MHz, C6D6): d = 209.8, 161.3, 138.8, 137.0, 132.6, 
130.4, 120.2, 116.6, 114.6, 114.3, 95.0, 75.1, 63.5, 58.9, 58.0, 54.6, 50.3, 43.1, 28.9, 27.2, 
22.3, 20.6; MS (m/z): 373 (16), 289 (30), 217 (18), 203 (66), 178 (13), 163 (23), 149 (38), 
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134 (24), 129 (36);  HRMS (EI) on (M+) for C22H32O3N2 requires: 372.2413, found: 
372.2422. 
 
 (+)-(4aS,9aS)-4-Methoxy-1-{[(R)-2-methoxymethyl-pyrrolidin-1-ylimino]-methyl}-
4a-methyl-4a,6,7,9a-tetrahydro-benzocyclohepten-5-one (70) 
 
Compound 69 (78 mg, 0.21 mmol) was treated following the procedure 
described for the preparation of 43. The residue was purified by FC 
(cyclohexane:AcOEt / 7:3) to give 70 (64 mg, 89 %) as a brown oil; 
[a] D20  = + 193.4 (c = 0.67, CHCl3); IR (CH2Cl2): n = 2978, 2878, 1699, 
1635, 1569, 1453, 1376, 1337, 1236, 1172, 1116, 1070, 1010, 744 cm-1; 
1H NMR (500 MHz, C6D6): d = 6.97 (s, 1H), 6.12-6.08 (m, 1H), 5.85 (d, 
J = 6.6 Hz, 1H), 5.75-5.70 (m, 1H), 4.92 (d, J = 6.6 Hz, 1H), 3.94-3.93 (m, 1H), 3.57-3.54 
(m, 1H), 3.58 (dd, J = 8.8, 3.4 Hz, 1H), 3.42 (dd, J = 8.8, 6.6 Hz, 1H), 3.15 (s, 3H), 3.10 (s, 
3H), 3.04-3.00 (m, 1H), 2.88-2.83 (m, 1H), 2.80-2.73 (m, 1H), 2.69-2.62 (m, 2H), 2.46-
2.40 (m, 1H), 1.75-1.64 (m, 3H), 1.72 (s, 3H), 1.49-1.43 (m, 1H); 13C NMR (500 MHz, 
C6D6): d = 208.7, 161.3, 133.3, 131.9, 126.5, 121.0, 93.6, 75.1, 63.2, 58.9, 54.8, 48.6, 46.2, 
45.6, 27.2, 27.1, 22.4, 22.2, 21.6; MS (m/z): 344 (13), 299 (19),248 (11), 203 (89), 175 
(10), 161 (12), 149 (13), 134 (27), 107 (11); HRMS (EI) on (M+) for C20H28O3N2 requires: 
344.2099, found: 344.2109. 
 
 (+)-(4aS,9aS)-4-Methoxy-4a-methyl-5-oxo-5,6,7,9a-tetrahydro-4aH-
benzocycloheptene-1-carbonitrile (71) 
 
A solution of the hydrazone 70 (41 mg, 0.12 mmol) in a mixture of 
MeOH: phosphate buffer pH = 7 (1:1) (0.3 mL) was added dropwise to a 
solution of magnesium monoperoxyphtalate hexahydrate (77 mg, 0.16 
mmol) in MeOH:phosphate buffer pH = 7 (1:1) (1 mL) at 0 °C. The 
mixture was stirred for 15 min and H2O was added. The solution was 
extracted with Et2O. The combined organic layers were washed with an aqueous solution 
of NaHCO3 and dried with MgSO4. The product 71 (25 mg, 91 %) was obtained as a 
yellow oil after purification by FC (AcOEt:cyclohexane / 3:7); [a] D20  = + 82.6 (c = 0.53, 
CHCl3); IR (CH2Cl2): n = 3062, 2936, 2850, 2203, 1708, 1639, 1563, 1454, 1380, 1275, 
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1253, 1075, 1005, 907, 808, 762 cm-1; 1H NMR (500 MHz, C6D6): d = 6.14 (dd, 1H, J = 
6.6, 3.9 Hz, 1H), 5.55-5.51 (m, 2H), 4.32 (d, J = 6.6 Hz, 1H), 2.81 (s, 3H), 2.73-2.69 (m, 
1H), 2.65 (ddd, J = 15.0, 6.0, 4.8 Hz, 1H), 2.42 (ddd,  J = 15.0, 10.1, 4.8 Hz, 1H), 2.18-
1.99 (m, 1H), 1.70-1.50 (m, 1H), 1.23 (s, 3H); 13C NMR (125 MHz, C6D6): d = 205.8, 
164.9, 137.2, 131.1, 128.8, 119.3, 104.2, 92.9, 55.2, 54.9, 45.6, 43.4, 23.1, 21.4; MS (m/z): 
229 (61), 205 (65), 200 (100), 186 (93), 172 (41) , 160 (96), 158 (46), 144 (39), 132 (44), 
116 (49), 104 (50); HRMS (EI) on (M+) for C14H15NO2 requires: 229.1106, found: 
229.1103. 
 
(+)-1-[(1R, 6S)-5-((4R)-4-Isopropyl-4,5-dihydro-oxazol-2-yl)-4-methoxy-1-methyl-6-
vinyl-cyclohexa-2,4-dienyl]-ethanone (72). 
 
Complex 60 (355 mg, 1 mmol) was treated following the procedure 
described for the preparation of 32. Purification by FC (cyclohexane:AcOEt 
/ 7:3) gave the product  72 as a mixture of 2 inseparable diastereoisomers 
(148 mg, 47 %, d.e. = 5 %) as a yellow brown oil; Major diasteroisomer: 1H 
NMR (400 MHz, C6D6): d = 6.98-6.96 (1H), 6.11-6.09 (1H), 5.03-4.95 
(2H), 4.73-4.70 (1H), 3.96-3.74 (3H), 3.71-3.68 (1H), 3.47-3.43 (1H), 3.04 
(3H), 2.49-2.46 (2H), 2.00 (3H), 1.43 (3H), 1.01 (3H), 1.19 (3H); 13C NMR (400 MHz, 
C6D6): d = 207.3, 165.6, 163.5, 136.8, 119.7, 115.6, 113.7, 93.4, 73.0, 69.7, 56.6, 54.6, 
44.7, 35.7, 33.3, 30.8, 21.7, 18.7. 
.  
(+)-1-((1S,6S)-2-Methoxy-5-{[(R)-2-methoxymethyl-pyrrolidin-1-ylimino]-methyl}-1-
methyl-6-allyl-cyclohexa-2,4-dienyl)-ethanone (73) 
 
Complex 67 (768 mg, 2 mmol) was treated following the procedure 
described for the preparation of 32. Purification by FC 
(cyclohexane:AcOEt / 8:2) gave the product 73 as a mixture of 2 
inseparable isomers (174 mg, 50 %, d.e. = 12 %) as a yellow brown oil; 
IR (CH2Cl2): n = 2922, 1700, 1638, 1553, 1454, 1216, 1111, 999, 918 cm-
1; Major diasteroisomer: 1H NMR (400 MHz; C6D6): d = 7.02 (1H), 6.21-
6.18 (1H), 5.93-5.88 (1H), 5.11-5.07 (2H), 4.97-4.93 (1H), 3.69-3.63 (2H), 3.58-3.53 (1H), 
3.47-3.42 (1H), 3.19 (3H), 3.13 (3H), 3.12-3.09 (1H), 2.75-2.68 (1H), 2.59-2.55 (2H), 2.21 
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(3H), 1.86-1.77 (3H), 1.56-1.54 (3H), 1.51-1.48 (1H); 13C NMR (100 MHz; C6D6): d 
= 208.8, 162.1, 134.5, 131.9, 129.7 121.2, 115.0, 94.7, 75.3, 75.0, 63.3, 58.8, 56.8, 54.7, 
49.1, 44.2, 35.6, 31.6, 27.1, 22.4; MS (m/z): 346 (18), 262 (15), 217 (75), 175 (29), 161 
(24), 151 (49), 134 (100); HRMS (EI) on (M+) for C20H30O3N2 requires: 346.2256, found: 
346.2258.  
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-1-methyl-6-vinyl-cyclohexa-
2,4-dienyl]-hex-5-en-1-one (74). 
 
NaHMDS (2 M in THF, 0.180 mL, 0.36 mmol) was slowly added to a 
solution of methyl ketone 34 (88 mg, 0.30 mmol) in THF (5 mL) at – 
78 oC. The mixture was stirred for 1 h at 0 °C and then cooled to – 78 
°C. 4-bromo-1-butene (41 mL, 0.45 mmol) was added and the 
yellow/brown solution was allowed to warm to rt 16 h and then the 
solvents were evaporated. The residue was purified by FC 
(cyclohexane:AcOEt / 7:3) to give 74 (16 mg, 18 %) as a pale yellow solid; 1H NMR (200 
MHz, C6D6): d = 6.93 (d, J = 6.7 Hz, 1H), 6.05-5.85 (m, 1H), 5.80-5.52 (m, 1H), 5.35 (dd, 
J = 17.0, 2.0 Hz, 1H), 5.08-4.91 (m, 3H), 4.73 (d, J = 6.7 Hz, 1H), 3.78 (d, J = 9.6 Hz, 1H), 
3.66 (s, 2H), 2.97 (s, 3H), 2.51-2.32 (m, 2H), 2.05-1.70 (m, 4H), 1.49 (s, 3H), 1.18 (s, 3H), 
1.12 (s, 3H). 
 
2-[4-Methoxy-5-methyl-5-(1-trimethylsilanyloxy-vinyl)-6-vinyl-cyclohexa-1,3-dienyl]-
4,4-dimethyl-4,5-dihydro-oxazole (75) 
 
A solution of 34 (305 mg, 1.05 mmol) in THF (5 mL) was added to a 
solution of LDA (prepared by the addition of 1.6M nBuLi (0.9 mL, 1.36 
mmol) to a solution of diisopropylamine (0.235 mL, 1.68 mmol) in THF 
(3 mL) at 0 ºC with stirring for 30 min) at – 78 ºC. The mixture was 
stirred at this temperature for 1.5 h before chlorotrimethylsilane (170 mL, 
1.36 mmol) was added. The mixture was stirred for 30 min before it was 
quenched with saturated aqueous NaHCO3 solution and extracted into Et2O. The organics 
layers were combined, dried over MgSO4 and concentrated in vacuo. The residue was dry 
loaded onto Florisil and purified by FC (Florisil; cyclohexane:AcOEt / 8:2) to give 75 (270 
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mg, 71 %) as a colourless oil; 1H NMR (200 MHz, CDCl3): d = 6.60 (d, J = 6.6 Hz, 1H), 
5.94-5.75 (m, 1H), 4.99 (d, J = 6.8 Hz, 1H), 4.93 (d, J = 2.2 Hz, 1H), 4.70 (dd, J = 10.2, 
2.1 Hz, 1H), 4.17 (d, J = 1.9 Hz, 1H), 4.05 (d, J = 1.9 Hz, 1H), 3.91 (dd, J = 7.9 Hz, 1H), 
3.80 (dd, J = 7.9 Hz, 1H) 3.57 (s, 3H), 3.15 (d, J = 8.8 Hz, 1H), 1.28 (s, 3H), 1.20 (s, 3H), 
1.19 (s, 3H), 0.1 (s, 9H); 13C NMR (100 MHz, C6D6): d = 167.3, 161.7, 159.2, 136.5, 
127.8, 118.1, 112.8, 92.4, 89.7, 78.2, 67.2, 55.1, 51.2, 49.8, 28.4, 28.2, 21.8, 0.1. 
 
V.3 - EXPERIMENTAL PART RELATED TO CHAPTER III 
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-cyclohexa-2,4-dienyl]-
ethanone (93) 
 
nBuLi (1.6M in hexanes, 8.9 mL, 14.3 mmol) was added to 
tetravinylstannane (1.3 mL, 7.1 mmol). The white suspension was stirred 
for 30 min and after it was cooled to - 78 °C. Then THF (90 mL) was added 
followed by complex 12 (3.72 g, 10.9 mmol). The orange solution was 
stirred for 1 h and then nBu4NBr (4.56 g, 14.2 mmol) and MeI (3.4 mL, 
54.5 mmol) were added. The mixture was placed under an atmosphere of 
CO (1.5 Bar) and warmed up to rt for 16 h. The CO was vented and the volatiles were 
removed in vacuo. Purification by FC (AcOEt:Cyclohexane / 4:6) gave the methyl ketone 
93 (2.33 g, 78 %) as an orange solid; mp = 54–56 °C; IR (CH2Cl2): n = 2970, 1713, 1609, 
1578, 1365, 1200, 1033 cm -1; 1H NMR (400 MHz, CDCl3): d = 7.04 (d, J = 6.4 Hz, 1H), 
6.11 (m, 1H), 5.36 (d, J = 17.4 Hz, 1H), 5.14 (d, J = 17.4 Hz, 1H), 4.89 (d, J = 6.4 Hz, 1H), 
4.58 (dd, J = 4.9, 1.1 Hz, 1H), 3.75 (d, J = 7.7 Hz, 1H), 3.72 (d, J = 7.7 Hz, 1H), 3.13 (s, 
3H), 3.04 (d, J = 1.1 Hz, 1H), 1.95 (s, 3H) 1.23 (s, 3H) 1.22 (s, 3H); 13C NMR (100 MHz, 
CDCl3): d = 203.7, 160.4, 157.8, 135.1, 128.9, 113.2, 93.6, 77.8, 66.2, 55.1, 54.5, 38.1, 
27.4, 27.1, 26.7; MS (m/z): 275 (12), 260 (6), 232 (100), 206 (26), 190 (6), 178 (10), 161 
(32), 135 (18), 103 (10); HRMS (EI) on (M+) for C16H21NO3 requires 275.1521, found: 
275.1521. 
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1-[5-(4,4-dimethyl-4,5-dehydro-oxazol-2-yl)-2-methoxy-6-vinyl-cyclohexa-2,4-dienyl]-
propenone (92) 
 
TMSOTf (535 mL, 3 mmol) was slowly added to a solution of 93 (545 mg, 
2 mmol) and NEt3 (415 mL, 3 mmol) in CH2Cl2 (20 mL) at 0 °C. The 
solution was stirred 1 h and then filtered with ether over a pad of neutral 
alumina activated with 10 % water. Solvents were evaporated and the 
yellow oil was dissolved in CH2Cl2 (30 mL) and was added via syringe to a 
suspension of Eschenmoser’s salt (727 mg, 4 mmol) in CH2Cl2 (60 mL) at 0 
°C. The mixture was stirred for 3 h and then NaOH (1M, 2.6 mL, 2.6 mmol) was added 
and the mixture was poured into brine and extracted 3 times with CH2Cl2. The combined 
organic layers were washed with brine and dried with Na2SO4. Solvents were evaporated to 
obtain a grey-green oil which was dissolved in CH2Cl2 (30 mL) and MeI (185 mL, 3 mmol) 
was added. After 15 min a precipitate appears and the mixture was stirred for 1.5 h. Then a 
saturated NaHCO3 aqueous solution (30 mL) was added. After 30 min stirring the mixture 
was extracted 3 times with CH2Cl2. The combined organic layers were washed with brine 
and dried with MgSO4. The solvent was evaporated and the residue was purified by FC 
(AcOEt:Cyclohexane / 4.5:5.5) to give the enone 92 (271 mg, 48 %) as a yellow solid; mp 
= 86–89 °C; IR (CH2Cl2): n = 2970, 1694, 1610, 1580, 1400, 1287, 1200, 1172, 1030, 999 
cm-1; 1H NMR (500 MHz, CDCl3): d = 6.80 (bs, 1H), 6.57 (dd, J = 17.2, 10.4 Hz, 1H), 
5.88 (d, J = 17.4 Hz, 1H), 5.89-5.84 (m, 1H), 5.74 (d, J = 10.6 Hz, 1H), 5.30 (d, J = 6.5 
Hz, 1H), 5.09 (d, J = 17.2, 1H), 5.04 (d, J = 11.5 Hz, 1H), 3.97 (bs, 1H), 3.92 (bs, 2H), 
3.71 (s, 3H), 3.34 (s, 1H), 1.34 (s, 3H), 1.28 (s, 3H); 13C NMR (125 MHz, CDCl3) : d = 
194.9, 161.5, 158.2, 136.4, 133.8, 129.9, 118.1, 114.3, 113.6, 95.3, 79.0, 67.3, 55.7, 53.7, 
39.1, 28.4, 28.0; MS (m/z): 287 (7), 272 (4), 232 (100), 206 (13), 190 (23), 178 (12), 161 
(38), 134 (16), 103 (6); HRMS (EI) on (M+) for C17H21NO3 requires 287.1521, found: 
287.1537. 
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1-[3-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-6-methoxy-2-vinyl-phenyl]-propanone 
(95) 
 
A solution of 92 (36 mg, 0.12 mmol) and catalyst 29 (11 mg, 10 mol %) in 
toluene (15 mL) was degassed and then warmed to 80 °C for 44 h. The 
mixture was then concentrated in vacuo and the residue was purified by FC 
(cyclohexane:AcOEt / 7:3) to give 95 (11 mg, 33 %) as a yellow solid; 1H 
NMR (200 MHz, CDCl3): d = 7.77 (d, J = 8.7 Hz, 1H), 7.11 (dd, J = 11.5, 
6.2 Hz, 1H), 6.84 (d, J = 8.7 Hz, 1H), 5.40-5.24 (m, 2H), 4.04 (bs, 2H), 3.83 
(s, 3H), 2.62 (q, J = 7.2 Hz, 2H), 1.36 (s, 6H), 1.11 (t, J = 7.2 Hz, 3H).  
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-cyclohexa-2,4-dienyl]-
prop-2-en-1-ol (96) 
 
Sodium borohydride (9 mg, 0.23 mmol) was added to a solution of 92 (68 
mg, 0.23 mmol) and cerium trichloride heptahydrate (88 mg, 0.23 mmol) 
in MeOH (3 mL) at 0 oC.  The mixture was stirred for 1 h and then poured 
into water and extracted 3 times with AcOEt. The combined organic 
layers were washed with brine and dried with MgSO4. Purification by FC 
(AcOEt:cyclohexane / 5.5:4.5) gave the colourless oil 96 (42 mg, 63 %) as 
a mixture of two diastereoisomers in a 68:32 ratio; 1H NMR (300 MHz, CDCl3): d = 6.83 
(1H), 6.80 (1H), 5.93-5.76 (4H), 5.58-5.17 (4H), 5.15-4.96 (6H),  4.24 (1H), 4.10 (1H), 
4.02-3.92 (4H), 3.80 (1H), 3.73 (3H), 3.63 (3H), 3.53 (1H), 2.73 (1H), 2.39-2.36 (2H), 
2.31 (1H), 1.37 (3H), 1.34 (3H), 1.31 (3H), 1.30 (3H). 
 
4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-7-methoxy-3a,7a-dihydro-1H-inden-1-ol (99 
and 100) 
  
tBuONa (172 mg, 1.79 mmol) was added to a solution 
of ketone 92 (419 mg, 1.46 mmol) in THF (4 mL) at – 
78 °C. The mixture which turned orange, was stirred 
for 15 min and then toluene (20 mL) was added. The 
solution was cooled to – 95 °C (toluene / N2 liquid 
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bath) and then acetic acid (110 mL, 1.94 mmol) dissolved in toluene (2 mL) was added 
rapidly. The mixture was stirred for 10 min, then poured into phosphate buffer solution pH 
= 7 and extracted 3 times with ether. The combined organic layers were dried with Na2SO4 
and the solvent was evaporated. The residue was dissolved in MeOH (15 mL) and the 
mixture was cooled to 0 °C. Then, CeCl3.7H2O (665 mg, 1.79 mmol) and NaBH4 (282 mg, 
7.45 mmol) were added. After stirring for 30 min, 15 mL of water were added and the 
mixture was extracted 3 times with AcOEt. Purification by FC (AcOEt:cyclohexane / 6:4) 
gave the alcohol 98 (115 mg, 26 %) as a mixture of 2 diastereoisomers in a 53:47 ratio, 
which was used directly. 
Catalyst 29 (4 mg, 0.004 mmol) was added to a degassed solution of diene 98 (12 mg, 0.04 
mmol) in toluene (4 mL), and the mixture was heated at 80 °C for 1 h. Then solvents were 
evaporated and the brown residue was purified by FC (AcOEt:cyclohexane / 6:4) to give 3 
mg of diasteroisomer 99 (29 %) and 2 mg (19 %) of disteroisomer 100. 
Diasteroisomer 99: IR (CH2Cl2): n = 3576, 2969, 1608, 1580, 1395, 1270, 1259, 1159, 
1088, 993 cm -1; 1H NMR (400 MHz, CDCl3): d =  6.68-6.66 (m, 1H), 6.64-6.58 (m, 1H), 
6.05-6.03 (m, 1H), 5.26 (d, J = 6.8 Hz, 1H), 4.92-4.87 (m, 2H), 4.07 (dd, J = 11.6, 2.3 Hz, 
1H), 4.05 (bs, 2H), 3.75 (s, 3H), 3.19 (dd, J = 11.9, 6.8 Hz, 1H), 1.44 (s, 3H), 1.37 (s, 6H); 
13C (100 MHz, CDCl3): d = 165.0, 161.8, 138.6, 130.7, 128.4, 116.9, 93.7, 87.9, 78.3, 67.2, 
55.4, 53.8, 49.2, 28.4, 28.3; MS (m/z): 261 (34), 232 (25), 206 (29), 176 (10), 161 (14), 
145 (7), 135 (100); HRMS (EI) on (M+) for C15H19O3N requires 261.1365; found: 
261.1368. 
Diasteroisomer 100: IR (CH2Cl2): n = 3576, 2969, 1659, 1608, 1580, 1463, 1345, 1302, 
1159, 909 cm-1; 1H NMR (400 MHz, CDCl3): d = 6.66 (d, J = 6.6 Hz, 1H), 5.94 (d, J = 5.1, 
2.5 Hz, 1H), 5.74 (d, J = 5.1 Hz, 1H), 4.98 (d, J = 6.6 Hz, 1H), 4.81 (s, 1H), 4.06 (d, J = 
8.1 Hz, 1H), 4.04 (d, J = 8.1 Hz, 1H), 3.66 (s, 1H), 3.56 (s, 3H), 1.98 (s, 1H), 1.44-1.38 (m, 
1H), 1.29 (s, 3H), 1.26 (s, 3H); 13C (100 MHz, CDCl3): d = 167.9, 162.8, 135.6, 132.4, 
129.1, 114.5, 91.3, 81.9, 78.7, 67.0, 55.5, 51.1, 50.2, 28.4, 19.8; MS (m/z): 261 (18), 232 
(14), 206 (8), 176 (9), 161 (11), 149 (10), 135 (100), 111 (12); HRMS (EI) on (M+) for 
C15H19O3N requires 261.1365; found: 261.1361. 
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E-Carbonic acid 1-[5-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-
cyclohexa-2,4-dienylidene]-ethyl ester methyl ester (104) 
 
NaOMe (5.4M (prepared by addition of Na to MeOH), 95 mL, 0.5 
mmol), was added dropwise to a solution of the ketone 93 (93 mg, 
0.34 mmol) in THF (5 mL) at - 78 °C. The colour of the mixture 
changes to orange and the mixture was stirred 1 h before methyl 
chloroformate (130 mL, 1.7 mmoles) was added, then it was warmed 
up to rt and stirred for 16 h. A saturated aqueous solution of NH4Cl 
was added and the mixture was extracted 3 times with Et2O. The combined organic layers 
were washed with brine and dried with MgSO4. Purification by FC with 
(AcOEt:cyclohexane / 3:7) gave the product 104 (79 mg, 70 %) as a yellow oil; IR 
(CH2Cl2): n = 2967, 1759, 1604, 1559, 1441, 1285, 1248, 1203, 1178, 1039, 1001 cm-1; 1H 
NMR (400 MHz, CDCl3): d = 6.78 (bs, 1H), 5.78-5.75 (m, 1H), 5.24 (d, J = 6.6 Hz, 1H), 
5.26-5.21 (m, 2H), 5.01-4.95 (m, 1H),  3.93 (d, J = 7.8 Hz, 1H), 3.90 (d, J = 7.8 Hz, 1H), 
3.82 (s, 3H), 3.70 (s, 3H), 2.27 (s, 3H), 1.33 (s, 3H), 1.28 (s, 3H); 13C (100 MHz, CDCl3): 
d = 153.4, 147.5, 135.6, 128.7, 120.8, 113.8, 96.8, 78.5, 67.4, 55.2, 55.0, 40.3, 28.3, 28.2, 
26.9, 19.4; MS (m/z): 333 (11), 318 (2), 274 (30), 257 (50), 242 (13), 232 (10), 177 (11). 
 
Z-Carbonic acid 1-[5-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-
cyclohexa-2,4-dienylidene]-ethyl ester methyl ester (105) 
 
Phenyl magnesium bromide (3M in Et2O, 160 mL, 0.48 mmol) was 
added at 0 °C to a solution of diisopropyl amine (135 mL, 0.96 mmol) 
in ether (5 mL) at 0 °C. The mixture was stirred for 30 min and then 
the ketone 93 (110 mg, 0.40 mmol) was added. Instantly the solution 
turned orange and a precipitate was formed. After 2 h of stirring 
methylchloroformate (90 mL, 1.2 mmoles) was added. The mixture 
was warmed up 16 h and then poured into a saturated aqueous solution of NH4Cl and 
extracted 3 times with ether. The combined organic layers were washed with brine and 
dried with MgSO4. Purification by FC (AcOEt:cyclohexane / 1:1) gave the product 105 (30 
mg, 23 %) as a yellow oil; 1H NMR (400 MHz, CDCl3): d = 6.74 (d, J = 6.8 Hz, 1H), 5.91-
5.81 (m, 1H), 5.21-5.17 (m, 2H), 5.08 (d, J = 10.1 Hz, 1H), 4.29 (s, 1H), 3.98 (d, J = 7.8 
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Hz, 1H), 3.96 (d, J = 7.8 Hz, 1H), 3.87 (s, 3H), 3.66 (s, 3H), 2.07 (s, 3H), 1.36 (s, 3H), 
1.32 (s, 3H); 13C NMR (100 MHz, CDCl3): d = 161.2, 156.2, 153.5, 146.1, 134.9, 128.8, 
120.1, 118.5, 114.4, 96.2, 78.5, 67.6, 55.2, 55.1, 41.9, 30.0, 28.4, 28.2, 17.7. 
 
Carbonic acid 1-[5-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-
cyclohexa-2,4-dienylidene]-allyl ester methyl ester (107) 
 
Compound 106 (132 mg, 0.46 mmol) was treated following the 
procedure described for the preparation of 104. The residue was 
purified by FC (AcOEt:cyclohexane / 1:1) to recover the product 107 
(59 mg, 37 %) as a yellow oil; 1H NMR (200 MHz, CDCl3): d = 7.25 
(dd, J = 15.6, 12.5 Hz, 1H), 6.90 (d, J = 6.5 Hz, 1H), 5.88-5.69 (m, 
1H), 5.42-5.31 (m, 2H), 5.23 (d, J = 15.6 Hz, 1H), 5.07-4.96 (m, 2H), 
4.56 (d, J = 5.8 Hz, 1H), 3.95 (bs, 2H), 3.84 (s, 3H), 3.75 (s, 3H), 1.33 (s, 3H), 1.29 (s, 
3H).  
 
Carbonic acid 4-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-7-methoxy-3H-inden-1-yl-
ester methyl ester (109) 
 
A solution of 107 (16 mg, 0.049 mmol) and RCM catalyst 29 (10 mol 
%, 4 mg, 0.005 mmol) in CH2Cl2 (25 mL) was degassed and then 
heated 16 h at reflux. The residue was purified by FC 
(AcOEt:cyclohexane / 1:1) to recover the product 109 (8 mg, 51 %) as 
a yellow oil; 1H NMR (300 MHz, CDCl3): d = 7.89 (d, J = 8.7 Hz, 1H), 
6.87 (d, J = 8.7 Hz , 1H), 6.15-6.13 (m, 1H), 4.12 (bs, 2H), 3.94 (s, 
3H), 3.92 (s, 3H), 3.75-3.74 (m, 2H), 1.42 (s, 6H); 13C NMR (75 MHz, CDCl3): d = 153.6, 
148.8, 130.9, 129.0, 126.9, 116.5, 114.0, 109.3, 78.9, 55.8, 55.5, 55.4, 36.6, 30.2, 28.4; MS 
(m/z): 317 (39), 272 (7), 259 (18), 258 (100), 246 (4), 205 (6). 
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1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-3-phenylsulfanyl-6-vinyl-
cyclohexa-2,4-dienyl]-ethanone (110) 
 
Ketone 93 (96 mg, 0.35 mmol) was added as a solid to a suspension of 
NaH (11 mg, 0.46 mmol) in THF (4 mL) at rt. The mixture turned red, 
it was stirred for 45 min and then cooled to - 78 °C. Diphenyl sulfide 
(154 mg, 0.70 mmol) was then added and the solution was allowed to 
warm up to rt for 16 h. A saturated NH4Cl aqueous solution was added 
and the mixture was extracted 3 times with ether. The combined 
organic layers were dried with MgSO4 and purified by FC (AcOEt:cyclohexane / 6:4) to 
give 110 (54 mg, 40 %) as a red oil; 1H NMR (500 MHz, CDCl3): d = 7.30-7.23 (m, 4H), 
7.15-7.12 (m, 1H), 6.65 (s, 1H), 5.93-5.84 (m, 1H), 5.20-5.14 (m, 2H), 4.11 (bs, 1H), 3.90 
(d, J = 8.1 Hz, 1H), 3.87 (d, J = 8.1 Hz, 1H), 3.86 (s, 3H), 3.50 (s, 1H), 2.30 (s, 3H), 1.30 
(s, 3H), 1.25 (s, 3H); 13C NMR (125 MHz, CDCl3): d = 204.5, 136.6, 135.5, 129.0, 127.7, 
125.6, 115.4, 104.9, 78.8, 67.3, 57.5, 55.4, 43.5, 39.8, 30.2, 28.3, 28.1, 26.9; MS (m/z): 
383 (18), 340 (100), 269 (10), 230 (34), 216 (8), 176 (6), 149 (7), 109 (8). 
 
1-[3-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-6-methoxy-5-phenylsulfanyl-2-vinyl-
phenyl]-ethanone (111) 
 
 Ketone 93 (132 mg, 0.48 mmol) was added as a solid to a suspension 
of NaH (15 mg, 0.62 mmol) in DMF (5 mL) at rt. The mixture 
immediately turned to red, it was stirred for 15 min and then cooled to 
- 78 °C. Diphenyl sulfide (200 mg, 0.92 mmol) was then added and the 
solution was allowed to warm up for 16 h. A saturated NH4Cl aqueous 
solution was added and the mixture was extracted 3 times with ether. 
The combined organic layers were dried with MgSO4 and purified by FC 
(AcOEt:cyclohexane / 1:9 to 6:4) to give 111 (63 mg, 34 %) as a pale yellow solid; mp = 
101-103 °C; IR (CH2Cl2): n = 3054, 2977, 1706, 1647, 1459, 1421, 1350, 1314, 1260, 
1159, 1083, 969 cm-1; 1H NMR (300 MHz, CDCl3): d = 7.51 (s, 1H), 7.40-7.30 (m, 5H), 
7.10 (dd, J = 17.7, 11.6 Hz, 1H), 5.43 (d, J = 11.6 Hz, 1H), 5.37 (d, J = 17.7 Hz, 1H), 4.00 
(s, 2H), 3.88 (s, 3H), 2.43 (s, 3H), 1.34 (s, 6H); 13C NMR (75 MHz, CDCl3): d = 203.9, 
161.1, 155.7, 137.5, 135.3, 133.4, 133.3, 133.2, 131.7, 129.8, 129.5, 127.8, 124.5, 121.1, 
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78.9, 68.2, 62.8, 32.5, 28.3; MS (m/z): 381 (73), 380 (100), 366 (15), 326 (4), 325 (5), 310 
(4), 295 (3), 294 (5). 
 
1-[3-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-6-methoxy-2-vinyl-phenyl]-ethanone 
(112)  
 
Ketone 93 (132 mg, 0.48 mmol) was added as a solid to a suspension of 
NaH (15 mg, 0.62 mmol) in THF (5 mL) at rt. The mixture turned a red 
colour and was stirred for 45 min, then cooled to - 78 °C. Dimethyl sulfide 
(85 mg, 0.96 mmol) was then added and the solution was allowed to warm 
up for 16 h. After this time, DMPU (570 mL, 4.8 mmol) and dimethyl 
sulfide (170 mg, 1.92 mmol) were added, and the mixture was stirred for 24 
h, then a saturated NH4Cl aqueous solution was added and the mixture was extracted 3 
times with ether. The combined organic layers were dried with MgSO4. Solvents were 
evaporated to give 112 (63 mg, 48 %); IR (CH2Cl2): n = 2971, 2895, 1705, 1646, 1572, 
1464, 1352, 1283, 1243, 1197, 1135, 1109, 1069, 1036 cm-1; 1H NMR (300 MHz, CDCl3): 
d = 7.80 (d, J = 8.7 Hz, 1H), 7.15 (dd, J = 17.5, 6.0 Hz, 1H), 5.94-5.78 (m, 1H), 5.42 (d, J 
= 6.0 Hz, 1H), 5.35 (d, J = 17.5 Hz, 1H), 4.07 (bs, 2H), 3.88 (s, 3H), 2.43 (s, 3H), 1.40 (s, 
6H); 13C NMR (50 MHz, CDCl3): d = 204.4, 162.2, 157.1, 136.6, 133.9, 132.9, 131.9, 
131.6, 120.7, 120.1, 109.4, 78.9, 67.7, 55.8, 35.5, 28.3; MS (m/z): 272 (100), 258 (33), 230 
(12), 219 (16), 202 (13). 
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-cyclohex-2-enyl]-
propenone (121 and 122) 
 
TMSOTf (2.2 mL, 12.2 mmol) was added dropwise to a 
solution of ketone 93 (2.4 g, 8.7 mmol) and NEt3 (1.8 mL, 
13.1 mmol) in CH2Cl2 (80 mL) at 0 °C. The solution was 
stirred for 30 min and then filtered over neutral Al2O3 
activated with 10 % water. The solvents were then 
evaporated and the yellow oil was dissolved in toluene (80 
mL), and DIBAL (1.5M in toluene, 9.9 mL, 14.8 mmol) was added. Instantly the colour 
became brilliant orange. After 15 min stirring, a saturated aqueous solution of Rochelle’s 
N O
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salt (40 mL) was added. The mixture was vigorously stirred for 30 min and then it was 
extracted 3 times with ether. The combined organic layers were washed with water and 
dried with Na2SO4. Solvents were evaporated and the yellow oil was dissolved in CH2Cl2 
(15 mL) and added to a suspension of Eschenmoser’s salt (2.0 g, 11.3 mmol) in CH2Cl2 
(70 mL). The mixture was stirred for 15 min and then NaOH (1M, 11.3 mL, 11.3 mmol) 
was added. The mixture was then poured into water and extracted 3 times with CH2Cl2. 
The combined organic layers were dried over Na2SO4 and solvents were then evaporated. 
The dark orange oil was dissolved in CH2Cl2 (50 mL) and then MeI (1.6 mL, 26.1 mmol) 
was added. The solution was stirred for 20 min before the addition of saturated NaHCO3 
aqueous solution (50 mL). After 5 min stirring, the mixture was extracted 3 times with 
CH2Cl2 and the combined organic layers were dried over MgSO4. Solvents were 
evaporated and the orange dark oil was purified by FC (AcOEt:cyclohexane / 4:6) to give 
1.286 g (51 %) of 121 as a yellow oil and 267 mg (11 %) of  122. 
Diastereoisomer 121: 
IR (CH2Cl2): n = 2969, 2931, 1701, 1670, 1615, 1463, 1401, 1355, 1292, 1214, 1175, 990 
cm-1; 1H NMR (400 MHz, CDCl3): d = 6.40 (dd, J = 17.2, 10.4 Hz, 1H), 6.21 (d, J = 17.2 
Hz, 1H), 5.64 (d, J = 10.6 Hz, 1H), 5.57-5.48 (m, 1H), 4.94-4.88 (m, 2H), 4.76 (d, J = 6.1 
Hz, 1H), 3.82-3.76 (m, 2H), 3.41 (s, 3H), 3.32 (d, J = 10.6 Hz, 1H), 2.71 (q, J = 9.6 Hz, 
1H), 2.68-2.42 (m, 2H), 2.33-2.26 (m, 1H), 1.18 (s, 3H). 1.16 (s, 3H); 13C NMR (100 
MHz, CDCl3): d = 198.7, 166.4, 152.0, 136.9, 134.2, 128.2, 117.3, 93.9, 78.7, 66.6, 55.6, 
54.4, 45.2, 38.7, 28.5, 26.7; elemental analysis calcd (%) for  C17H23NO3 : C 70.56, H 8.01, 
N 4.84; found : C 69.26, H 7.97, N 4.6. 
Diastereoisomer 122: 
IR (CH2Cl2): n = 2969, 2931, 1676, 1611, 1464, 1400, 1207, 1166, 970; 1H NMR (400 
MHz, CDCl3): d = 6.54 (dd, J = 17.4, 10.4  Hz, 1H), 6.32 (dd, J = 17.4, 1.0 Hz, 1H), 5.85-
5.76 (m, 2H), 5.15-5.08 (m, 1H), 4.88-4.84 (m, 2H), 3.85 (d, J = 7.8 Hz, 1H), 3.83 (d, J = 
7.8 Hz, 1H), 3.52 (s, 3H), 3.45 (s, 1H), 3.06-3.03 (m, 1H), 2.76-2.71 (m, 1H), 2.41-2.37 
(m, 2H), 1.21 (s, 3H), 1.18 (s, 3H); 13C NMR (100 MHz , CDCl3): d = 198.9, 166.1, 150.7, 
135.8, 135.1, 129.1, 116.6, 95.3, 79.2, 67.0, 54.5, 52.5, 41.6, 33.5, 28.7, 27.9, 22.7; HRMS 
(ESI) on ([M + H]+) for C17H23O3N requires 290.1750; found: 290.1738. 
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4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-6-(1-hydroxy-allyl)-5-vinyl-cyclohex-1-enol 
(124) 
 
Aluminium isopropoxide (3.2 g, 15.9 mmol) was added to a solution of 
enone 121 (766 mg, 2.6 mmol) in toluene (25 mL), and the mixture was 
stirred for 48 h at 80 °C. The solution was cooled to rt and then a saturated 
aqueous solution of Rochelle’s salt (10 mL) was added to the yellow brown 
solution and the mixture was stirred for 45 min. The organic phase was 
recovered and the aqueous phase was extracted 3 times with ether. The 
combined organic phases were dried with MgSO4 and purified by FC 
(AcOEt:cyclohexane:EtOH / 5:4.5:0.5) to give alcohol 124 (430 mg, 57 %) as a white 
solid; mp = 104-107 °C; IR(CH2Cl2): n = 3557, 2969, 2930, 1667, 1464, 1365, 1210, 1172, 
995, 925 cm-1; 1H NMR (400 MHz, CDCl3): d = 6.03-5.95 (m, 1H), 5.80-5.71 (m, 1H), 
5.23-5.10 (m, 3H), 4.79 (d, J = 6.6 Hz, 1H), 4.56 (bs, 1H), 3.87 (d, J = 7.8 Hz, 1H), 3.84 
(d, J = 7.8 Hz, 1H), 3.54 (s, 1H), 3.46 (s, 3H), 2.65 (dd, J = 20.2, 9.8 Hz, 1H), 2.55-2.35 
(m, 3H), 2.27-2.22 (m, 1H), 2.14 (d, J = 8.2 Hz, 1H), 1.33 (s, 6H); 13C NMR (100 MHz, 
CDCl3): d = 167.0, 153.2, 140.7, 140.7, 139.6, 116.9, 113.6, 94.3, 78.5, 72.9, 66.1, 53.8, 
48.1, 44.4, 39.0, 28.1, 27.9; MS (m/z): 291 (2), 276 (4), 274 (2), 236 (7), 235 (37), 234 
(77), 232 (12), 221 (15), 220 (100). 
 
1-[5-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-methoxy-6-vinyl-cyclohex-2-enyl]-
ethanol (128) 
 
Alcohol 124 (330 mg, 1.1 mmol) was treated following the procedure 
described for the preparation of 109. Purification by FC 
(AcOEt:cyclohexane / 8:2) gave the product 128 (177 mg, 61 %) as a brown 
oil; IR (CH2Cl2): n = 3592, 3054, 2985, 1663, 1421, 1270, 1224, 1071, 992, 
896 cm-1; 1H NMR (400 MHz, CDCl3): d = 6.04-6.02 (m, 1H), 5.89-5.87 
(m, 1H), 4.81-4.79 (m, 1H), 4.51 (dd, J = 5.8, 2.8 Hz, 1H), 3.95 (s, 2H), 
3.59 (s, 3H), 2.70-2.45 (m, 6H), 1.30 (s, 6H); 13C NMR (100 MHz, CDCl3): d = 167.2, 
155.6, 136.4, 133.1, 117.0, 91.0, 78.9, 66.9, 56.0, 54.3, 48.4, 47.8, 45.2, 38.0, 29.6, 28.5, 
28.4; MS (m/z): 263 (29), 248 (100), 246 (3), 232 (8), 194 (3). 
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4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-7-methoxy-7a-methyl-3a,7a-dihydro-inden-
1-one (130) 
 
MnO2 (1.5 g, 17.67 mmol) was added to a solution of alcohol 47 in ether (10 
mL). The reaction was followed by TLC and stopped after 3 h. The mixture 
was then filtered over a Celite pad and rinsed with ether. The solvents were 
then evaporated and the ketone 130 (240 mg, 100 %) was obtained as a pale 
yellow solid; mp = 127-130 °C; IR (CH2Cl2): n = 2970, 2932, 1714, 1661, 
1607, 1578, 1457, 1271, 1258, 1172, 1094, 1050, 817 cm-1; 1H NMR (400 
MHz, CDCl3): d = 7.62 (dd, J = 5.0, 2.2 Hz, 1H), 6.77 (d, J = 6.8 Hz, 1H), 6.36 (dd, J = 
5.6, 2.2 Hz, 1H), 5.11 (d, J = 6.8 Hz, 1H), 4.01 (d, J = 8.1 Hz, 1H), 3.8 (d, J = 8.1 Hz, 1H), 
3.87 (bs, 1H), 3.66 (s, 3H), 1.38 (s, 3H), 1.37 (s, 3H), 1.36 (s, 3H); 13C NMR (100 MHz, 
CDCl3): d = 207.4, 162.6, 161.4, 132.2, 129.4, 114.4, 92.2, 78.7, 67.5, 55.9, 53.4, 51.9, 
51.4, 28.6, 28.3, 21.9; MS (m/z): 263 (29), 248 (100), 234 (32), 220 (45), 206 (11), 180 
(15), 126 (9), 72 (16). 
 
4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-2-(1-hydroxy-allyl)-3-vinyl-cyclohexanone 
(131) 
 
p-Toluene sulfonic acid (280 mg, 1.48 mmol) was added to a solution of 
alcohol 124 (430 mg, 1.48 mmol) in acetone (20 mL). The solution was 
stirred for 2.5 h and then poured into a saturated NaHCO3 aqueous solution. 
The mixture was extracted 6 times with ether, then neutralized with HCl 1M 
and extracted 3 times more with ether. The combined organic phases were 
dried with MgSO4 and solvents were evaporated to give 131 (353 mg, 86 
%) as an orange solid; mp: 116-118 °C; IR (CH2Cl2): n = 3548, 3045, 2971, 1705, 1666, 
1365, 1265, 1261, 994, 928, 909 cm-1; 1H NMR (500 MHz, CDCl3): d = 6.10-6.02 (m, 
1H), 5.68-5.59 (m, 1H), 5.21 (d, J = 15.9 Hz, 1H), 5.18 (dd, J = 8.6, 1.5 Hz, 1H), 5.12 (dd, 
J = 10.4, 1.5 Hz, 1H), 4.28-4.21 (m, 1H), 3.88 (d, J = 8.0 Hz, 1H), 3.86 (d,  J = 8.0 Hz, 
1H), 3.01 (d, J = 11.2 Hz, 2H), 2.97 (d,  J = 11.4 Hz, 1H), 2.74 (td, J = 12.4, 3.8 Hz, 1H), 
2.46-2.40 (m, 3H), 2.25-2.19 (m, 1H), 2.07-1.99 (m, 1H), 1.24 (s, 3H), 1.23 (s, 3H); 13C 
NMR (125 MHz, CDCl3): d = 211.4, 165.9, 140.1, 137.6, 118.6, 114.8, 79.0, 70.9, 66.8, 
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57.7, 49.3, 42.1, 41.6, 29.6, 28.4, 28.3; HRMS (ESI) on ([M + H]+) for C16H24O3N requires 
278.1750; found: 278.1728. 
 
7-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-3-hydroxy-3,3a,5,6,7,7a-hexahydro-inden-4-
one (132) 
 
1st generation Grubb’s catalyst 20 (62 mg, 0.068 mmol) was added to a 
solution of diene 131 (125 mg, 0.45 mmol) in CH2Cl2 (22 mL). The mixture 
was degassed and stirred for 16 h at 48 °C. Solvents were then evaporated 
and the brown residue purified by FC (AcOEt:cyclohexane:EtOH / 
5:4.5:0.5) to give a brown oil that was dissolved in ether (5 mL). Silica gel 
was added and the mixture was stirred for 15 h, after this time it became red. 
Then the mixture was filtered through a silica pad and was rinsed with EtOH:ether (1:9) to 
give 132 (83 mg, 74 %) as a brown oil; mp: 125-128 °C; IR (CH2Cl2): n = 3596, 2970, 
1702, 1663, 1461, 1261, 1194, 990 cm-1; 1H NMR (500 MHz, CDCl3): d = 6.17 (dd, J = 
5.6, 2.4 Hz, 1H), 5.98 (d, J = 5.6 Hz, 1H), 4.97 (dd, J = 7.0, 2.4 Hz, 1H), 3.98 (s, 2H), 3.19 
(dd, J = 9.4, 7.5 Hz, 1H), 2.99 (dd, J = 7.5, 7.0 Hz, 1H), 2.57-2.52 (m, 2H), 2.34-2.28 (m, 
1H), 2.22-2.19 (m, 1H), 1.99-1.78 (m, 3H), 1.32 (s, 3H), 1.28 (s, 3H); 13C NMR (125 
MHz, CDCl3): d = 212.5, 167.4, 138.3, 132.5, 79.2, 66.8, 53.9, 47.5, 41.2, 40.7, 29.7, 28.3, 
28.2, 27.0; HRMS (ESI) on ([M + H]+) for C14H20O3N requires 250.1437; found: 
250.1408. 
 
7-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-3-hydroxy-3,3a,5,6,7,7a-hexahydro-4-(1,3-
dioxolanyl)-indene (133) 
 
CuBr2 (23 mg, 0.1 mmol) was added to a solution of ketone 132 (128 mg, 
0.51 mmol) in ethylene glycol (5 mL). The mixture was stirred at 80 °C for 
4 h, then was poured into water and extracted with ether 6 times. The 
combined organic phases were dried with MgSO4 and the solvent was 
evaporated. Purification by FC (AcOEt:EtOH / 9.5:0.5) gave product 133 
(60 mg, 30 %) as a brown oil; 1H NMR (400 MHz, CDCl3): d = 6.31 (dd, J = 
N O
OOH H
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5.8, 2.5 Hz, 1H), 5.92 (dd, J = 5.8, 2.0 Hz, 1H), 4.72 (dd, J = 5.8, 5.2 Hz, 1H), 4.04-3.96 
(m, 4H), 3.92 (s, 2H), 2.91-2.87 (m, 1H), 2.31-2.17 (m, 3H), 2.00-1.97 (m, 1H), 1.89-1.78 
(m, 3H), 1.29 (s, 3H), 1.28 (s, 3H). 
 
4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-7,7-dimethoxy-3a,4,5,6,7,7a-hexahydro-1H-
inden-1-ol (134) and 4,4-Dimethyl-2-(1,7,7-trimethoxy-3a,4,5,6,7,7a-hexahydro-1H-
inden-4-yl)-4,5-dihydro-oxazole (135) 
 
CuBr2 (7 mg, 0.03 mmol) was added to a solution of the 
ketone 133 (53 mg, 0.21 mmol) and methyl orthoformate 
(116 mL, 1.06 mmol) in MeOH (5 mL). The mixture was 
stirred 16 h at 80 °C. Then the brown solution was poured 
into water and extracted 3 times with ether and 3 times 
more with CH2Cl2. The combined organic layers were 
washed with brine and dried with MgSO4. The products were recovered (134: 25 mg, 40 
%; 135: 12 mg, 19 %) after FC with (AcOEt:EtOH / 9.5:0.5). 
134: IR (CH2Cl2): n = 3562, 3054, 2967, 1661, 1462, 1365, 1265, 1110, 1073, 1047, 992, 
921, 896 cm-1; 1H NMR (400 MHz, C6D6): d = 6.58 (dd, J = 5.8, 2.8 Hz, 1H), 5.92 (dd, J = 
5.7, 2.8 Hz, 1H), 4.61 (dd, J = 5.7, 2.7 Hz, 1H), 3.53 (s, 2H), 3.14-3.11 (m, 1H), 2.94 (s, 
3H), 2.85 (s, 3H), 2.61-2.52 (m, 1H), 2.38-2.28 (m, 1H), 2.04-1.98 (m, 1H), 1.86-1.72 (m, 
4H), 1.09 (s, 6H); 13C NMR (100 MHz, C6D6): d = 167.1, 141.2, 131.6, 127.6, 101.7, 78.3, 
74.9, 66.7, 47.7, 46.7, 45.7, 43.1, 31.2, 28.2, 28.1, 26.7; MS (m/z): 295 (45), 280 (36), 264 
(29), 248 (35), 234 (16), 230 (20), 212 (17), 198 (17), 190 (41), 180 (23), 134 (18), 126 
(49), 113 (28), 101 (29); HRMS (ESI) on ([M + H]+) for C16H26O4N requires 296.1861; 
found: 296.1864. 
135: IR (CH2Cl2): n = 2966, 2831, 1661, 1462, 1364, 1270, 1190, 1115, 1075, 1049 cm -1; 
1H NMR (400 MHz, CDCl3): d = 5.96 (d, J = 5.8 Hz, 1H), 5.91-5.89 (m, 1H), 4.03 (d, J = 
2.5 Hz, 1H), 3.91 (d, J = 4.7 Hz, 1H), 3.88 (d, J = 4.7 Hz, 1H), 3.41-3.34 (m, 1H), 3.29 (s, 
3H), 3.21 (s, 3H), 3.13 (s, 3H), 2.62 (dd, J = 11.4, 5.8 Hz, 1H), 2.05-2.01 (m, 1H), 1.89-
1.85 (m, 2H), 1.66-1.61 (m, 2H), 1.26 (s, 3H), 1.24 (s, 3H); 13C NMR (100 MHz, CDCl3): 
d = 167.7, 137.8, 131.2, 100.1, 89.4, 78.9, 66.8, 57.1, 51.2, 47.6, 47.2, 43.2, 36.1, 28.5, 
28.4, 27.8, 24.8;  MS (m/z): 309 (9), 294 (53), 278 (41), 262 (89), 246 (31), 230 (11), 213 
N O
H
H
OH
MeO OMe
N O
H
H
MeO OMe
MeO
+
 Chapter V  
 
 143 
(35), 198 (30), 147 (25), 126 (31), 101 (100); HRMS (ESI) on ([M + H]+) for C17H28O4N 
requires 310.2018; found: 310.2000. 
 
7-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-3-oxo-3,3a,5,6,7,7a-hexahydro-4-(1,3-
dimethoxy)-indene (136) 
 
Dess-Martin periodinane (142 mg, 0.33 mmol) was added to a solution of 
alcohol 132 (68 mg, 0.22 mmol) in CH2Cl2 (5 mL). The mixture was 
stirred for 16 h and then purified by FC (AcOEt:EtOH / 9.5:0.5) to 
recover the product 136 as an colourless oil (36 mg, 56 %); IR (CH2Cl2): 
n = 2968, 2930, 1712, 1662, 1462, 1374, 1246, 1118, 1048, 909 cm -1; 1H 
NMR (400 MHz, CDCl3): d = 7.86–7.84 (m, 1H), 6.11 (d, J = 5.8 Hz, 
1H), 3.97 (s, 2H), 3.39-3.36 (m, 1H), 3.34 (s, 3H), 3.25 (bs, 1H), 3.20 (s, 3H), (d, J = 5.8 
Hz, 1H), 2.05-1.85 (m, 4H), 1.79-1.65 (m, 1H), 1.32 (s, 6H); 13C NMR (100 MHz, CDCl3): 
d = 203.5, 166.4, 165.0, 132.6, 100.0, 79.0, 67.1, 52.4, 48.9, 47.0, 44.1, 43.1, 29.2, 28.4, 
24.6; MS (m/z): 294 (5), 293 (3), 278 (57), 262 (59), 246 (38), 212 (16), 174 (27), 163 
(19), 126 (40); HRMS (ESI) on ([M + H]+) for C16H24O4N requires: 294.1705; found: 
294.1723. 
 
4-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-7-methoxy-7a-methyl-3-vinyl-2,3,3a,7a-
tetrahydro-inden-1-one (137) 
 
Vinyl Magnesium bromide (5.97 mL, 5.97 mmol) was slowly added to a 
suspension of dried CuI (227 mg, 1.19 mmol) in THF (20mL) at - 40 °C, the 
mixture was stirred for 30 min and the colour changed from yellow to grey. 
Then the ketone 130 dissolved in THF (10 mL) was slowly added. The 
solution was stirred for 1 h and a black precipitate formed. Then a saturated 
NH4Cl aqueous solution (30 mL) was added and the mixture was extracted 3 
times with ether. Combined organic layers were dried with MgSO4 and purified by FC 
(AcOEt:Cyclohexane / 1:1) to recover 137 (774 mg, 84 %) as a yellow solid; mp = 100-
104 °C; IR (CH2Cl2): n = 2969, 2929, 1742, 1605, 1573, 1454, 1347, 1249, 1177, 1089, 
1049, 1006, 910 cm-1; 1H NMR (400 MHz, CDCl3): d = 6.83 (d, J = 6.8 Hz, 1H), 5.63-5.54 
(m, 1H), 5.08 (d, J = 6.8 Hz, 1H), 4.89-4.82 (m, 2H), 3.98 (d, J = 7.8 Hz, 1H), 3.91 (d, J = 
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7.8 Hz, 1H), 3.60 (s, 3H), 3.22-3.20 (m, 2H), 2.55-2.50 (m, 1H), 2.23 (dd, J = 19.4, 1.5 Hz, 
1H), 1.35 (s, 3H), 1.27 (s, 3H), 1.19 (s, 3H); 13C NMR (100 MHz, CDCl3): d = 216.6, 
162.1, 161.6, 138.0, 129.2, 116.5, 115.6, 93.7, 78.6, 67.2, 55.9, 51.4, 49.1, 41.1, 40.7, 28.6, 
28.1, 22.5.  
 
V. 4 - EXPERIMENTAL PART RELATED TO CHAPTER IV 
 
4,4-Dimethyl-2-[5-acetyl-4-methoxy-5-methyl-6-[1,3]-dithianyl-cyclohexa-1,3-diene]-
4,5-dihydro-oxazole (154) 
 
nBuLi (1.6M in hexanes, 0.6 mL, 0.97 mmol) was slowly added to a 
solution of dithiane (120 mg, 1 mmol) in THF (10 mL) at - 78 °C and 
stirred for 2 h at - 20 °C. Then the solvent was evaporated and toluene (2 
mL) was added. The mixture was cooled to - 78 °C and added via a 
cannula to a solution of complex 12 (170 mg, 0.5 mmol) at this 
temperature. The colour turned to yellow-orange solution. After stirring 
for 20 min, DMPU (1 mL) and MeI (155 mL, 2.5 mmol) were added, then the mixture was 
placed under a 2.5 bar atmosphere of CO and allowed to warm up for 16 h. The orange 
solution was then evaporated and THF (5 mL) was added. After cooling it to - 78 °C, 
NaOEt (2.56 M (freshly prepared by slowly addition of Na to EtOH), 292 mL, 0.75 mmol) 
was added and the mixture was stirred for 1 h before addition of MeI (93 mL, 1.5 mmol). 
The mixture was warmed up for 4 h and then the product 154 (110 mg, 58 %) was 
recovered by FC (AcOEt: cyclohexane / 3:7) as a yellow pale solid; IR (CH2Cl2): n = 2970, 
2935, 2900, 1699, 1654, 1608, 1571, 1462, 1380, 1354, 1275, 1254, 1200, 1073, 1043, 
1002, 968 cm-1; 1H NMR (400 MHz, C6D6): d = 7.10 (d, J  = 6.6 Hz, 1H), 4.75 (d, J = 6.6 
Hz, 1H), 4.50 (d, J =  4.3 Hz, 1H), 3.96 (d, J = 4.3 Hz, 1H), 3.81 (d, J = 7.8 Hz, 1H), 3.71 
(d, J = 7.8 Hz, 1H), 2.30 (s, 3H), 2.47 (s, 3H), 2.34 (m, 4H), 1.46 (m, 2H), 1.44 (s, 3H), 
1.33 (s, 3H), 1.23 (s, 3H); 13C NMR (100 MHz, C6D6): d = 207.4, 166.1, 162.3, 130.0, 
116.7, 94.3, 78.7, 67.7, 56.5, 54.9, 51.5, 49.7, 31.5, 31.3, 28.3, 28.2, 26.9, 25.6, 23.2; MS 
(m/z): 381 (7), 232 (6), 220 (38), 204 (5), 149 (13), 119 (100); HRMS (EI) on (M+) for 
C19H27NO3S2 requires: 381.1432, found: 381.1416. 
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4,4-Dimethyl-2-[5-allyl-4-methoxy-5-methyl-6-[1,3]-dithianyl-cyclohexa-1,3-diene]-
4,5-dihydro-oxazole (164) 
  
nBuLi (1.6M in hexanes, 0.6 mL, 0.97 mmol) was slowly added to a 
solution of dithiane (170 mg, 1 mmol) in THF (5 mL) at - 78 °C and 
stirred for 2 h at - 20 °C. THF was evaporated and toluene (2 mL) was 
added. The mixture was cooled to - 78 °C and was added via a cannula to 
a solution of complex 12 (177 mg, 0.5 mmol) in toluene (4 mL) at this 
temperature and the colour of the solution turned yellow-orange. After 
stirring for 1 h the mixture was warmed to - 40 °C and nBu4NBr (322 mg, 1 mmol) was 
added. It was stirred for 1 h, and allylbromide (217 mL, 2.5 mmol) was added at -78 °C, 
then the solution was warmed up for 16 h. The brown solution was then evaporated and the 
product 164 (74 mg, 40 %) was recovered by FC (AcOEt:cyclohexane / 3:7) as a yellow 
oil; mp = 121-123 °C; IR (CH2Cl2): n = 2970, 2903, 1655, 1608, 1575, 1385, 1274, 1201, 
1175, 1031, 997; 1H NMR (500 MHz, C6D6): d = 7.12 (d, J = 6.5 Hz, 1H), 5.92-5.86 (m, 
1H), 5.14-5.05 (m, 2H), 4.72 (d, J = 6.5 Hz, 1H), 4.43 (d, J = 7.4 Hz, 1H), 3.79 (d, J = 7.4 
Hz, 1H), 3.74 (d, J = 7.9 Hz, 1H), 3.68 (d, J = 7.9 Hz, 1H), 3.30-3.27 (m, 1H), 3.07 (s, 
3H), 2.91-2.84 (m, 1H), 2.52-2.48 (m, 1H), 2.44-2.41 (m, 1H), 2.33-2.23 (m, 3H), 1.58-
1.54 (m, 2H), 1.22 (s, 6H); 13C NMR (125 MHz, C6D6): d = 165.9, 162.9, 135.8, 130.4, 
117.9, 117.4, 92.6, 78.6, 67.6, 54.8, 49.0, 41.7, 41.1, 36.4, 30.1, 28.5, 28.4, 26.0; MS 
(m/z): 365 (11), 334 (3), 293 (4), 247 (16), 246 (90), 245 (14), 232 (4), 231 (4), 230 (21). 
 
(+)-1-[(1S,6S)-6-[1,3]Dithian-2-yl-5-((R)-4-isopropyl-4,5-dihydro-oxazol-2-yl)-2-
methoxy-1-methyl-cyclohexa-2,4-dienyl]-ethanone (167) 
 
Complex 60 (192 mg, 0.5 mmol) was treated following the procedure 
described for the preparation of 154. The residue was purified by FC 
(AcOEt:Cyclohexane / 3:7) and the product 167 (70 mg, 35 %, d.e. = 78 
%) was recovered as a yellow oil; [a] D20  = + 71.1 (c = 0.35, CHCl3); IR 
(CH2Cl2): n = 23055, 2962, 2902, 1699, 1654, 1609, 1571, 1355, 1254, 
1074, 1049, 1002, 970 cm-1; 1H NMR (500 MHz, C6D6): d = 7.14 (d, J = 
6.6 Hz, 1H), 4.76 (d, J = 6.6 Hz, 1H), 4.59 (d, J = 4.1 Hz, 1H), 4.04-3.97 (m, 2H) 3.95 (d, J 
= 4.1 Hz, 1H), 3.76 (t, J = 6.9 Hz, 1H), 3.00 (s, 3H), 2.50 (s, 3H), 2.38-2.33 (m, 4H), 1.73-
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1.68 (m, 1H), 1.56-1.48 (m, 2H), 1.52 (s, 3H), 0.95 (d, J = 6.8 Hz, 3H), 0.79 (d, J = 6.8 Hz, 
3H); 13C NMR (125 MHz, C6D6): d = 207.7, 166.4, 163.9, 130.5, 116.5, 94.6, 73.0, 69.9, 
56.6, 55.1, 50.3, 33.0, 31.9, 31.5, 27.2, 25.8, 23.2, 19.1, 18.4; MS (m/z): 395 (7), 234 (35), 
232 (18), 190 (16), 149 (17), 135 (10), 121 (13), 119 (100). 
 
(+)-1-((1S,6S)-6-[1,3]Dithian-2-yl-2-methoxy-5-{[(S)-2-methoxymethyl-
cyclopentylimino]-methyl}-1-methyl-cyclohexa-2,4-dienyl)-ethanone (168) 
 
Complex 67 (192 mg, 0.5 mmol) was treated following the procedure 
described for the preparation of 154. The residue was purified by FC  
(AcOEt:Cyclohexane / 3:7) and the product 168 (80 mg, 38 %, d.e.> 
95 %) was recovered as a yellow oil; [a] D20  = + 132.9 (c = 0.85, 
CHCl3); IR (CH2Cl2): n = 2976, 2937, 2899, 2836, 1698, 1635, 1569, 
1461, 1353, 1244, 1120, 1069, 1010 cm-1; 1H NMR (400 MHz, C6D6): 
d = 7.10 (s, 1H), 6.08 (d, J = 6.8 Hz, 1H), 4.97 (d, J = 6.8 Hz, 1H), 4.66 (d, J = 3.6 Hz, 
1H), 3.95 (d, J = 3.6 Hz, 1H), 3.90-3.88 (m, 1H), 3.73-3.67 (m, 3H), 3.28 (s, 3H), 3.14 (s, 
3H), 3.13-3.08 (m, 1H), 2.61 (s, 3H), 2.46-2.40 (m, 4H), 1.77-1.70 (m, 5H), 1.52 (s, 3H) 
1.45-1.40 (m, 1H); 13C NMR (125 MHz, C6D6): d = 208.7, 162.5, 134.3, 127.3, 123.3, 
95.7, 75.3, 63.3, 59.0, 56.6, 54.9, 52.5, 49.5, 48.4, 32.8, 32.0, 31.5, 27.3, 26.3, 23.3, 22.4; 
MS (m/z): 424 (1), 263 (10), 248 (13), 245 (39), 203 (94), 160 (25), 149 (29), 119 (100). 
 
2-{5-[1-(tert-Butyl-dimethyl-silanyloxy)-vinyl]-6-[1,3]dithian-2-yl-4-methoxy-5-
methyl-cyclohexa-1,3-dienyl}-4,4-dimethyl-4,5-dihydro-oxazole (169) 
 
Triethylamine (80 mL, 0.58 mmol) was added to a solution of the 
methyl ketone 154 (148 mg, 0.39 mmol) in CH2Cl2 (5mL) and then 
TBDMSOTf (110 mL, 0.47 mmol) was added. The reaction was 
followed by TLC and was stirred for 5 h at rt. The brown gold mixture 
was then diluted with CH2Cl2 and washed with NaHCO3. The mixture 
was extracted twice with CH2Cl2 and the combined organic layers 
were dried with MgSO4. Purification by FC (AcOEt:cyclohexane / 3:7) gave the silyl enol 
169 (123 mg, 64 %) as a yellow solid; IR (CH2Cl2): n = 3637, 2959, 2932, 2899, 2859, 
1653, 1608, 1570, 1463, 1363, 1269, 1202, 1126, 1064, 1005, 836 cm-1; 1H NMR (400 
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MHz, C6D6): d = 7.22 (d, J = 7.1 Hz, 1H), 4.90 (m, 2H), 4.82 (d, J = 6.8 Hz, 1H), 4.58 (d, J 
= 1.3 Hz, 1H), 3.83 (m, 2H), 3.72 (d, J = 7.6 Hz, 1H), 3.08 (s, 3H), 2.85-2.20 (m, 4H), 1.65 
(m, 1H), 1.54 (s, 3H),1.50 (m, 1H) 1.38 (s, 3H), 1.22 (s, 3H), 1.02 (s, 9H), 0.30 (s, 3H), 
0.22 (s, 3H); 13C NMR (125 MHz, C6D6): d = 167.2, 162.8, 156.8, 130.4, 128.5, 116.0, 
94.8, 93.6, 78.8, 68.0, 55.0, 54.3, 51.0, 49.0, 33.0, 31.6, 30.5, 28.6, 26.5, 26.2, 23.9, 18.5, -
4.4, -4.8; MS (m/z): 495 (5), 376 (13), 243 (4), 232 (4), 220 (100), 205 (5), 149 (16), 119 
(29), 115 (14), 73 (70), 59 (7);  HRMS (EI) on (M+) for C25H41NO3SiS2 requires: 
495.2297, found: 495.2307. 
  
2-[3-(tert-Butyl-dimethyl-silanyloxy)-7-methoxy-7a-methyl-1-methylene-1,3,3a,7a-
tetrahydro-isobenzofuran-4-yl]-4,4-dimethyl-4,5-dihydro-oxazole (172) 
 
A solution of the methyl ketone 154 (88 mg, 0.23 mmol) in 
acetone:H2O (9:1) (1 mL) was added via a cannula to a solution of N-
chlorosuccinimide (67 mg, 0.50 mmol) and NaHCO3 in acetone:H2O 
(9:1) (2 mL) at 0 °C, stirred for 5 min and then a saturated Na2S2O3 
aqueous solution was added. the mixture was extracted with AcOEt 
and dried with MgSO4. The solvents were evaporated and the residue 
was dissolved in CH2Cl2 (3 mL). NEt3 (0.047mL, 0.46 mmol) and TBDMSOTf (0.152 mL, 
0.58 mmol) were added. The mixture was stirred for 2 h, then extracted with CH2Cl2, and 
dried with MgSO4. Product 172 (21 mg, 22 %) was recovered after FC with 
(AcOEt:cyclohexane / 1:9) as a yellow oil; 1H NMR (300 MHz, C6D6): d = 7.12 (d, J  = 
7.0 Hz, 1H), 6.13 (d, J = 3.8 Hz, 1H), 4.79 (d, J = 1.1 Hz, 1H), 4.77 (d, J = 7.0 Hz, 1H), 
4.40 (d, J = 1.1 Hz, 1H), 3.77 (d, J = 7.9 Hz, 1H), 3.76 (d, J = 7.9 Hz, 1H), 3.73 (d, J = 3.8 
Hz, 1H), 3.06 (s, 3H), 1.57 (s, 3H), 1.29 (s, 3H), 1.26 (s, 3H), 1.17 (s, 9H), 0.38 (s, 3H), 
0.36 (s, 3H); 13C NMR (125 MHz, C6D6): d = 167.3, 163.9, 161.8, 129.7, 115.3, 104.7, 
92.0, 82.9, 78.4, 67.9, 55.8, 55.0, 48.7, 28.7, 26.0, 23.9, - 4.2, - 4.7; MS (m/z): 405 (41), 
390 (17), 362 (11), 348 (63), 272 (87), 250 (77), 246 (32), 230 (50), 200 (28), 149 (86), 
133 (21), 73 (100); HRMS (EI) on (M+) for C22H35NO4Si requires: 405.2335, found: 
405.2349. 
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